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ABSTRACT 
A microarray was constructed and applied to transcriptional profiling and genetic 
variation studies of Mycoplasma hyopneumoniae. The genome sequence enabled the 
construction of the microarray to allow a global approach to understanding fundamental 
processes in M. hyopneumoniae. These studies focused on whether M. hyopneumoniae 
regulates its genes under different environmental conditions and if genetic changes can be 
correlated with virulence. The microarray consisted of 632 open reading frames represented 
by polymerase chain reaction products and were used in a two-color experimental design. 
Data were analyzed using a mixed linear statistical model. Unique features implemented in 
these studies included the printing of two complete arrays per substrate, reducing the slide to 
slide variation; the scanning of each dye channel of each array at different laser power 
settings to increase the dynamic range of expression measurement; and the use of a unique 
set of hexamer primers to generate fluorescently labeled targets for microarray analysis. The 
first series of studies focused on transcriptional profiling during heat shock and iron 
deprivation, two environmental changes that M. hyopneumoniae encounters on the 
respiratory epithelial surface during disease. Key genes responsive to these stresses were 
identified, and interestingly, fifty-three were regulated in common to the two conditions at 
p<0.05. Since adherence to swine cilia is a prerequisite for colonization and disease, the next 
series of studies involved the comparison of an adherent, pathogenic strain 232 to a 
nonpathogenic, nonadherent type strain J. In conjunction with this study, two strain 232 
adherence variants, one high and one low, were also compared. Thirty genes were identified 
that differed between the strains 232 and J. Nineteen genes were up-regulated in the high 
adherent variant including the heat shock protein DnaJ, and fifteen genes were up-regulated 
in the low adherent strain. In a comparison of eight field isolates to strain 232, two were 
indistinguishable from strain 232 and the others varied in an many as twenty-five loci and as 
few as one. In summary, these studies attempt to unravel some of the underlying mechanisms 
and pathways M. hyopneumoniae uses to infect the host and cause disease. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
Estimated annual economic loss to the US swine industry is greater than $200 million due 
to Mycoplasma hyopneumoniae, the etiological agent of swine pneumonia. Adherence of the 
organism to the cilia of the swine lung is necessary to cause disease, however, current 
research has been unable to determine the pathogenic mechanisms by which M. 
hyopneumoniae causes disease. Research has been hindered due to the fastidious growth of 
M. hyopneumoniae and the inability to study the organism using traditional molecular 
techniques. This challenge can be overcome to some extent using microarray technology, 
which gives researchers a tool to examine a genome and its transcriptional regulation on a 
global basis. The work outlined in the studies below will increase the understanding of the 
mechanisms by which M. hyopneumoniae regulates gene function in response to 
environmental conditions. Additionally, studies examining transcriptional variation among 
adherence variants will give insight into mechanisms of pathogenesis. Finally, genomic 
evaluation can provide insight into the conserved genome of the organism and genetic 
variation that may occur in the field. These studies will lay the foundation for future 
experiments that will continue to aid in our understanding of pathogenesis and the 
development of novel preventive and therapeutic strategies. 
Dissertation Organization 
This dissertation is organized into several chapters, five of which will be submitted for 
publication and includes a final summary and direction of future studies. Chapter one is the 
introduction containing the background information regarding the disease, application of 
novel technology and justification of the research. Chapters 2 and 3 describe environmental 
studies examining the response of M. hyopneumoniae to heat shock and low-iron conditions. 
Chapter 4 examines transcriptional differences between the pathogenic strain 232 and the 
non-pathogenic strain J. Transcriptional differences between strain 232 and the high-adherent 
and low-adherent clone variants are discussed in Chapter 5. Evaluation of genetic variation 
found among field isolates and strain 232 are the focus of Chapter 6. General conclusions and 
ideas for future research comprises Chapter 7, and five appendices complete the dissertation. 
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Literature Review 
Mycoplasmas 
Mycoplasmas infect a wide range of hosts, including humans, mammals, fish, reptiles, 
arthropods and plants (71). They are also often found as common contaminants of tissue 
culture cell lines. Mycoplasmas are members of the class Mollicutes, which includes eight 
genera including the pathogenic Mycoplasma, Ureaplasma and Spiroplasma (41, 99). There 
are more than 200 species that have been identified with additional species being reported 
every year (http://www.the-icsp.org/subcoms/mollicutes.htm). Many of these newly 
identified species are pathogens responsible for what are thought to be newly emerging 
diseases in animals and plants (10-12, 61). Some genera, i.e., Acholeplasma, are considered 
saprophytes, but even that has come into question (99). Mycoplasmas inhabit a wide variety 
of niches, but for the most part, they are host-specific. 
Unique features delineate the class Mollicutes. The defining characteristic of this class is 
the lack of cell walls, unique among the eubacteria (98). This deficiency is thought to be the 
result of degenerative evolution resulting in a significant reduction in genome size (70). In 
fact, with a diameter of 0.3-1 and genomes ranging from 580 to 2220 kilobase pairs, 
mycoplasmas are among the smallest self-replicating organisms known (97). Some of the 
ramifications of genome reduction have been the loss of the metabolic pathways including 
those involved in amino acid, purine and pyrimidine, and phospholipid synthesis. Also, the 
loss of the biosynthetic capacity to generate a cell wall has caused the mycoplasmas to be 
highly dependent on an osmotically stable environment, such as mucosal linings of their 
hosts or the internal regions of plants. Several species have been able, however, to retain a 
semblance of stable morphology indicating the presence of proteins that serve as 
cytoskeletal-like structures (99). Although not classified as such, mycoplasmas actually 
persist as obligate parasites obtaining their biosynthetic precursors from their hosts. For 
animal pathogens, these precursors are obtained from the mucosal surfaces upon which they 
reside, and from mucosal secretions and/or cell surfaces to which they are attached. For the 
sake of clarity, the generic term mycoplasmas will be used in reference to the members of the 
animal pathogenic genus Mycoplasma throughout the remainder of this dissertation. 
The need for the acquisition of macromolecular precursors limits the types of 
environments in which mycoplasmas can prosper and grow. While they may survive for short 
periods of time on external surfaces, they can only grow and survive long term on host 
tissues. There they reside on mucosal surfaces, occasionally becoming septicemic and 
moving to other tissues (74, 114). Required nutrients are available either on the cell surfaces 
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to which they are attached or in body secretions. They are also thought to reside 
intracellularly on occasion (5, 104), although that has not been rigorously tested; studies have 
only been reported using tissue culture systems (5, 104, 136). The exceptions are the newly 
reclassified hemotrophic mycoplasmas(73). With this in mind, mycoplasmas must have 
mechanisms for the acquisition of amino acids, purines and pyrimidines, phospholipids and 
cholesterol, the building blocks of macromolecules and membranes. Few studies have 
focused on surface activities with the potential to participate in these acquisition mechanisms 
(54, 76, 77), and it is thought these systems may play important roles in pathogenesis. 
Whether mycoplasmas reside on cell surfaces or are suspended in complex growth media, 
they must assimilate phospholipids and cholesterol from their environment and use those 
materials (sometimes with little modification) to produce their own membrane. This feature 
of mycoplasmas led to their use as models of membrane structure, and these models were 
instrumental in development of the mosiac model of membrane structure (96). 
The small size of the mycoplasma genome has also led researchers to use them as models 
for a minimal genome (40, 51, 52). These studies will help to define the minimal 
requirements of life (52) and possibly lead to the construction of the first completely 
synthetic cell (J. I. Glass, N. Alperovich, N. Assad-Garcia, H. Baden-Tillson, C. A. 
Hutchison III, H. Khouri, M. Lewis, F. C. Minion, W. C. Nierman, W. C. Nelson, C. 
Pfannkoch, K. Remington, V. Subba, S. Yooseph, H. O. Smith, and J. C. Venter. Abstr. 14th 
Congr. Int. Org. Mycoplasmol. abstr. 49, 2002). 
The mycoplasma genome is not only small in size, but it also has unusual features. 
Mycoplasmas contain a relatively low G+C content of 27-32 mol%. The one outlier is the 
human pathogen Mycoplasma pneumoniae with a 40 mol% G+C content (46). The low G+C 
content of the genome is thought to result from a strong AT-biased mutation pressure that has 
operated during the evolution of mycoplasmas (83). The genetic systems of mycoplasmas 
have unusual features as well. For example, they utilize UGA as a tryptophan codon rather 
than as a stop codon (83, 139). They also contain a minimal set of tRNAs (approximately 20 
of the 62 potential), but yet can translate all available codons (83). How gene expression is 
controlled has yet to be defined in mycoplasmas. With the advent of high-throughput 
sequencing, many of the mycoplasmas have been among the first genomes sequenced. To 
date, ten mycoplasma genome sequences have been completed [M. pneumoniae (46), 
Mycoplasma genitalium (40), Mycoplasma pulmonis (18), Ureaplasma urealyticum (42), 
Mycoplasma gallisepticum (91), Mycoplasma penetrans (105), Mycoplasma mycoides subsp. 
mycoides SC (133), Phytoplasma asteris Onion Yellows strain (88), Mycoplasma mobile 
(53), and M. hyopneumoniae (79)] and more are under analysis (Mycoplasma alligatoris, 
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Mesoplasma florum, Mycoplasma arthritidis, Mycoplasma bovis, Mycoplasma capricolum 
subsp. capricolum, Mycoplasma fermentans, Mycoplasma haemofelis, Spiroplasma kunkelii, 
Spiroplasma citri, Mycoplasma agalactiae). These sequencing projects promise to accelerate 
our understanding of the molecular basis of pathogenesis. 
Much research has gone into the study of mycoplasmas associated with human disease. 
Two such organisms are M. pneumoniae and M. genitalium, which have been well studied 
and characterized. The sequencing of M. pneumoniae and M. genitalium has enhanced the 
molecular characterization of many of the surface adhesions, cytoskeleton proteins and their 
accessory proteins, allowing for greater understanding of their pathogenic mechanisms. 
Comparative studies also indicate their parasitic lifestyle makes them highly dependent on 
well-defined transport systems, delivering the necessary exogenous precursors and nutrients 
to the cells (99). 
Mycoplasma hyopneumoniae 
Disease characteristics 
Disease caused by M. hyopneumoniae, the causative agent of enzootic pneumonia, is 
characterized by low mortality but high morbidity of swine. Mycoplasma hyopneumoniae 
attaches to the cilia of the respiratory epithelium of the airways. The disease is characterized 
by a chronic, dry, non-productive cough 10-14 days post infection usually without any signs 
of lethargy, anorexia or fever (126). Lung lesions observed in pigs infected with 
M. hyopneumoniae appear as tan to dark purplish areas of lung consolidation occurring 
primarily in the cranioventral areas of the lung and are slow to develop, taking 2 to 3 weeks 
to appear (126). 
The economic losses associated with M. hyopneumoniae cost producers over $200 
million annually. The losses are often associated with decreased feed efficiency, resulting in 
longer times to attain market weight. Mycoplasma hyopneumoniae has also been identified as 
a component of the porcine respiratory disease complex (PRDC). The damaging effects to 
lung tissue and a heightened immune response during co-infection with porcine reproductive 
and respiratory syndrome virus are exacerbated by infection with M. hyopneumoniae (125). 
Although commercially available vaccines decrease the number of organisms present, they 
do not completely prevent colonization of the lungs and upper respiratory tract. Prophylactic 
use of antibiotics does not prevent infection by M. hyopneumoniae. More effective vaccines 
and prevention practices are needed to limit the spread of M. hyopneumoniae. 
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Several obstacles prevent traditional molecular techniques from being used to study M 
hyopneumoniae. It is difficult to culture due to its fastidious growth and nutritional 
requirements that necessitate complex culture media. In addition, transformation studies are 
problematic because M. hyopneumoniae is difficult to grow on agar surfaces preventing 
isolation of single mutants or colonies. Mycoplasma hyopneumoniae like all mycoplasmas 
uses the stop codon UGA to code for tryptophan, making gene cloning and protein 
expression studies a challenge. With the completed genome sequencing of M. 
hyopneumoniae, annotated data suggests many gene products may contribute to M. 
hyopneumoniae pathogenesis (80). 
Detection 
Much research has focused on detection methods for M. hyopneumoniae to use in 
diagnostic applications. Culturing M. hyopneumoniae from clinical samples is a challenge 
due to competition of multiple bacteria recovered from lung samples. Even when antibiotics 
are used to prevent growth of walled bacteria, Mycoplasma hyorhinis, a common pig 
colonizer, outgrows M. hyopneumoniae cultures preventing its isolation and detection. 
Serological detection of the organism is often unreliable due to the cross-reactions with other 
mycoplasmas (7). Also, the current enzyme linked immunosorbent assays (ELISA) have 
inherent problems. There is no correlation between antibody levels and protection. Also, a 
study by Erlandson et al. gave false negative rates for three commercially available ELISA 
kits in the range of 34.1% to 61.0% (K. Erlandson, B. Thacker, M. Wegner, R. Evans, and E. 
Thacker. Abstr. 17th Congr. Int. Pig Vet. Soc., abstr. 249, 2002). If a vaccine is given, those 
animals will test positive as a result of the antibodies they produce. There are no "marked" 
vaccines that can differentiate between vaccinated and non-vaccinated individuals. 
Detectable levels of antibodies in infected pigs can vary depending on the time when the 
animal sero-converts. Challenged pigs have shown variation in sero-conversion from two to 
four weeks post infection or longer (125). This variability, as well as a lack of agreement for 
consistent cut-off thresholds, is indicative of the need for better diagnostic tests. Despite 
these limitations, the ELISA continues to be the assay of choice for most diagnostic 
laboratories around the world. 
The use of polymerase-chain reaction (PCR) to detect organisms has greatly improved 
sensitivity and decreased diagnostic times (4, 65). Specific primers are designed flanking the 
target of interest, so some knowledge of the DNA sequence is required to design the 
oligonucleotide primers. The DNA is amplified exponentially using a thermal stabile 
polymerase, which allows for repeated rounds of denaturation, annealing and elongation 
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without adding additional polymerase after each round. Thermal cyclers allow consistent 
temperature and for streamlined automation. The amplified product can then be sized, 
sequenced, used for genotyping, and used as probes in hybridization experiments. The 
sensitivity of PCR makes it an appealing candidate for diagnostic tests, but it can be 
hampered by contamination and poor choice of sampling site. Since negative and positive 
controls are run in all evaluations, the false positive rate is low. 
Several research groups have identified individual genes with unique sequences for 
specific identification of M. hyopneumoniae by PCR (16, 65, 128), and the resulting tests 
range in sensitivity and specificity (65). During assay development, samples were collected 
from experimentally infected pigs, field isolates or from diagnostic labs. Sample sites are 
critical for the proper performance of the PCR test, however. Results can vary depending on 
how samples are collected, the environment, the disease state of the animal and the types of 
samples examined. A recent study by Kurth et al. showed that nasal swabs were not reliable 
for detecting M. hyopneumoniae infections, but bronchial alveolar lavage samples proved 
100% accurate in detecting infected pigs using a nested PCR assay (65). At the point of 
necropsy, gross lesion characteristics and immuno-histochemistry tests can be used to 
identify diseased animals, but those with a low level of infection can be problematic. Thus, 
the inclusion of BAL samples in the diagnostic repertoire will improve the detection rate for 
M. hyopneumoniae-infected pigs. 
The detection systems that have been developed in the last several years are capable of 
identifying infected pigs, but most pigs throughout the world are considered to be M. 
hyopneumoniae positive. Thus, improved diagnostics has not led to decreased incidence of 
pneumonia nor improved herd health. The issue is no longer one of detection, but of 
protection. 
Vaccines 
Mycoplasma hyopneumoniae vaccines offer some protection against disease but they fail 
to eliminate the organism. The resulting low level of colonization has important ramifications 
for total herd health, particularly in relation to other infectious agents (87, 125, 126). 
Immunizing with whole cell lysates has been shown to provide protection against disease 
(30, 31, 69, 102). However, the treatment of these cells and the adjuvants used in the vaccine 
preparation are important in providing protection. For instance, immunization with cells that 
had undergone a freeze-thaw preparation did not provide sufficient immunity and in some 
cases increased lesion size (101). Subunit vaccines have not proven more effective against 
challenge than whole cell bacterins (38, 60), but given the complexity of the membrane 
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surface and the number of proteins exposed to the host immune system, perhaps the question 
that needs answering is which proteins are protective and how do you present them to the 
host in the most effective manner? 
Studies have been conducted on the detection of unique proteins and individual genes for 
developing more efficacious vaccines. Surface proteins are often chosen as potential vaccine 
targets because of their exposure to antibodies and because of their potential roles in 
virulence. Heat shock proteins have also been investigated for their immunogenicity. Several 
of these proteins have been identified by researchers as potential immune modulators in the 
hopes of developing a more protective vaccine. Species-specific monoclonal antibodies have 
been isolated for proteins P46 and P65 (19). P42 is another candidate protein used as a 
potential DNA vaccine. Studies have shown that antibodies to P42 can block growth of M 
hyopneumoniae (22). 
A variety of approaches have been used to enhance vaccine effectiveness including oral 
immunization with a recombinant Salmonella (39) or Erysipelothrix vaccine (113), DNA 
(molecular) vaccines (23), microencapsulation (67, 68), and fusions of M. hyopneumoniae 
proteins with immune stimulating sequences (20). Single protein vaccines, however, rarely 
protect against bacterial infections unless a toxin is involved. Additionally, antibody 
responses to M. hyopneumoniae in infected swine are not indicative of protection (127). 
One approach to vaccine development, expression library immunization (ELI), can 
provide a means of identifying sets of immunogenic proteins that can provide protection. 
Following construction of a random chromosomal or cDNA library, a preselection of clones 
with fragments identified by a poly-His tag reduces the total number of cDNA clones used 
for immunization, and thus the total number of animals needed to evaluate for vaccine 
efficacy (81). Several problems arise when screening mycoplasma libraries, however. 
Mycoplasma genes contain UGA codons that code for tryptophan; in other organisms it is a 
stop codon. This unusual codon usage prevents identification of many potentially protective 
antigens by routine genetic screens because of the failure to properly express in heterologous 
genetic systems. Also, the antibody screen requires only that a small peptide be produced as a 
fusion to the poly-histidine sequence. It may not represent an in-frame sequence or one in the 
proper orientation. Nevertheless, this technique in combination with other technologies will 
probably play a role in identifying protective antigens of M. hyopneumoniae. 
Virulence mechanisms 
Little has been done to elucidate the mechanisms of disease in M. hyopneumoniae. The 
most significant progress has been in the area of adherence to host tissues. Mycoplasma 
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hyopneumoniae binds exclusively to the cilia of the epithelial cells lining the respiratory tract 
of pigs (122). Adherence to respiratory epithelium is required for infection and disease (26, 
27, 144). Studies in the mid 1990s by Richard Ross and colleagues led to the identification 
and analysis of the cilium adhesin (141-143). Development of a cilium-binding assay led to 
the identification of monoclonal antibodies (Mabs) that blocked adherence of M. 
hyopneumoniae (143), and immunoblot analysis using those Mabs then led to the 
identification of the major adhesin, P97 (142). The Mabs were pivotal in cloning the gene for 
P97 (48) and the surrounding chromosomal region (50). Further studies involved the cloning 
and expression of functional P97, the first time that a mycoplasma adhesin had been cloned 
and expressed in a heterologous host in a functional form (48). The P97 protein contains two 
repeat regions near the carboxy terminus, R1 and R2. Additional analyses proved 
unequivocally that the R1 region of P97 was responsible for cilium binding and was the 
recognition site for adherence-blocking Mabs (49, 75). The function of the R2 region remains 
unknown. 
The P97 protein has several unusual features. Unlike the attachment proteins found in M. 
pneumonia and other mycoplasmas, the M. hyopneumoniae adhesin protein P97 does not 
directly attach to the mycoplasmal membrane (142). In all immunogold electron micrographs 
developed using the adherence-blocking Mabs, P97 appears to be attached to the membrane 
surface by thin fibers (29). This is in stark contrast to similar studies with PI, the adhesin of 
M. pneumoniae (43). The P97 protein is also posttranslationally cleaved, an unusual and 
provocative observation for mycoplasmas (29). None of the cleavage fragments have motifs 
suitable for interacting with membrane surfaces, suggesting that the P97 fragments must be 
interacting with other proteins to maintain their association with the mycoplasmal cell 
surface (29). More recent unpublished studies have shown that mycoplasma proteins and 
proteolytic fragments can bind host extracellular matrix proteins (T. Burnett, K. Dinkla, M. 
Rohde, G. S. Chhatwal, S. Cordwell, S. Geary, F. C. Minion, M. Walker, and S. Djordjevic. 
Abstr. 15th Congr. Int. Org. Mycoplasmol. abstr. 27, 2004; J. Wilton, K. K Stewart, F. C. 
Minion, P. Young, A. Collins, M. F. Walker, and S. P. Djordjevic. Abstr. 15th Congr. Int. 
Org. Mycoplasmol. abstr. 257, 2004) suggesting that these interactions serve an important 
role in pathogenesis. Finally, the recent completion of the M. hyopneumoniae genome 
sequence (80) revealed several paralogs of P97 lacking the R1 region suggesting that other 
regions of P97 have been duplicated. These paralogs are unusual in that they are gene fusions 
with non-homologous sequences and have been maintained within the genome suggesting 
that these gene sequences may be important to survival of the organism. 
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The interactions of M. hyopneumoniae with respiratory epithelium results in loss of cilia 
from the trachea, bronchi and bronchioles (72). Similar effects are seen in tracheal ring 
cultures (27). The mechanism by which M. hyopneumoniae can cause ciliostasis and cell 
death is unknown, but there is evidence that calcium release is involved (28, 92). Interesting, 
only strains that could bind cilia could induce calcium rises within the cell suggesting that the 
phenomenon is associated with a protein on the mycoplasma surface or associated with the 
cell (92). 
Microarrays 
History 
All groundwork for microarrays began in the 1960's with the fixation of DNA to 
nitrocellulose filters followed by detection with radiolabeled probes. In 1975, Southern 
expanded the technology to include separation of specific fragments prior to fixation to filters 
(119). In these experiments, the unknown nucleic acid sequences were transferred to 
membranes and the known labeled sequence or probe was allowed to interact. By doing so, 
Southern was able to detect specific sequences in complex populations of DNA digested with 
restriction enzymes. The technology is based upon the ability of single stranded DNA to 
hybridize to regions of homology forming stable hydrogen-bonded double-stranded 
molecules. Microarrays are based upon the same technology, but only in a much smaller 
footprint and in an opposite format. The known sequences are deposited on a solid substrate 
and the unknown nucleic acids (i.e., mRNAs, cDNAs) are labeled and interacted with the 
bound sequences. In contrast to Southern technology, however, microarrays offer a massively 
parallel gene expression and gene discovery approach to complex biological problems. One 
experiment can provide information on thousands of genes simultaneously. When cDNAs are 
used as targets, the level of signal intensity can be directly correlated with the steady state 
levels of mRNAs in the experimental system. Alternatively, DNA has been used to 
interrogate microarrays to identify non-homologous sequences. In these cases, fluorescence 
differences indicate sequence variation (13). The technology has been incorporated into the 
study and research of all types of organisms including viruses, bacteria, yeast, plants, animals 
and humans. 
The use of microarrays in molecular research is relatively new, being first described by P. 
Ekins and colleagues in the late 1980s (35). The principles on which microarrays are based 
have as their foundation in ligand assays relying on the binding of target molecules to a 
specific recognition reagent (37). The concept of miniaturized, multianalyte "microspot" 
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assays was first described by Ekins and coworkers (36), but it was not until 1995 when 
experiments using multiple genes in a miniature format was first reported in a study of 1,000 
genes from Arabidopsis (108). The first genome-wide array was reported shortly after in 
1997 on yeast (66). The pace of reports using microarrays has been accelerating over the past 
decade with over 3,300 articles that have used the Affymetrix platform for transcriptional 
analysis. Affymetrix has been producing commercially available microarrays called 
GeneChips® since 1994 (www. affymetrix. co m). Their technology revolves around the use of 
short oligonucleotides bound to glass slides. The oligonucleotides are produced in situ on 
glass substrates using photolithography as opposed to spotting presynthesized 
oligonucleotides using a pin based or ink jet style robot. The use of short oligonucleotides in 
microarrays presents some specific problems in terms of gene coverage and cross reactivity 
between genes, but computer algorithms have been developed to account for these adverse 
reactions. 
Construction of microarrays requires genome or cDNA sequence information. Early 
microarrays were based on cDNA sequences, but 251 genomes have been completely 
sequenced and another 1,087 are in the process (www.genomesonline.org). With the advent 
of whole genome sequencing, microarrays offer a low cost global approach to comparing 
within species variation, as well as between species variation either at the genomic or 
transcriptional level. 
Types of arrays 
Microarrays can be divided into two basic types: oligonucleotide or cDNA. 
Oligonucleotide arrays can be constructed by photolithography in situ or they can consist of 
spotted preformed oligonucleotides. The former is a high-density microarray that is 
constructed using a combination of photolithography and combinatorial chemistry; tens of 
thousands of probes can be arranged on a single array (2, 85). Construction of such arrays 
begins with amine-modified glass substrates, which are further modified to contain the 
reactive group methynitropiperonyloxycarbonyl (MeNPOC)(106). This group is stable to a 
wide variety of chemical reagents, but it can be activated with ultraviolet light and thus is a 
photo-protecting group. Ultraviolet light removes the MeNPOC modification and allows the 
deprotected region to react with reactive phosphoramidite modified deoxyribose. By 
repeating the deprotection and coupling steps, any sequence of bases can be constructed on 
the glass surface. Photo masks allow the deprotection to occur at specific regions on the 
microarray surface. These masks can be manufactured in any configuration to allow the 
synthesis of DNA base pair at any location in the array. Affymetrix is printing arrays with 
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over 250,000 features (spots). The advantage of such arrays is that only four nucleotide 
building blocks are needed to construct the array, significantly reducing storage needs. The 
main disadvantage is that only short (<30 nucleotides) oligonucleotides can be reliably 
constructed using this technology (106). Because the oligonucleotides are relatively short, 
each probe is designed with a perfect match and a mismatch sequence to allow for a semi­
quantitative means of measuring each target. Multiple probes are designed to represent 
different regions in the gene or target sequence that has been identified from expressed 
sequence tag (EST) libraries or DNA sequence data. Algorithms help to identify probes best 
suited to identify all possible transcripts (www.affVmetrix.com). 
Maskless array synthesizer technology is also now available. This technology uses 
mirrors to direct an ultraviolet light beam to any location on the array (115). These mirrors 
are linked to computer memory substrates so that deflection of the mirror can be achieved by 
accessing individual memory bits. Microarray densities of-390,000 features/cm2 have been 
achieved using this technology (115). 
Spotted arrays are DNA sequences that represent individual genes, printed on treated 
glass substrates. The treatments of these substrates are to enhance DNA binding and include 
poly-L-lysine coating and glass modifying treatments such as gamma aminopropylsilane, 
aldehyde and epoxy 3-glycidoxypropyltrimethoxysilane epoxide. Additional coatings are 
now available to support the construction of protein arrays or other modified macromolecules 
(avidin, streptavidin, hydrophobic polymers). The amine-modified substrates are best used 
with long oligonucleotides and PCR products while the epoxy-modified substrates can 
accomodate shorter (~30-mers) oligonucleotides in addition to cDNA and longer 
oligonucleotides. The aldehyde-modified substrates can also be used with proteins. Variation 
in glass quality and flatness, autofluorescence due to glass purity, coatings or treatments, 
efficiency of probe binding resulting from treatment type, uniformity of coating or treatment, 
etc., are only some of the many parameters that must be stringently controlled during the 
manufacturing process of the substrates. 
The spotted DNA, referred to as probes, represent known DNA sequences. The sequence 
information needed to produce the specific probes can be obtained from genome sequencing 
projects, expressed sequence tag projects, or could be individual cDNA clones spotted as 
plasmids. The latter could be sequenced later once specific targets have been identified 
through array analysis. These probes can be PCR amplified sequences from whole genomes 
generally ranging in size from 200-500 bp, cDNA libraries in plasmids or individual 
oligonucleotides approximately 50-70 bp in length. The spotting process requires motion-
control systems, robots, computer software, and deposition devices (106). Deposition can 
12 
occur using solid pins, split pins, capillary tubes, pin and ring devices, and non-contact 
piezoelectric technologies (ink jet technology). Each has its own advantages and 
disadvantages; split pins in a contact robot were used in the construction of the arrays used in 
these studies. The spotting process, like other aspects of microarray technology, has 
numerous elements that must be carefully controlled. Elements such as pin design, pin 
arrangement, pin cleaning efficiency, robot speed, pin contact speed, contact time, humidity 
during printing, etc. all impact the quality of the arrays (106). In addition, there is the issue of 
probe generation for microarray construction. This process must be carefully controlled as 
well, taking into consideration things like PCR primer design (for oligonucleotide arrays, 
oligonucleotide design is the single most important factor), PCR conditions, PCR product 
purification and purity, product concentration, and spotting buffer composition. Once 
spotted, arrays are allowed to dry in place, heated under vacuum to remove all water 
molecules and maximize chemical cross-linking, and then the arrays are cross-linked using 
ultraviolet light to maximize the retention of the probes to the glass surface during the 
subsequent hybridization and washing steps. A more detailed analysis of microarray 
construction can be obtained from Schena (106), which describes the dozens of variables 
involved in array construction from glass substrates and their modification, probe design, 
manufacturing technologies, detection systems, and informatics. 
The importance of the spotting buffer is often overlooked, but it is one of the most 
important factors in array construction because of the small volumes involved and the effect 
that evaporation plays in the spotting process. Evaporation occurs in two places, in the plate 
that contains the individual probes or oligonucleotides and in the pins used to transfer the 
probes from the plates to the glass surface. The former can result in increasing concentration 
of probe deposition during the spotting cycle and the latter can result in loss of probe at the 
end of the printing cycle. Too rapid evaporation of the substrate following spotting can also 
result in non-uniform spot morphology causing problems in data analysis. Spotting buffers 
that significantly reduce evaporation while allowing proper interaction of the probe with the 
modified glass surface are desired such as the spotting buffer produced by Coming (Coming, 
Inc.). Buffers like Tris-ethylenediamine tetraacetic acid are subject to rapid evaporation and 
can be problematic. Buffers that contain dimethyl sulfoxide (50%) are less subject to 
evaporation, but can cause DNA precipitation when plates containing the probes are frozen 
and thawed or if the concentration of dimethyl sulfoxide reaches 70% or more as a result of 
evaporation. These precipitates cannot be solubilized in an effective manner, and thus the 
probes are lost and must be produced again. 
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Once spotted, these microarrays can be hybridized with fluorescently labeled "targets", 
such as fragmented genomic DNA, cDNA, or RNA. They represent the unknown sequences 
or sequence quantities of your sample and are the elements of the study under investigation. 
Ideally, each labeled target is represented in the population in the same relative ratio or 
concentration as in the sample. A variety of labeling techniques are now available, which can 
be defined as direct and indirect labeling methods. For transcriptional studies, cDNA is 
generated from RNA preparations using reverse transcriptase and random primers, oligo-dT 
primers (to selectively identify eukaryotic mRNAs), or gene specific primers (used primarily 
in bacterial systems or where low numbers of targets are being interrogated by the array). 
The cDNA can then be labeled directly or indirectly. Direct labeling schemes incorporate the 
fluorescent tags directly into the probes during the reverse transcriptase or PCR reaction. 
This can occur either by using prelabeled primers or labeled nucleotides. The former results 
in probes of low signal strength and the latter are differentially incorporated into the product 
because of the large size differences of the fluorescent tags (i.e., Cy3 and Cy5) and their 
interference with the polymerization reaction. Consequently, dye "swap" experiments, where 
the labeled dyes are swapped with respect to the mRNA sources in two different 
experiments, are critical to minimize error associated with dye bias. Newer dyes such as the 
Alexa series from Molecular Probes are more similar in size and structure and present fewer 
problems during incorporation. These dyes also have higher fluorescence and photostability 
than the cyanine dye derivatives and are more suitable for microarray experiments where 
signal intensities are critical (see http://www.probes.invitrogen.com/handbook for more 
details on the structure and performance of the Alexa dyes). 
The indirect labeling schemes can be divided into two variations. Amine modified 
nucleotides can be incorporated into the DNA product and then reacted with fluorescent 
dyes. The amine modification has little effect on the polymerization reaction and such 
modified nucleotides are incorporated at high efficiency. The tag coupling reaction is simple 
and efficient resulting in strong signals. There is less need for dye swap experiments using 
this indirect method for labeling targets, but this should always be confirmed. In lieu of 
conjugating the fluorescent tag directly to the target, biotin can be incorporated during the 
target generation reaction and a streptavidin-phycoerythrin conjugate can be used to generate 
signals (107, 130). This approach is suitable only for one-color platforms such as Affymetrix. 
A second approach called Tyramide Signal Amplification (TSA™) utilizes biotin and 
dinitrophenol (DNP) or fluorescein epitopes as well as streptavidin and antibody conjugates 
linked to horseradish peroxidase (l)(Perkin Elmer, Boston, Mass.). The technology works on 
the principle of catalyzed reporter deposition where horseradish peroxidase oxidizes the 
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phenolic ring of fluorescently labeled tyramide conjugates to create reactive intermediates 
that subsequently bind to the biotin molecule. Two-color detection is accomplished using 
matched hapten/cyanine-tyramide pairs and sequential detection (130). This technology is 
reported to increase sensitivity 50-100 fold over other labeling methods. 
Bacterial systems present unique problems in fluorescent target generation because of the 
difficulty in identifying bacterial mRNA during the labeling reaction; they have no poly-
adenylated tails that can be used to purify or selectively label the mRNA molecules. Thus, 
either total RNA must be labeled (mRNA represents only -5% of the sample) reducing the 
signal intensities significantly on the arrays, the ribosomal RNAs must be removed from the 
total RNA preparations, or gene-specific primers must be used to generate the labeled targets. 
Procedures and reagents are now available for removing the ribosomal RNAs from many 
prokaryotic total RNA preparations, but they are not useful for mycoplasmas (Ambion, 
Austin, TX). 
The microarray hybridization parameters such as buffer composition, pH, salt 
concentrations, and temperature are generally determined empirically. This is important 
particularly for arrays that represent probes from organisms with skewed G+C mol% content 
such as streptococci (high G+C) and mycoplasmas (low G+C). Betaine, dimethyl sulfoxide 
or glycerol is sometimes added to enhance hybridization specificity and efficiency. 
Following target labeling and hybridization, the fluorescent intensities of each spot 
should accurately represent the concentration of each probe in the sample. The fluorescent 
intensities from each spot can then be analyzed for statistical significance of genomic or 
transcriptional differences. The spotted arrays are usually hybridized with two or more 
labeled targets so that control and experimental samples can be analyzed on the same spot 
and on the same slide thus allowing background subtraction and normalization to be 
performed for both control and experimental data from the same array. 
Informatics 
The development of microarray technology has brought needs for additional data 
management and analyses. Software development alone has been extensive and includes 
primer design, image acquisition and quantitation, database design and statistical analysis. 
Primer design software must produce primers that are unique and perform well depending on 
the type of array under construction. For long oligonucleotide-based arrays, the 
oligonucleotides must be specific and not allow cross-reactions with more than a single 
transcript. For the generation of PCR products for array construction, primers must bind to a 
single chromosomal region and must generate PCR products of a preselected size at high 
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efficiency. Thus, each primer must be tested against all other chromosomal sequences to 
ensure specificity. This problem increases exponentially as the number of open reading 
frames included in the array increases. Other problems may include limited sequence 
information, sources of samples and availability, and the restrictive costs of large 
experiments. Finally, the experimental design must take into account the variables within 
each of the subject areas above. 
Image analysis may seem straightforward, but several features of microarrays present 
problems. The processing of a scanned image requires three separate tasks: addressing or 
gridding, segmentation, and intensity extraction (106). Addressing is assigning the 
coordinates to each of the spots on the image. This is usually accomplished using a grid or 
spot array and displacing those to positions that overlap the spots on the image. Different 
programs vary in the way this is accomplished, but in all cases, small variations within the 
array symmetry require some manual input to the process. The goal here is to perform this 
aspect in an automated fashion with minimal human input to allow for high throughput. 
Segmentation classifies the pixels as foreground (within the spot) or background (outside 
the spot). This can be accomplished in various ways, including fixed circle, adaptive circle, 
adaptive shape, and by histogram. The fixed circle is usually the standard option in 
commercial software and is the easiest to implement. The adaptive circle method relies on 
individual sizing of the circles as a function of the spot size. This can be done automatically 
or it can be done manually (14). For large arrays, this can be time consuming. Adaptive 
shape segmentation might be the most accurate, but the method requires starting points from 
which the process grows. In most cases this can be accomplished from array images, but 
deviations in array structure do occur. This approach has the advantage of being able to cope 
with spot shapes that are not symmetrical. Histogram segmentation uses a target mask that is 
larger than the spots to analyze and from which the pixel values are calculated. Foreground 
and background values are estimated from these values as a predetermined percentile such as 
5th and 20th percentile for background and the 80th and 95th percentile for foreground. Several 
implementations of this approach have been used including one that used the Mann-Whitney 
test to compute threshold values (21). 
Intensity extraction involves both summing the pixel intensities within the spot mask and 
the calculation of local background intensities that arise from nonspecific hybridization and 
fluorescence emitted from other chemicals on the glass. The process of background 
estimation can use several different approaches including those that measure each spot 
individually and those that use a global background for all spots. 
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Presentation and analysis of microarray data are rapidly evolving. Early studies presented 
false color images (109, 132), scatter plots (45), and cluster diagrams (34). These methods of 
analysis give an overview of the data, but do not provide critical evaluation of the data or its 
significance. To accurately test and evaluate data of such magnitude and complex design as 
significant, statistical methods needed to be adapted to answer the questions being asked 
using microarray technology. 
Microarray data is not normally distributed and therefore it is necessary to normalize the 
data. Normalization adjusts for systematic differences in the relative intensity of each signal 
channel, and corrects for differences in intensities within the same slide or between slides 
that are array dependent and not due to true biological variation (106). A number of 
approaches have been defined for normalization and are discussed by Schena (106). Usually 
a set of genes is identified for normalization, such as housekeeping genes, that are not 
expected to differ within the experiment. This rarely occurs so some investigators have used 
spiked controls. Several companies (i.e., Stratagene) sell kits that contain spike mixes and 
housekeeping genes for validation and normalization. An approach that is gaining popularity 
is to use all of the genes on the array with the assumptions that only a relatively few of the 
genes will vary significantly in expression, and that there is symmetry in the expression of 
up-regulated and down-regulated genes. 
Many features of array construction and design can help to ensure the quality of the array 
and hence the value of statistics resulting from an experimental study. Increasing the number 
of biological replicates is favored over increasing technical replicates from limited biological 
samples (25). Normalizing data compensates for the variation introduced by the technical 
aspects, such as unequal fluorescent dye incorporation and the array-to-array variation, but 
not variation due to biological differences (117). Normalization in two-color systems is 
almost always necessary due to the varied incorporation rates and stability of the fluorescent 
dyes. Normalizing data is completed before statistical analysis. 
A two-color array design is powerful because it has the ability to directly compare two 
samples (25). However, the degree of freedom is reduced because the two-color factor is 
included in the statistical model. Additional factors included in the model are the arrays, 
experimental treatments, genes, array by gene interaction, and the most interesting effect 
being that of treatment by gene (56). Kerr et al. describe the ease with which data is 
normalized and then analyzed to reflect the significant effects of treatment upon a specific 
gene (56). Using a logarithmic scale to transform the raw data and not the log ratio values 
also allows for ease of representing the data as a fold-change in gene expression with 
statistical significance associated with that change in expression. Relying strictly on fold-
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change values results in numerous false positives and false negatives (123). Tanaka et al. 
found that differentially expressed genes in the 1.2 to 2-fold change can often be overlooked 
as non-significant, when they have actual biological and statistical significance in replicated 
data sets (123). 
A mixed-model includes factors that are fixed and random. In typical microarray 
analyses, factors considered fixed are the treatment effect and dye effect. Factors usually 
considered random are slides and slide-by-area. Generally, random factors account for 
variability so that differences can be determined for the factors of interest (i.e., fixed effects). 
Examples of variability are spatial variation caused by either defects on the slide surface or 
non-uniform coating of the slide surface, and dye incorporation rates. 
The probability of finding a gene statistically significant when in reality it is not 
significant (i.e., type I error) is substantially increased when multiple comparisons are made 
with data from a single experiment. Traditional analyses rely on methods like Bonferroni, 
Scheffe, and Tukey to control type I error rate (89). Storey et al. explains a method to 
determine type I errors in microarray analysis, the false discovery rate (FDR)(120). 
Determining the FDR helps researchers identify genes that are not transcriptionally 
differentiated even though a /-test indicates otherwise. False discovery rates are determined 
by calculating a q-value. The q-value is similar to a p-value, indicates the probability of 
committing a type I error and establishes a level of confidence in determining statistical 
significance. False discovery rate is used to control for experiment-wise error. 
Applications 
Microarrays are used to elicit information about genetic or transcription differences 
represented on the array. For example, genetic variation in clinical or field isolates of 
pathogens, transcriptional variation and its effects in tumorgenesis, effects of stress on 
transcriptional variation in pathogens are all suitable topics for investigation using 
microarrays. Although too many to list, the number of publications utilizing microarray 
technology is growing rapidly and the possible experiments seem limitless. 
Genomic comparisons (within/without species) 
Through examination of the genetic content of bacteria, variations often indicate the 
emergence of new strains and adaptations to new environmental niches. Genetic comparisons 
allow the medical field to track how bacterial species may acquire genes, increasing the 
occurrence of infections in human populations (124, 134). Additional studies outline the 
similarity of laboratory and clinical strains giving validity to in vitro assays using laboratory 
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strains (118). Snyder and colleagues also indicate that multi-strain, multi-species microarrays 
would truly make them a more informative tool compared to single genome arrays (118). 
With the heightened awareness of potential bioterrorism threats, microarrays are being 
developed to identify infectious agents. This progress is slow and only a limited number of 
arrays are currently being reported. Most arrays currently in use require some knowledge 
regarding the sequence of the organism. Belosludtsev et al. have designed an array to detect 
Bacillus subtilis, Yersinia pestis, Streptococcus pneumoniae, Bacillus anthracis and Homo 
sapiens using a universal probe set tested against the various species (6). Their results 
indicate arrays can be designed for species not yet sequenced and accurately identify 
unknown samples. The ability to identify various bacteria from mixed samples is relevant for 
environmental samples. Arrays fabricated by Kim et al. using random probes also 
distinguished individual species from mixed populations (57). As the need for surveillance of 
the environment continues, more random probe microarrays will continue to be developed to 
by-pass the need for sequencing entire genomes. 
Single nucleotide polymorphism detection 
Genetic variation at the nucleotide level is readily amenable to microarray technology 
and can be used in several applications of patient health. Much of the single nucleotide 
polymorphism (SNP) studies focus on defining the natural variation present in a population 
versus mutations occurring at those loci. By detecting SNP s associated with disease, 
researchers are able to determine the predisposition to infection, cancer and other disorders. 
Genotypes have been previously associated with psychotropic medication treatment outcome 
(82). By determining the genetic sequence of a particular locus, doctors are able to better predict 
which medications to prescribe and their predicted outcomes. A course of treatment can then be 
tailored to a specific patient based on their genetic make-up. Once accurate probe detection is 
available, any subsequent genetic screening, especially for highly heritable traits in offspring, 
can be established (112). 
Epidemiological studies often provide data regarding disease states. Examining SNPs 
associated with a particular cancer and comparing that to normal tissue can identify unstable 
regions in the genome (47). Due to the loss of heterozygosity often associated with cancer 
and various diseases, current research is focusing on validating SNP microarrays using 
current gold standards (137). This is an ever-expanding field of study. As more SNPs are 
validated for detection of disease and therapeutic treatment of those diseases are identified, 
SNP microarrays will become the standard tool for doctors and researchers to examine the 
course of treatment. One area of research that is utilizing genomic arrays is that of breast 
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cancer research. Researchers are using arrays to compare genetic make-up of the tumors for 
the purposes of better classifying and treating them (84). Once multiple tumor types have 
been classified genetically, insight can be gained from the genetic component of oncogenesis, 
hopefully developing novel and effective preventatives and therapeutics. 
Forensic science also wishes to exploit SNP technology to identify unknown persons, 
suspects and/or victims in a particular criminal case. Research is ongoing to optimize current 
databases, and improve those regions of detection. Validation of SNP technology is ongoing 
in area of mitochondrial DNA sequencing and identification of suitable probes. 
Mitochondrial DNA is often an ideal choice for analysis given the degradation that occurs in 
many forensic samples, especially those of remains cases. Robust databases must be created 
to allow for greater comparisons of unknown samples and identification of individuals. 
NanoChip arrays have been developed to allow for minimal sample, increase throughput and 
sensitivity when analyzing forensic samples (8). This system will require validation before it 
can withstand the rigorous examination in the courtroom. 
Gene expression 
Expression profiles for numerous bacteria have now been constructed using microarrays. 
Experiments designed to examine differences due to strain variation and environmental 
factors such as temperature, antibiotics, nutrient requirements and host effects, frequent the 
list of current publications (44, 116). 
Pathogens 
In the realm of pathogenic bacterial microarrays, the studies seem to be limitless. 
Microarrays are used as a means of surveillance for the presence of bacteria, for 
identification of varying serovars, to examine host-pathogen interactions and to assess 
genetic contributions to pathogenicity (86, 90, 93, 94). Using microarrays, researchers have 
been able to study in vivo host-pathogen interactions and not just in vitro laboratory models. 
Historical samples can also be used, giving an indication of genetic variation during disease 
progression. Epidemiological studies can tract changes in an organism over both time and 
space. As the microarray data is gathered and analyzed, a more complete picture of the 
mechanisms of bacterial pathogenesis will be developed. 
Food safety 
One area of research in which microarrays may prove to be beneficial is food-borne 
pathogenesis. Current research in the area has targeted Listeria monocytogenes, Escherichia 
coli 0157:H7, Campylobacter jejuni, and Salmonella enterica serovar Enteritidis, as well as 
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other pathogens associated with the preparation, distribution and storage of food. 
Microarrays can be used for pre- and post-harvest diagnostics, for epidemiological studies 
into sources of outbreaks and for studies into the pathogenesis of the diseases. 
Listeria monocytogenes microarrays have been able to identify the differences between 
serotypes. Genomic hybridizations were able to identify divergent lineages and screen for 
genetic markers in clinical samples (15). Additional research using a mixed genome 
microarray revealed data similar in resolution to pulsed field gel electrophoresis for 
epidemiologically linked strains (9). 
Research studies using C. jejuni microarrays have included environmental detection 
systems, genome mapping, and determining the effects of nutrients on the physiology of the 
bacteria. Global mapping studies allow for a selection of markers that can identify genetic 
variation in strains of C. jejuni and eventually may be used in genotyping methods (121) by 
analyzing physiological variation, mechanisms of survival and the physiological role 
particular elements play in pathogenesis. Microarray studies examining the functional groups 
associated with iron acquisition by C. jejuni reveals many of the same pathways are required 
for colonization of the gastrointestinal tract (121). Chickens are often the source for intestinal 
disorders due to C. jejuni, and as such, a focus for many detection studies and protocols. 
Danish researchers were able to use microarrays to expedite analyses of contamination levels 
in broiler chickens (55). In this study, the researchers were able to detect C. jejuni at the 
species level in all but 6% of the samples tested compared to 19% in PCR testing. The 
inherent specificity, low sample volume and lack of a need to culture samples make 
microarrays an efficient means of evaluating the presence of C. jejuni in food sources. 
Escherichia coli 0157:H7 microarray research has also focused its efforts on identifying 
the genes relevant to pathogenesis and to distinguish between pathogenic and non-pathogenic 
strains (138). As an emerging infectious agent having been identified in the 1980s, studies 
are now focused on identifying the etiology of the organism (134). By designing arrays with 
unique genes related to pathogenesis, the arrays can then be used to identify E. coli strains in 
clinical and environmental samples. 
Salmonella enterica serovar Enteritidis studies currently look at the spread of disease and 
identification of particular serovars in relation to outbreaks and prevalence (3, 135). By 
identifying regions of variation at the genetic level, new classifications can be made that 
determine pathogenicity and host range (94). The authors also coined the term "genovars" to 
differentiate variation at the genetic level between common serovars. Genomic analysis of 
several serovars of Typhimurium determined that intrastrain divergence is limited, but 
interstrain divergence exists and may play a role in virulence (100). In a study by Prouty et 
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al. the role of bile salts contributed to transcriptional regulation and probably pathogenesis as 
well (95). The array results confirmed the down-regulation of virulence and flagellular 
biosynthesis genes. The role of "swarming" has also been investigated using microarrays 
indicating that many of the genes associated with the type III secretion system, 
lipopolysaccharide synthesis and iron regulation are differentially transcribed compared to 
cells grown in culture (129). These findings give additional information and focus to studies 
of how serovar Typhimurium is able to colonize the host intestinal tract. 
Microarrays have traditionally examined the genetic make-up and overall transcription 
levels of a single organism. Another approach is to combine several gene-specific probes on 
a single array to screen for many types of contaminants. Sergeev et al. were able to detect 
Staphylococcus aureus enterotoxin genes, Listeria spp., Campylobacter spp. and Clostridium 
perfringens toxin genes using microarrays (111). This array combined the ability to detect 
low numbers of organisms in a given sample with the ability to screen for several different 
pathogens in one test. 
An area of research currently lacking in microarray research of food pathogens is the pre-
and post-harvest analysis of foodstuffs. With the sequencing of many species of bacteria, sets 
of unique genes capable of identifying low levels of contaminants should be possible. This 
would be a significant addition to the monitoring process and protection of our food supply. 
Mycoplasmas 
Seemingly overlooked in the realm of microarray studies are the mycoplasmas. With 
their endemic existence, broad host base, and small genomes, mycoplasmas should be 
actively studied using this technology. To date, only three reports have applied arrays in their 
studies. Using a high-density tissue macroarray, Chinese researchers examined the 
prevalence of M. hyorhinis in gastric tissue samples compared to non-cancerous tissues 
(140). Diagnostic analysis using an oligonucleotide array to various respiratory infections 
included M. hyorhinis (103). The final study examined the transcriptional response of M. 
pneumoniae to heat shock conditions (131). Herrmann and co-workers were able to identify 
transcriptional differences similar to the results from other bacterial heat shock studies. The 
minimal amount of microarray data for mycoplasmas is indicative of need for additional 
studies. 
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Summary with Goals and Hypothesis 
As described above, M. hyopneumoniae presents several problems when attempting to 
use classic molecular biology tools to study pathogenesis. This is true for mycoplasmas in 
general, although there are some exceptions where genetic tools are available (17, 24, 32, 33, 
58, 59, 62-64, 78, 110). Consequently, progress in understanding the genetic basis of 
pathogenesis for M. hyopneumoniae has been slow, and little information is currently 
available regarding the molecular mechanisms of pathogenesis. The recent sequencing of the 
genome (Appendix A) has provided the information necessary to initiate new lines of 
investigation that have been heretofore closed to mycoplasmologists. Using this genome 
sequence information, we were able to construct microarrays to initiate studies of both 
genetic and transcriptional differences under changing environmental conditions. Since there 
has only been a single report of a global transcriptional study in mycoplasmas (131), this 
study offers new insight into mycoplasma gene regulation. In addition, the information 
gained from these studies may add insight as to the functions for hypothetical genes, and 
thus, targets for new, effective vaccines may be revealed. 
The overall hypothesis of this study is that variation occurs in M. hyopneumoniae that 
impacts its response to environmental changes, ability to adhere to swine cilia, and cause 
disease. Genetic variation may also be contributing to these factors. Therefore, the goal of 
this study was to assess the ability of a genome-wide microarray to measure changes at the 
genomic and transcriptional levels and reveal new information regarding mycoplasma gene 
regulation and genome variability. 
The first set of experiments reported in Chapters 2 and 3 focus on analyzing 
transcriptional differences during two stress-related conditions, heat shock and iron 
deprivation. These two stresses have been shown to impact an organism's ability to survive 
in vivo during disease. By providing insight into how M hyopneumoniae responds to stress in 
vitro, these studies further our understanding of fundamental genetic processes that seem 
common to all bacteria but only now are being revealed in mycoplasmas. These studies also 
impact our understanding of the ability of mycoplasmas to regulate transcription in response 
to environmental changes. 
Chapter 4 compares virulent strain 232 with laboratory-adapted virulent strain J. This 
study was undertaken to define differences in the transcription profiles between a virulent 
strain and an avirulent strain with the intent of identifying changes that may be related to 
pathogenesis. 
The studies reported in Chapter 5 examine transcriptional differences in cilium adherence 
variants obtained from M. hyopneumoniae strain 232. Transcriptional analysis of a low 
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adherent 60-3 variant and high adherent 91-3 variant should give insight into swine cilium 
adherence-related gene expression differences and possibly identify genes involved in the 
adherence process in addition to P97, the cilium adhesin. Since adherence is required to 
cause disease, these data should provide knowledge of the genes required by M 
hyopneumoniae in vivo. 
Chapter 6 reports the genetic differences in field isolates as revealed by this microarray. 
Since these isolates came from field cases they are considered to be pathogenic, but the 
extent of virulence has been assessed in only a few of the strains using a pig challenge model 
(Strait et al., unpublished). These data could also be used to define genomic regions suitable 
for development of better diagnostic reagents for M. hyopneumoniae. One of the drawbacks 
of this microarray is that only known genes in strain 232 are represented. Any gene 
acquisition by the field isolates would not be detected. Since mycoplasmas are thought to 
have evolved by degenerative evolution and are thought to be a model for the minimalist 
genome, gene acquisition should be limited. Additionally, there is no evidence that strain 232 
had acquired any gene sequences in the recent past since the GC skew in the genome was 
unremarkable (80). 
This dissertation ends with the General Conclusions and Future Studies. Microarrays are 
often thought of as hypotheses generating tools in addition to their ability to measure 
variation in a massively parallel format. Unexpected results are common because we do not 
know how all of the pieces fit together in living systems to produce defined phenotypes. 
Microarrays provide not only the tools to examine change, but they also do so in accelerated 
fashion. These studies will enhance our understanding of basic mechanisms employed by M. 
hyopneumoniae and by mycoplasmas in general in unanticipated ways, the true hallmark of 
scientific investigation. 
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Abstract 
Bacterial pathogens undergo stress during host colonization and disease processes. These 
stresses result in changes in gene expression to compensate for potentially lethal 
environments developed in the host during disease. Mycoplasma hyopneumoniae colonizes 
swine epithelium and causes a pneumonia that predisposes the host to enhanced disease from 
other pathogens. How M. hyopneumoniae responds to changing environments in the lung 
during disease progression is not known. In fact, little is known concerning the capabilities of 
mycoplasmas to respond to changing growth environments. With limited genes, 
mycoplasmas are thought to lack complex regulatory circuits and few mechanisms for gene 
regulation. A microarray consisting of 632 of the 698 open reading frames of M. 
hyopneumoniae was constructed and used to study gene expression differences during a 
temperature shift from 37°C to 42°C, a temperature swing that might be encountered during 
disease. To enhance sensitivity, a unique hexamer primer set was employed for generating 
cDNA from only mRNA species. Our analysis identified ninety-one genes that were either 
up- or down-regulated in response to heat shock conditions (p <0.01) with an estimated false 
discovery rate of four percent. Many of the heat shock proteins previously characterized in 
other bacteria were identified as significant in this study as well. A proportion of the 
identified genes (54 of 91) had no assigned function. 
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Introduction 
Mycoplasma hyopneumoniae is the causative agent of porcine enzootic pneumonia and is 
a major contributor to the porcine respiratory diseases complex (24, 28). Like other 
mycoplasmas, M. hyopneumoniae has a small genome with limited biosynthetic potential 
(18). Mycoplasmas in general are rarely exposed to severe environmental changes; they are 
transmitted animal to animal and do not survive long outside their host. They do, however, 
encounter changing environmental conditions within the host as the immune response 
develops and responds with the recruitment of large numbers of neutrophils and macrophages 
to the infection site and the host becomes febrile (29). Some invasive mycoplasma species, 
i.e. Mycoplasma bovis, encounter different environments within the tissues it colonizes after 
becoming systemic. Thus, it is of interest to study potential growth conditions that might 
impact the mycoplasmas^ ability to adapt to and survive these changing conditions. 
Heat shock proteins (Hsps) are a group of proteins induced during stressful conditions 
that result in denaturation of polypeptides. Temperature extremes, high pressure and 
exposure to toxic compounds can induce expression of these proteins, conditions that result 
in protein unfolding and denaturation (21). The Hsps are generally thought of as chaperones, 
proteins involved in the correct folding of polypeptides as they emerge from the ribosome. 
They operate by binding to exposed hydrophobic residues in improperly folded protein 
structures. They can also be involved in the assembly or disassembly of multimeric protein 
structures and translocation of proteins across membranes. An additional class of Hsps 
includes proteases that degrade misfolded or abnormal proteins (9, 10). The Hsps are highly 
conserved and appear to be universal, having functions required for normal cell growth. 
The regulation of heat shock proteins falls into four general classes, proteins regulated by 
sigma32 (rpoH) and sigma24 (rpoE) (10), those regulated by transcriptional repressors (20), 
and those with unknown regulatory mechanisms (31). Mycoplasmas, however, do not have 
the typical sigma factors involved in responses to high temperature shifts; only a single sigma 
factor has been identified in any mycoplasma genome (2, 12, 18, 22, 33). Consequently the 
current thought on gene regulation in mycoplasmas is that the majority of genes are 
constitutively expressed and some of these may undergo phase shifting due to genetic 
changes occurring during DNA replication (36), and that those that undergo regulation are 
controlled by a limited number of transcriptional regulators (19). 
Heat shock has long been considered a stress condition that many pathogens encounter in 
their pathogen-host relationship. While much has been learned about the Hsp genes and their 
regulation in many bacterial species (10), few studies have examined mycoplasmas for heat 
shock responses. In 1990, two reports of heat shock studies involved identification of heat 
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shock proteins (Hsps) by gel electrophoresis in Mycoplasma capricolum subsp. capricolum 
and Acholeplasma laidlawii (1,3, 4). More recently, transcriptional profiling was performed 
on Mycoplasma pneumoniae (32) to identify a set of genes that undergo regulation in 
response to changing growth temperatures. The results of that study indicated that 47 genes 
were up-regulated and 30 genes were down-regulated during a temperature shift from 32°C 
to 42°C at ap-value <0.001. This report is also notable in that it was the first genome-wide 
transcriptional profiling study performed in a mycoplasma species. 
Despite its importance to swine production, there have been few studies of potential 
molecular mechanisms of pathogenesis with M. hyopneumoniae and how it might respond to 
environmental changes. This has probably been due to the difficulty in growing the organism 
and its recalcitrance to genetic manipulation. The few reports have focused on mechanisms 
of adherence to swine cilia (13, 14, 17, 38) with no reports of potential stress-related 
proteins. Analysis of the genome sequence has identified putative Hsps DnaK (mhp072), 
DnaJ (mhp073), ClpB (mhp278), GrpE (mhpOl 1), Lon (mhp541), and a putative heat shock 
regulator HrcA (mhpOlO) (18). To better understand the mechanisms involved in stress 
responses, we have determined M. hyopneumoniae's response to heat shock using a 
microarray approach. Our studies show significant changes in transcriptional activities in 
numerous genes suggesting that M. hyopneumoniae like other bacteria tightly regulate their 
genes in response to the environment. 
Materials and Methods 
Mycoplasma strains and culture conditions 
Pathogenic M. hyopneumoniae strain 232, a derivative of strain 11, was used in this study 
(16). Cultures used were passed fewer than 15 times in vitro in Friis media as previously 
described (8). Two hundred fifty ml flasks containing 125 ml cultures were grown at 37°C to 
early-log phase as determined by medium color change and optical density. Flasks were 
shifted to 30°C for 2 h and then paired flasks shifted to 37 or 42°C for 30 min. There were 
six replicates. Cells were pelleted by centrifugation at 24,000 x g, and 500 (il of RNAlater 
(Ambion, Inc. Austin, Tex.) was added to pellet. Pellets were stored at -70°C until the total 
RNA was isolated. 
Microarray construction 
The M. hyopneumoniae microarray consists of polymerase chain reaction (PCR) products 
(probes) spotted to glass substrates. To identify primers for PCR reactions, a FASTA file was 
40 
first generated from the M. hyopneumoniae strain 232 sequence (18) containing the DNA 
sequences for all putative open reading frames (ORFs). This file was then analyzed with 
Primer3 software (26) using a set of scripts to allow for iteration and unique primer design 
across the genome. The software began the design process (Figure 2.1) by reading and 
storing the sequences for each of the ORFs. The program then iterated through each ORF, 
determining those for which valid primers have been identified. At this point, a mispriming 
library file was created, which consisted of the sequences of all ORFs except for the one for 
which primers were to be designed. This ensured that any primers found would not match 
any other ORFs besides the ORF requiring primers. Next, the Primer3 parameters were 
written to a file (Table 2.1), and this file and the mispriming library were passed to Primer3 
and the results appended to another file. The program then moved on to the next ORF. Once 
each ORF had been examined, any ORFs still needing primers were identified. The 
parameters passed to Primer3 (i.e., melting temperature, primer product size, mispriming 
score, etc.) were relaxed, and the process was then repeated a total of three times, iterating 
through each of the ORFs and re-running Primer3 on any ORFs that did not already have 
primers. At the end of the third evaluation, any ORFs for which unique primers could not be 
identified were not included in the microarray design. Two sets of primers were identified for 
each ORF. Primers were purchased from Integrated DNA Technologies (Coralville, la.) and 
were obtained as a frozen solution of 100 picomoles per microliter in water in 96 well plates. 
The primer sequences used to generate PCR products for array spotting are given in the 
Appendix B. 
Polymerase chain reactions were performed in 96 well plates in a MJ Research Dyad 
Thermal Cycler (Bio-Rad Laboratories, Inc., Waltham, Mass.) on all sets of PCR primers in 
100 (j.1 reactions using the following conditions: IX PCR Buffer; 2.5 mM MgCh; 2.0 mM 
each dATP, dCTP, dTTP and dGTP (Roche Diagnostics Corp., Indianapolis, Ind.); 2 pmol of 
each primer, forward and reverse; 2.5 units Taq polymerase (New England Biolabs, Beverly, 
Mass.); and 100 ng M. hyopneumoniae strain 232 chromosomal DNA, which had been 
isolated by phenol : chloroform extraction. The thermal cycling conditions were denaturation 
at 95°C for 5 min; and then 30 cycles of denaturation at 94°C for 1 min, annealing at 50°C 
for 1 min, and elongation at 72°C for 30 sec; and a final elongation at 72°C for 10 min. 
Products were analyzed by 2% agarose gel electrophoresis to confirm that a single product of 
correct size was present. For failed reactions, a second round of PCR was performed with the 
first primer pair with lowered temperatures or the second set of PCR primers was used with 
the same reaction conditions. Forty-eight PCR products were sequenced to verify that the 
correct product was being made. The PCR products were purified by combining the PCR 
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Figure 2.1. Flow chart for PCR primer design. 
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Table 2.1. Initial Primer3 criteria for designing primers for the M. hyopneumoniae ORFs. 
PRIMER DESIGN OPTIONS CRITERIA 
PRIMER MISPRIMING LIBRARY screen, seq 
PRIMER MAX MISPRIMING 12.0 
PRIMER PAIR MAX MISPRIMING 24.0 
PRIMER PRODUCT SIZE RANGE 250-350 100-500 
PRIMER TASK pick_pcr_primers 
PRIMER GC CLAMP 1 
PRIMER MIN SIZE 18 
PRIMER OPT SIZE 20 
PRIMER MAX SIZE 25 
PRIMER MIN TM 55.0 
PRIMER OPT TM 61.0 
PRIMER MAX TM 63.0 
PRIMER MAX DIFF TM 5.0 
PRIMER MIN GC 30.0 
PRIMER OPT GC PERCENT 50.0 
PRIMER MAX GC 70.0 
PRIMER NUM RETURN 2 
PRIMER FIRST BASE INDEX 1 
products with 3 volumes of 6 M potassium iodide and applying to FilterEX™96 well glass 
filter plates (Corning #3510; Corning, Inc., Big Flats, N.Y.). The plate was subjected to 
vacuum for 1 min and each well was washed with 100 gl of 80% ethanol, twice. After the 
second wash, the plates were dried under vacuum for 2 min and tapped to remove any 
residual ethanol droplets in the nozzle. Each plate was placed on its side and air dried at room 
temperature for 90 min. The DNA was eluted by adding 80 |xl of 10 mM Tris pH 8.5 per well 
and centrifuged for 2 min at 782 x g. The eluted DNA was captured in a 96 well plate 
(Coming #3365). Purified PCR products were quantified using a Spectramax 250 
spectrophotometer (Molecular Devices, Sunnyvale, Calif.) and CoStar UV transparent 96-
well flat-bottom plates (Coming #3635). Samples were dried using a Savant vacuum 
centrifuge with a microtiter plate adapter and resuspended to an approximate concentration of 
200 ng per jj.1 in spotting buffer (Coming). A 1 pi volume of probe was diluted in 5 jul 
distilled water with 1 pi of loading dye (10 mM Tris-HCl (pH 7.6), 0.03% bromophenol blue, 
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0.03% xylene cyanol FF, 60% glycerol, 60 mM ethylenediamine tetraacetic acid) and 
electrophoresed in 2% agarose gels to confirm the concentration and purity of each product. 
Products were arrayed into 384 V-well plates (#781280; Greiner Bio-One, Inc., Longwood, 
Fl.) to prepare for printing. 
The microarrays were printed using a BioRobotics MicroGrid (Genomic Solutions, Ann 
Arbor, Mich.)(see Appendix C for the printing file) onto Corning UltraGAPS™ substrates. 
Each probe was printed in triplicate, in non-adjacent spots to reduce non-uniform substrate 
errors in replicated probes. The array consisted of 16 subarrays, with a 12-column x 12-row 
configuration. Two arrays were printed per slide. Humidity was increased during printing and 
pin strike speed slowed according to Coming's recommendation. The slides were allowed to 
dry on the printing deck overnight and stored for 48 h in a dessicator prior to transport and 
crosslinking. Slides were UV cross-linked at 450 mJ in a Stratalinker (Stratagene, La Jolla, 
Calif.) to immobilize DNA. Preliminary staining experiments were performed to determine 
the optimal cross-linking energy needed for each batch of arrays. Arrays were cross-linked 
with 350, 450 and 550 mJ and stained with SpotQC (Integrated DNA Technologies) per 
manufacturer's instructions. The energy giving the most uniform and highest signal strength 
was chosen for the batch treatment. Prior to hybridization, arrays were prehybridized with 
sodium borohydride to reduce background according to methods outlined by Raghavachari et 
al. (23). 
RNA isolation 
RNA was isolated from frozen cell pellets using the Versagene™ RNA Purification 
System (Gentra Systems, Minneapolis, Minn.) according to the manufacturer's protocol. The 
optional step of DNase treatment was routinely performed on column according to the 
manufacturer's recommendation. With a cut-off of 150 bp, 5S rRNA and tRNAs were 
removed from the samples, limiting interference in downstream manipulations. Samples were 
quantified and checked for purity using the Nanodrop® ND-1000 Spectrophotometer 
(Nanodrop, Wilmington, Del.). If necessary, samples were concentrated using Microcon 
YM-30 micro-concentrators (Millipore, Billerica, Mass.) for optimal cDNA generation. 
Random primer set for M. hyopneumoniae 
A set of 129 six-mer oligonucleotide primers was designed to generate cDNA sequences 
from M. hyopneumoniae mRNA (Appendix D). The hexamer oligonucleotide sequences 
were screened to remove any sequences that would potentially amplify rRNA or tRNA, 
which make up 95% or more of the total RNA preparation. All 4,096 potential hexamer 
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oligonucleotide sequences were generated in silico. Those sequences that were homologous 
with the 41 tRNA or rRNA genes were removed from the analysis. The remaining 327 
primers were compared to the 698 ORFs in the annotated sequence. Primers were identified 
that would theoretically hybridize to the coding strand of the mRNA, and a minimal set of 
primers that would amplify all ORFs was identified. One hundred picomoles of each primer 
(Integrated DNA Technologies) were then combined to form a primer mixture for cDNA 
generation. 
Target generation and hybridization 
Targets were generated from total RNA extracted from cell pellets as described above. 
Fluorescently labeled cDNA targets were generated and purified using the SuperScript™ 
Indirect cDNA Labeling System (Invitrogen Corp., Carlsbad, Calif.). Targets were labeled 
with Alexa Fluor™ 555 Reactive Dye or Alexa Fluor™ 647 Reactive Dye (Molecular 
Probes, Inc., Eugene, Ore.). Following purification of the labeled cDNA, samples were dried 
in a vacuum centrifuge and then resuspended in 10 pi Pronto! cDNA/long oligo hybridization 
solution (Coming). Targets were denatured at 95°C for 5 min and centrifuged at 13,000 x g 
for 2 min at room temperature. Targets from a control and heat shocked culture were then 
combined, pipetted to an array, and covered with a 22 x 22 mm HybriSlip™ (Schleicher & 
Schuell, Keene, N. H.). Slides were placed in a Coming hybridization chamber and incubated 
in a 42°C water bath for 12-16 h. Slides were washed according to Coming's UltraGAPS™ 
protocol and dried by centrifugation. 
Image acquisition and data analysis 
Each dye channel of each array was scanned using a ScanArray Express laser scanner 
(Applied BioSystems, Inc., Foster City, Calif.) three times under varying laser power and 
PMT gain settings to increase the dynamic range of expression measurement (6). Images 
were quantified using the softWorRx Tracker analysis software package (Applied Precision, 
Inc., Issaquah, Wash.). Spot-specific mean signals were corrected for local background by 
subtracting spot-specific median background intensities. The natural logarithm of the 
background-corrected signals from a single scan were adjusted by an additive constant so 
that all scans of the same array-by-dye combination would have a common median. The 
median of these adjusted-log-background-corrected signals across multiple scans was then 
computed for each spot to obtain one value for each combination of spot, array, and dye 
channel. These data for the two dye channels on any given array were normalized using 
LOWESS normalization to adjust for intensity-dependent dye bias (7, 35). Following 
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LOWE S S adjustment, the data from each channel were adjusted by an additive constant so 
that the median for any combination of array and dye would be the same for all array-by-dye 
combinations. The normalized values for triplicate spots were averaged within each array to 
produce one normalized measure of expression for each of the 632 probe sequences and each 
of the 12 RNA samples. 
Statistical analysis 
A separate mixed linear model analysis was conducted for each probe sequence using the 
normalized data (34). Each mixed model included fixed effects for treatment (heat shock 
versus control), slide region (upper versus lower), and dye (Alexa 555 versus 647) as well as 
random effects for slide and slide-by-region interaction. A t-test for differential expression 
across treatments was conducted for each probe as part of our mixed linear model analyses. 
The 632 p-values from these /-tests were converted to ^-values using the method of Storey 
and Tibshirani (27). These ^-values can be used to obtain approximate control of the False 
Discovery Rate (FDR) at a specified value. For example, declaring probes with ^-values less 
than or equal to 0.05 to be differentially expressed produces a list of significant results for 
which the FDR is estimated to be approximately 5%. Along with ^-values, estimates of fold-
change were computed for each probe by taking the inverse natural log of the mean treatment 
difference estimated as part of our mixed linear model analyses. 
Validation of microarray data 
To confirm significant transcriptional differences between genes, semi-quantitative PCR 
analysis was performed. PCR was performed in 96 well plates in a MJ Research Dyad 
Thermal Cycler (Bio-Rad Laboratories, Inc., Waltham, Mass.) in 20 pi reactions, with the 6 
study replicates for each ORF from control and heat shocked samples, using the following 
conditions: IX PCR Buffer; 2 mM MgCli; 1.0 mM each dATP, dCTP, dTTP and dGTP 
(Fisher Bioreagents, Fairlawn, NJ); 5 pmol of each primer, forward and reverse; 2.5 units 
Taq polymerase (New England Biolabs, Beverly, Mass.); and 2 pi cDNA from heat shocked 
samples diluted 1:50 or 2 pi cDNA from control samples diluted 1:50. The thermal cycling 
conditions were denaturation at 95 °C for 5 min; and then 25 cycles of denaturation at 94°C 
for 1 min, annealing at 50°C for 1 min, and elongation at 72°C for 30 sec; and a final 
elongation at 72°C for 10 min. The reactions were mixed with 4 pi 6X loading dye and 10 pi 
were analyzed by 1.5% agarose gel electrophoresis then stained with 0.5 pg/ml ethidium 
bromide to confirm that a single product of correct size was present. The gel was visualized, 
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digitized and band density was measured with FlourChem 8000 version 2.0 software (Alpha 
Innotech Corp., San Leandro, Calif.). 
Analysis of variance was performed to determine differences between band density 
values of heat shocked versus control samples. Band densities were background corrected by 
subtracting the background density within the reaction lane from the sample band density. 
Estimated differences were considered significant if the /rvalue of a /-test was <0.05. 
Results 
Primer design and array construction 
Primers were designed for PCR reactions based on the M. hyopneumoniae genome 
sequence. Of the 698 putative ORFs, primers could be designed for 686 ORFs based on the 
criteria shown in Table 2.1. Polymerase chain reaction conditions were optimized for product 
yield using a temperature gradient program (data not shown). Also, the deoxynucleotide 
concentrations were optimized by increasing to 2 mM, which significantly improved product 
concentration. This was probably necessary because of the 28.6% A+T content of the 
genome. When the first set of primers failed to give positive PCR products, a second set of 
primers were tested. In some instances a third set of primers were designed with reduced 
stringencies. The 66 missing ORFs (Appendix E) included those with no unique primers, 
multiple products, incorrect product size, or failed reactions. Ninety-two percent of the ORFs 
with designed primer pairs (632/686) gave positive reactions and were spotted on the array. 
Following purification, PCR reaction products were analyzed by agarose gel for consistency 
in concentration and product size (Figure 2.2). 
Figure 2.2. Example of agarose gel of purified PCR products. 
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Microarrays were printed to Corning UltraGAPS™ substrates and allowed to dry on the 
printing platform overnight. For each batch of substrates, the substrates were cross-linked at 
350, 450 and 550 mJ, prehybridized, and several slides per batch were stained with SpotQC 
to determine the spot morphology, general array quality, and optimal cross-linking energy. 
Figure 2.3 gives an example of spot morphology and optimization of the cross-linking 
energy. 
Figure 2.3. Determination of cross-linking energy. Following cross-linking, slides were 
stained with SpotQC and scanned with the Cy3 channel. The image shown represents the 
same subarray from three slides cross-linked at 350, 450 and 550 mJ (left to right). The 
signal is given in false color to indicate intensity. Not all spots reacted with the dye equally 
because of the sequence variation. 
Heat shock studies 
Six independent RNA samples from heat-shocked cells were paired with six independent 
RNA samples from control cells for hybridization on six two-color microarrays. The six 
arrays were printed on a total of three slides. Each slide was divided into two regions (upper 
and lower), and each region contained the full array of spots. Each of the 632 sequences in 
the array was represented by at least three replicate spots. 
For three of the six arrays, the control sample was labeled with Alexa 555 dye and 
compared to the heat-shocked sample labeled with Alexa 647 dye. The dye assignment to 
control and treated samples was reversed for the other three arrays to account for variation 
due to labeling efficiencies. The three slides were hybridized under identical conditions as 
described below. 
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Each sample was isolated and independently labeled prior to hybridization. Total RNA 
concentrations post purification were approximately 7-18 jag. In each cDNA reaction, 7-12 
(ig of total RNA was added yielding cDNA concentrations of 2-7 (ig. Control versus heat 
shock samples were paired and had the same concentration of total RNA added to the cDNA 
reactions. Three samples from each treatment were labeled with Alexa Flour 555 and three 
with Alexa Fluor 647. The label incorporation of fluorescent dyes ranged from 20-81 bp/dye 
molecule for each dye, which is well within the recommended range of label incorporation 
(http://probes.invitrogen.com/ resources/calc/basedyeratio.html). To account for any 
variation due to dye incorporation, the experimental design included a dye swap. Some 
amount of error was attributed to the dye, but was not significant. Data from each of the six 
replicates was used in the statistical analysis. 
Statistical analysis indicated that 91 genes had significant transcriptional differences with 
a />value<0.01 and an estimated false discovery rate of four percent. Results are presented in 
Tables 2.2 and 2.3. The results are also displayed as a volcano plot, with up and down 
regulated genes indicated (Fig. 2.4). 
cl, W) 
: 
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Log 2 Fold Change 
2.5 3 3.5 4 
Figure 2.4. Volcano plot of transcriptional differences in M. hyopneumoniae during heat 
shock conditions. Data represent individual gene responses plotted as Log2 fold change 
versus -Log p-value. Points above -Log p-value = 2 are significantly up- or down-regulated 
at pO.Ol. 
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Table 2.2. Heat shock up-regulated genes in M. hyopneumoniae. 
Gene Gene* Description P- q- Fold 
ID value value Change 
mhp032 CH Conserved Hypothetical 0.0015 0.0192 1.27 
mhp034 parC Topoisomerase IV Subunit A 0.0001 0.0135 1.83 
mhp057 CH Conserved Hypothetical 0.0034 0.0251 1.23 
mhp060 # Signal Recognition Particle Protein 0.0086 0.0378 1.52 
mhp064 CH Conserved Hypothetical 0.0007 0.0135 1.24 
mhp069 CH Conserved Hypothetical 0.0061 0.0325 1.10 
mhp071 UH Unique Hypothetical 0.0019 0.0224 1.39 
mhp072 dnaK Chaperone Protein DnaK 0.0000 0.0064 13.75 
mhp073 dnaJ Heat-Shock Protein 0.0002 0.0135 1.91 
mhp078 lepA 30 kDa GTP-Binding Protein LepA 0.0040 0.0266 1.47 
mhpl28 serS Seryl-tRNA Synthetase 0.0042 0.0267 1.85 
mhpl44 CH Conserved Hypothetical 0.0080 0.0362 1.70 
mhpl45 CH Possible D-Ribose-Binding Protein 0.0049 0.0286 1.75 
mhpl47 rbsA Ribose Transport ATP-Binding Protein 0.0053 0.0302 1.68 
mhpl48 CH Conserved Hypothetical 0.0014 0.0192 1.33 
mhpl49 iolD Myo-Inositol Catabolism 0.0045 0.0273 2.13 
mhpl50 CH Conserved Hypothetical 0.0011 0.0179 2.33 
mhplSl CH Conserved Hypothetical 0.0013 0.0192 2.31 
mhpl52 iolC Myo-Inositol Catabolism 0.0041 0.0266 2.04 
mhpl53 mmsA Methylmalonate-Semialdehyde 0.0005 0.0135 2.53 
Dehydrogenase 
mhpl71 CH Conserved Hypothetical 0.0054 0.0304 1.36 
mhpl72 thdF Thiophene and Furan Oxidation Protein 0.0008 0.0135 1.38 
mhp209 map Methionine Amino Peptidase 0.0077 0.0362 1.31 
mhp211 rpsM 3 OS Ribosomal Protein S13 0.0015 0.0192 1.54 
mhp212 rpsK 30S Ribosomal Protein SI 1 0.0005 0.0135 1.41 
mhp214 50S Ribosomal Protein LI 7 0.0034 0.0251 1.32 
mhp221 DeoB Phosphopentomutase 0.0034 0.0251 1.34 
mhp224 CH Conserved Hypothetical 0.0069 0.0339 1.22 
mhp254 CH Conserved Hypothetical 0.0080 0.0362 1.16 
mhp271 CH Conserved Hypothetical, Putative 0.0005 0.0135 1.61 
Adhesin 
mhp275 CH Hypothetical Protein PI02 0.0023 0.0224 1.40 
mhp277 tpiA Triosephosphate Isomerase 0.0079 0.0362 1.40 
mhp278 clpB ATP-Dependent Serine Proteinase, Heat 0.0003 0.0135 6.29 
Shock 
mhp289 CH Conserved Hypothetical 0.0006 0.0135 1.40 
* UH= unique hypothetical; CH=conserved hypothetical 
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Table 2.2. Continued. 
P- q- Fold 
Gene ID Gene* Description value value Change 
mhp308 UH Unique Hypothetical 0.0023 0.0224 1.38 
mhp334 UH Unique Hypothetical 0.0024 0.0224 1.24 
mhp356 UH Unique Hypothetical 0.0099 0.0405 1.21 
mhp369 g/pF Glycerol Uptake Facilitator Protein 0.0072 0.0346 1.44 
mhp370 g#: Glycerol kinase 0.0087 0.0378 1.43 
mhp374 CH Conserved Hypothetical 0.0010 0.0173 1.41 
mhp399 CH Conserved Hypothetical 0.0003 0.0135 2.64 
mhp445 CH Conserved Hypothetical 0.0020 0.0224 1.55 
mhp446 CH Conserved Hypothetical 0.0007 0.0135 1.81 
mhp459 rplK Ribosomal Protein LI 1 0.0003 0.0135 2.01 
mhp476 atpD ATP Synthase Beta Chain 0.0055 0.0307 1.28 
mhp497 asnS Asparaginyl-tRNA Synthetase 0.0024 0.0224 1.57 
mhpSOO oppC Oligopeptide Transport System 0.0072 0.0346 2.00 
Permease 
mhpSOl oppB Oligopeptide Transport System 0.0049 0.0286 1.72 
Permease 
mhp511 46kD Surface Antigen Precursor 0.0022 0.0224 1.70 
mhp596 CH Conserved Hypothetical 0.0066 0.0336 1.30 
* UH= unique hypothetical; CH=conserved hypothetical 
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Table 2.3. Heat shock down-regulated genes in M. hyopneumoniae. 
Fold 
ID Gene Description pvalue qvalue Change 
mhpOOS CH Conserved Hypothetical 0.0033 0.0251 1.53 
mhpOO? UH Unique Hypothetical 0.0007 0.0135 1.41 
mhp013 UH Unique Hypothetical 0.0065 0.0336 1.55 
Ribosomal Large Subunit Pseudouridine 1.23 
mhpO 15 rluC Synthase 0.0016 0.0200 
Putative ABC Transporter ATP-Binding 1.03 
mhp023 CH Protein 0.0041 0.0266 
Glu-tRNA(Gln) Amidotransferase, 1.69 
mhp030 ga# Subunit B 0.0032 0.0251 
mhp038 CH Conserved hypothetical 0.0056 0.0307 1.19 
mhpl35 rpsT 30S Ribosomal Protein S20 0.0058 0.0316 1.42 
mhpl36 CH Conserved Hypothetical 0.0066 0.0336 1.32 
mhpl76 CH Conserved Hypothetical 0.0031 0.0251 1.48 
mhp235 CH Conserved Hypothetical 0.0093 0.0390 1.16 
mhp240 CH Conserved Hypothetical 0.0043 0.0268 1.27 
mhp241 glutamyl tRNA synthetase 0.0011 0.0179 1.24 
mhp310 UH Unique Hypothetical 0.0027 0.0249 1.39 
mhp330 mod Site-specific DNA-methyltransferase 0.0030 0.0251 1.13 
mhp337 UH Unique Hypothetical 0.0020 0.0224 1.28 
mhp353 CH conserved hypothetical 0.0002 0.0135 2.03 
mhp373 CH Conserved Hypothetical 0.0039 0.0266 1.07 
mhp393 CH Conserved Hypothetical 0.0022 0.0224 1.09 
mhp397 proS Prolyl aminoacyl-tRNA synthetase 0.0037 0.0257 1.56 
mhp410 metG Methionyl-tRNA Synthetase 0.0029 0.0249 1.31 
mhp419 CH Conserved Hypothetical 0.0005 0.0135 1.28 
mhp454 acpD Acyl Carrier Protein Phosphodiesterase 0.0092 0.0390 1.33 
mhp465 CH Conserved Hypothetical 0.0015 0.0192 1.34 
mhp466 CH Conserved Hypothetical 0.0007 0.0135 2.05 
mhp467 hcrA ABC Transporter 0.0092 0.0390 1.34 
mhp468 CH Conserved Hypothetical 0.0029 0.0249 1.26 
mhp474 CH Conserved Hypothetical 0.0032 0.0251 1.32 
mhp485 mgtE Mg2+ Ion Transporter 0.0081 0.0362 1.52 
mhp486 CH Conserved Hypothetical 0.0067 0.0336 2.00 
mhp509 UH Unique Hypothetical 0.0036 0.0257 1.38 
mhp526 CH Conserved Hypothetical 0.0003 0.0135 1.40 
mhp584 UH Conserved Hypothetical 0.0041 0.0266 1.65 
mhp598 polA DNA polymerase I 0.0007 0.0135 1.47 
* UH= unique hypothetical; CH=conserved hypothetical 
Table 2.3. Continued. =========== ==^_===_==^=___= 
Fold 
ID Gene Description pvalue qvalue Change 
mhp619 CH Conserved Hypothetical 0.0087 0.0378 1.37 
mhp620 CH Conserved Hypothetical 0.0001 0.0135 2.13 
mhp621 CH Conserved Hypothetical 0.0006 0.0135 1.40 
mhp658 UH Unique Hypothetical 0.0046 0.0278 1.17 
mhp672 rplM 50S Ribosomal Subunit Protein L13 0.0099 0.0405 1.39 
mhp674 CH Conserved Hypothetical 0.0022 0.0224 1.43 
mhp697 CH Conserved Hypothetical 0.0068 0.0337 1.34 
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Validation of the microarray data 
Analysis indicated the four genes verified were significant using semi-quantitative PCR. 
The primers used in generating the RT-PCR products are given in Table 2.4. The results are 
shown in Figure 2.5. 
Table 2.4. RT-PCR primers. 
Gene ID Primer Name 
rRNA RNA-F 
RNA-R 
mhp072 072-F 
072-R 
mhp073 073-F 
073-R 
mhp511 511-F 
511-R 
mhp620 620-F 
620-R 
Primer Sequence (5'-) 
AGACGAT GAT GTTT AGCGGGG 
TGCTGCTCTTTGTAGTAGCCATG 
ATT AT CCGGT GG AACCTTCG 
AGTTCAACGTT AAT CGGCCC 
T GGTTTT GGT GGCT C AC A AG 
TTTTTCCACGGCACTTTTTG 
A AGGT CTTTC ACTTGCT GCG 
GATT GG ATT CTTT GACCGGC 
TTACTTACAACCAGCGCGAC 
AAACAGTT G ACGGCTTTTCG 
-ÇeneL 1 3 5 7 9 11 i3p'value 
mhp16S 0.474 
mhp072 Q 0.011 
<0.001 mhp073 
mhp511 
mhp620 
<0.001 
<0.001 
Figure 2.5. Semi-quantitative RT-PCR. Semi-quantitative RT-PCR was performed on the 
m RNA transcripts in control and heat shocked samples. Lanes 1, 3, 5, 7 and 9 are control 
samples from M. hyopneumoniae incubated in normal growth media at 37°C. Lanes 2, 4, 6, 8 
and 10 are samples from M. hyopneumoniae incubated in media at 42°C. Lane 13 is the 
genomic DNA control. The gene designation is given on the left and the /j-value of the 
densitometry readings is given on the right. 
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Discussion 
Little is known about the mechanisms M. hyopneumoniae uses to colonize the respiratory 
epithelium and circumvent the host immune response. During infection, M. hyopneumoniae 
must encounter different environments as the numbers of organisms increase and the host 
responds accordingly with an influx of macrophages and neutrophils. If mycoplasmas are 
like other bacterial pathogens, they have mechanisms to respond to the changing in vivo 
environment, ensuring the organism's survival during active host immune responses. 
The host employs both innate and adaptive immune response strategies to protect it 
against pathogens. These environmental changes are generally thought of as stress conditions 
because they are often detrimental to the pathogen. For instance, cytokine release by host 
immune effector cells can lead to temperature fluxes in the host that may impact the 
organism's ability to maintain itself in the respiratory tract. Most bacteria have several genes 
that are induced to respond to this "heat shock". These genes usually encode proteins 
involved in protein folding and the prevention of protein aggregation, and in protein 
degradation of improperly folded proteins. The increased transcription of these genes during 
temperature shifts is indicative of an important role in survival. Denatured or nascent proteins 
do not function properly and would eventually lead to bacterial death. 
Fifty two-percent of the up-regulated genes (Table 2.2) have been assigned a function 
based on their sequence homology. These include functions involved in protein folding, 
metabolism, and translation. dnaK (mhp072), a member of the Escherichia coli hsp70 family, 
was identified as the most significantly up-regulated gene. Its role as a chaperone to protect 
proteins from improperly folding is well known. It also serves a regulatory function by 
sequestering a32 from the cytoplasm and presenting it to proteases. During heat shock, DnaK 
binds to denatured proteins thus releasing a32 to interact with RNA polymerase and up-
regulate heat shock genes (37). Other heat shock-related genes,parC (mhp034), dnaJ 
(mhp073), and clpB (mhp278), were also significantly up-regulated in M. hyopneumoniae. 
These genes function to assist in protein folding, in degrading improperly folded proteins and 
in cell partitioning activities associated with DN A structure. Some of the genes appear to be 
members of opérons, e.g. mhpl44 through mhp 153 whose products are thought to be 
involved in carbohydrate metabolism, and mhp211 through mhp214 that code for ribosomal 
proteins and RpoA (mhp213), the a subunit of RNA polymerase. The structure of this operon 
is different than that found in E. colv, the M. hyopneumoniae operon lacks S4, the 
transcriptional regulator that binds to the leader sequence upstream of S13 (15). In other 
bacteria the ribosomal protein genes in this operon, the a operon, are regulated by 
translational coupling, but not rpoA. Thus, the mode of regulation for this operon in M. 
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hyopneumoniae is unknown, but it appears different than in other bacteria. mhp213 had a p-
value of 0.013266 and just missed our arbitrary cutoff (p<0.01) for inclusion in Table 2.2. 
Forty-eight percent of the genes had unassigned functions and may represent important 
stress-related functions required for host colonization and persistence. 
One of the more interesting genes up-regulated during heat stress was ffh, the/ifty-/our 
kilodalton subunit homologue of the eukaryotic signal recognition particle. This is the first 
report of its regulation in response to heat stress and may represent a need to increase protein 
translocation in M. hyopneumoniae either to stabilize the membrane or maintain the integrity 
of membrane proteins, ffh is normally thought not to undergo regulation, but recent evidence 
suggests that in Gram positive bacteria it may be regulated in response to acid stress (11). In 
addition,^ was not regulated in M. pneumoniae during heat stress (32), suggesting that 
mycoplasmas may regulate different sets of genes during heat shock as a consequence of host 
adaptation. 
At least 41 genes were down-regulated in response to elevated temperatures. A larger 
proportion (73%) of these genes had unassigned functions compared to those up-regulated 
(48%). Many of these genes are involved in translation and DNA replication showing that 
temperature stress slows translation and replication, reducing energy needs, and slowing 
cellular physiology. These genes include rluC (mhp015), rpsT (mhpl35), and rplM 
(mhp672), as well, as DNA polymerase I (mhp598). This suggests that ribosomal proteins 
may have alternative functions since some are up-regulated in response to heat shock and 
some are down-regulated . Other genes fall into the classes of transporters, mgtE (mhp485) 
and bcrA (mhp467); carrier proteins, acpD (mhp454); and tRNA synthases, metG (mhp410), 
gatB (mhp030) andproS (mhp397). This is similar to other bacterial pathogens and suggests 
that reduction in energy requiring processes in the bacterial cell during heat stress is a 
fundamental property of pathogenesis and bacterial physiology. 
Little is known about the response of mycoplasmas to heat shock, particularly at the 
transcriptional level. Several studies have identified heat shock proteins or specific gene 
products in mycoplasmas (4, 25, 32). Weiner et al. analyzed the response of M. pneumoniae 
to heat shock conditions on a global scale using microarrays and identified 47 up-regulated 
genes (32). No other studies have taken a global approach to identifying heat shock related 
genes in mycoplasmas, however. A report that Hsp60 was present in M. hyopneumoniae (25) 
could not be substantiated by the genome sequence of strain 232, the strain used in these 
studies (18). In fact, both GroEL and GroES are missing in the M. hyopneumoniae genome. 
The experimental design to use a temperature shift of 37 to 42°C following equilibration 
at 32°C was based on several reasons. A temperature of 32°C is the usual starting 
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temperature for heat shock studies and was the starting temperature used by Weiner et al. for 
their studies with M. pneumoniae (32). Unlike M. pneumoniae, however, M. hyopneumoniae 
does not grow at measurable levels at 32°C. Mycoplasma pneumoniae was able to replicate 
albeit slowly at 32°C and thus, they were able to perform their studies starting at 32°C after 
an extended (144 h) culture period. In the reported studies, the 32°C temperature was used to 
synchronize the cultures prior to shifting to the experimental temperatures. A two hour time 
point was chosen because it represents an approximate generation time at 37°C. The 
temperature differential of 37 to 42°C, which was chosen to reproduce the effects of elevated 
temperatures in the infected host, was maintained for 30 min to allow the mRNA transcripts 
of the slow growing organisms to come to steady state. While a temperature shift of 5 
degrees is unusual for heat shock studies, M. hyopneumoniae is host adapted and cannot 
survive for any length of time in the environment. Thus, it would normally be exposed only 
to temperature fluctuations within the host. 
These studies place maximum stress on M. hyopneumoniae in the form of an upper 
temperature limit of 42°C to maximize transcriptional variation and increase the probability 
of identification of regulated genes. A temperature higher than 42°C, e.g. the 43 °C used by 
Weiner et al. (32), would not be reached within the host. These data indicate that 91 M. 
hyopneumoniae genes are either up-regulated or down-regulated in response a 37 to 42°C 
temperature shift at a significance level of /?<0.01 (Tables 2.2 and 2.3). It suggests that M. 
hyopneumoniae responds to temperature changes by altering transcriptional activities of 
specific genes through unknown mechanisms. It also suggests that mycoplasmas respond 
differently depending on the species and possibly host. 
A large percentage of heat shock responsive genes (-60%) have no functional 
assignment. Future studies will be required to identify either the roles of these gene products 
in physiology and pathogenesis. How these genes are controlled in the absence of typical 
heat shock regulators (i.e. rpoH) is not known, but perhaps mechanisms operative in related 
Gram positive bacteria might be involved. However, now that these genes have been 
identified, studies of upstream sequences may provide insight into regulatory mechanisms 
despite the lack of genetic tools in M. hyopneumoniae. These studies focused on 
transcriptional changes, but other mechanisms involving ribosome conformation (30) or 
posttranslational processing (5) might also be involved. 
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Abstract 
Mycoplasma hyopneumoniae, the causative agent of swine enzootic pneumonia and a 
major component of the porcine respiratory disease complex, continues to confound swine 
producers despite control programs worldwide. The disease is chronic and self-limiting, but 
the host is subject to immunopathologic changes that potentiate respiratory disease associated 
with other pathogens. The response of M hyopneumoniae to environmental stress is of 
interest because of the relevance to virulence mechanisms in other bacterial pathogens. One 
of these stressors, iron deprivation, is a prominent feature of the host innate immune 
response, and most certainly impacts growth of mycoplasmas in vivo. To study this, 
microarray technology was applied to the transcriptome analysis of M hyopneumoniae 
during iron deprivation. An array consisting of 632 of the 698 open reading frames in the 
genome was used to compare the mRNA isolated from organisms grown under normal 
laboratory conditions with those subjected to iron deprivation with the chelator 2,2'-
dipyridyl. We employed a unique hexamer primer set for generating cDNA from only mRNA 
species. Our analysis identified 27 genes that were either up- or down-regulated in response 
to low iron growth conditions (p <0.01) with an estimated false discovery rate below ten 
percent. Among these were transport proteins, enzymes involved in energy metabolism, and 
components of the translation process. A proportion of the identified genes (10 of 27) had no 
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assigned function. These studies indicate that M. hyopneumoniae can respond to changes in 
environmental conditions, but the mechanism employed remains unknown. 
Introduction 
Mycoplasma hyopneumoniae is the causative agent of swine enzootic pneumonia (23) 
and contributes significantly to porcine respiratory disease complex (29). Despite aggressive 
vaccination programs, M. hyopneumoniae continues to induce lesions in as many as 80% of 
the pig population (24). It colonizes the respiratory epithelia where it attaches exclusively to 
the cilia (17) causing ciliostasis and cell death (7, 14). 
Like all mycoplasmas, M. hyopneumoniae must acquire essential nutrients from its host 
because it lacks biosynthetic pathways due to the limited coding capacity of its genome (18). 
One of these nutrients, iron, is an essential metal for almost all living systems. The one 
known exception is the agent of Lyme disease, Borrelia burgdorferi (20). Iron serves as a 
cofactor or as a prosthetic group for essential enzymes that are involved in basic cellular 
functions (19). Free iron, however, does not exist in useful concentrations under neutral pH 
conditions since it is readily oxidized forming the hydroxide Fe(OFI)^, which is soluble only 
at 1.4 x 10"9 M at pH 7 (2). Free iron catalyzes the formation of free oxygen radicals and as 
such is highly toxic to cells. Therefore, iron is normally bound to specific proteins in the host 
such as transferrin and lactoferrin to prevent its precipitation in aqueous systems and to 
protect the cell from damaging UV light and lipid peroxidation reactions. In this way, iron is 
both sequestered for use by the host and prevents its use by invading pathogens. 
Most bacteria require iron concentrations in the range of 10"6 to 10"7 M for their 
metabolic processes (33). Therefore, bacteria have evolved mechanisms to compete with the 
host for available iron. These mechanisms usually involve multiple components that are 
highly coordinated to achieve their goal. In most bacteria iron binding molecules, 
siderophores, are secreted to compete with the host transferrin or lactoferrin for iron, and 
then the iron-siderophore complex is taken up by specific surface receptors and porin-like 
transporters (26). Since, considerable energy investment is needed by the bacteria to express 
competitive iron acquisition systems, their expression is often tightly regulated by iron 
availability (5). 
Unlike other bacteria, mycoplasmas have minimal gene coding capacity (12) and lack 
cell walls, so it is thought that their interactions with the host are less complex, including the 
acquisition of essential nutrients. Pathogenic mycoplasmas pose interesting questions 
concerning iron metabolism because they lack a host-free lifestyle, they have single limiting 
membranes and few studies have been performed on iron requirements. While it has not been 
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unequivocally shown that iron is essential for growth, Bauminger et al. showed iron was 
stored in Mycoplasma capricolum (4) and Try on and Baseman have shown that Mycoplasma 
pneumoniae can take up human lactoferrin (30). Mycoplasmas also contain enzymes that 
have been shown in other systems to contain iron such as dehydrogenases. 
Whether mycoplasmas contain complex iron acquisition mechanisms is not known. Iron 
deprivation in other bacterial systems triggers not only the genes required for its acquisition 
but also in many pathogens is a signal for controlling virulence factor expression (13, 22, 26, 
28). Thus, virulence factors can sometimes be identified by their response to low iron growth 
conditions. These studies show that iron deprivation in vitro leads to transcriptional changes 
in M. hyopneumoniae. The iron chelator 2,2'-dipyridyl was used to chelate iron in the serum 
rich media, and the transcriptional responses to iron sequestration were measured using 
microarrays. Genes that were both up-regulated and down-regulated were identified in this 
study. 
Materials and Methods 
Mycoplasma strains and culture conditions 
Pathogenic M. hyopneumoniae strain 232, a derivative of strain 11, was used in this study 
(16). Cultures used were passed fewer than 15 times in vitro in Friis media as previously 
described (11). Twelve 250 ml flasks containing 125 ml cultures were grown at 37°C to 
early-log phase as determined by medium color change and optical density. To six flasks, 
2,2'-dipyridyl (Sigma Chemical Co., St. Louis, Mo.) was added to a final concentration of 1 
mg/ml. Six flasks were left untreated, and all flasks were incubated for 2 h at 37°C. Cells 
were pelleted by centrifugation at 24,000 x g, and 500 jal of RNAlater (Ambion, Inc. Austin, 
Tex.) was added to pellet. Pellets were stored at -70°C until the total RNA was isolated. 
Mycoplasma gallisepticum (ATCC19610) and Mycoplasma pulmonis UAB6510 (6) were 
grown in modified Hayflick's media as described except that the media was supplemented 
with 25 pg/ml cefoperazone (Pfizer, New York) instead of thallium acetate and 
benzylpenicillin (10). To assess the effect that various iron chelators would have on 
mycoplasmas growth, Hayflick's media was supplemented with 2,2'-dipyridyl (0.2 and 1 
mg/ml), sodium citrate (1, 2, 5 and 7.5 mM) and desferoxamine (desferyl) mesylate (0.2 and 1 
mg/ml). Growth was determined by plating 10-fold serial dilutions of these broth cultures at 
different time points onto Hayflick's agar media lacking chelators. Colony forming units were 
determined after incubation at 37°C for 4-5 days. 
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Microarray 
The M. hyopneumoniae microarray consists of polymerase chain reaction (PCR) products 
(probes) spotted to Corning (Corning, Inc., Big Flats, N.Y.) UltraGAPS glass substrates. 
Ninety-one percent (632/698) open reading frames (ORFs) are represented on the array as 
PCR products of 125-350 bp in length. Each product is a unique sequence even within 
paralogous families as described by Minion et al. (18). The 66 missing ORFs are due to an 
inability to design suitable primers (12 ORFs) or failed PCR reactions due to incorrect 
product size, multiple bands or no band (54 ORFs). Only ORFs greater than 125 bp are 
represented on the array and no tRNAs or rRNas were included. The primer design, array 
construction and validation have been described (Chapter 2). 
Experimental design 
Six independent RNA samples from iron-depleted cells were paired with six independent 
RNA samples from control cells for hybridization on six two-color microarrays. The six 
arrays were spotted on a total of three slides. Each slide was divided into two regions (upper 
and lower), and each region contained the full array of spots. Each of the 632 sequences in 
the array was represented by three replicate spots. 
For three of the six arrays, the control sample was labeled with Alexa 555 dye and 
compared to the iron-depleted sample labeled with Alexa 647 dye (Molecular Probes, Inc., 
Eugene, Ore.). The dye assignment to control and treated samples was reversed for the other 
three arrays. The three slides were hybridized under identical conditions as described below. 
RNA isolation 
RNA was isolated from frozen cell pellets using the Versagene™ RNA Purification 
System (Centra Systems, Minneapolis, Minn.) according to the manufacturer's protocol. The 
optional step of DNase treatment was performed on column according to the manufacturer's 
recommendation. With a cut-off of 150 bp, 5S rRNA and tRNAs were removed from the 
samples, limiting interference in downstream manipulations. Samples were quantified and 
checked for purity using the Nanodrop® ND-1000 Spectrophotometer (Nanodrop, 
Wilmington, Del.). If necessary, samples were concentrated using Microcon YM-30 micro-
concentrators (Millipore, Billerica, Mass.) for optimal cDNA generation. 
Target generation and hybridization 
Targets were generated from total RNA extracted from cell pellets as described above. 
Fluorescently labeled cDNA targets were generated and purified using the SuperScript™ 
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Indirect cDNA Labeling System (Invitrogen Corp., Carlsbad, Calif.) with a set of 129 ORF-
specific six-mer oligonucleotide primers designed as previously described (Chapter 2). 
Targets were labeled with Alexa Fluor™ 555 Reactive Dye or Alexa Fluor™ 647 Reactive 
Dye (Molecular Probes, Inc.). Following purification of the labeled cDNA, samples were 
dried in a vacuum centrifuge and then resuspended in 10 |il Pronto! cDNA/long oligo 
hybridization solution (Coming). Targets were denatured at 95°C for 5 min and centrifuged at 
13,000 rpm for 2 min at room temperature. Targets from a control and iron-deprived culture 
were then combined, pipetted to an array, and covered with a 22x22 mm HybriSlip™ 
(Schleicher & Schuell, Keene, N. H.). Slides were placed in a Coming hybridization chamber 
and incubated in a 42°C water bath for 12-16 h. Slides were washed according to Coming's 
UltraGAPS protocol and dried by centrifugation. 
Data acquisition and normalization 
Each array was scanned with each dye channel using a ScanArray Express laser scanner 
(Applied BioSystems, Inc., Foster City, Calif.) at least three times under varying laser power 
and PMT gain settings to increase the dynamic range of expression measurement (8). Images 
were quantified using the softWorRx Tracker analysis software package (Applied Precision, 
Inc., Issaquah, Wash.). Spot-specific mean signals were corrected for local background by 
subtracting spot-specific median background intensities. The natural logarithms of the 
background-corrected signals from a single scan were adjusted by an additive constant so 
that all scans of the same array-by-dye combination would have a common median. The 
median of these adjusted-log-background-corrected signals across multiple scans was then 
computed for each spot to obtain one value for each combination of spot, array, and dye 
channel. These data for the two dye channels on any given array were normalized using 
LOWE S S normalization to adjust for intensity-dependent dye bias (9, 35). Following 
LOWES S adjustment, the data from each channel were adjusted by an additive constant so 
that the median for any combination of array and dye would be the same for all array-by-dye 
combinations. The normalized values for triplicate spots were averaged within each array to 
produce one normalized measure of expression for each of the 632 probe sequences and each 
of the 12 RNA samples. 
Data analysis 
A separate mixed linear model analysis was conducted for each probe sequence using the 
normalized data (34). Each mixed model included fixed effects for treatment (iron depletion 
versus control), slide region (upper versus lower), and dye (Alexa 555 versus 647) as well as 
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random effects for slide and slide-by-region interaction. A /-test for differential expression 
across treatments was conducted for each probe as part of our mixed linear model analyses. 
The 632 p-values from these /-tests were converted to q-values using the method of Storey 
and Tibshirani (27). These ^-values can be used to obtain approximate control of the False 
Discovery Rate at a specified value. For example, declaring probes with ^-values less than or 
equal to 0.05 to be differentially expressed produces a list significant results for which the 
False Discovery Rate is estimated to be approximately 5%. Along with ^-values, estimates of 
fold-change were computed for each probe by taking the inverse natural log of the mean 
treatment difference estimated as part of our mixed linear model analyses. 
Confirmation of microarray data 
To confirm significant transcriptional differences between genes, semi-quantitative RT-
PCR analysis was performed on a subset of genes that showed significant up- or down-
regulation in the microarray analysis. The PCR was performed in 96 well plates in a MJ 
Research Dyad Thermal Cycler (Bio-Rad Laboratories, Inc., Waltham, Mass.) in 20 jxl 
reactions. The six cDNA preparations for each control and iron depleted sample was used 
with the following conditions: IX PCR Buffer; 2 mM MgCla; 1.0 mM each dATP, dCTP, 
dTTP and dGTP (Fisher Bioreagents, Fairlawn, NJ); 5 pmol of each forward and reverse 
primer; 2.5 units Taq polymerase (New England Biolabs, Beverly, Mass.); and 2 p.1 cDNA 
from either control or iron depleted samples diluted 1:50. The thermal cycling conditions 
were as follows: denaturation at 95°C for 5 min; and then 25 cycles of denaturation at 94°C 
for 1 min, anneal at 50°C for 1 min, and elongation at 72°C for 30 sec. A final elongation step 
at 72°C for 10 min was performed. The reactions were mixed with 4 |il 6X loading dye [10 
mM Tris-HCl (pH 7.6), 0.03% bromophenol blue, 0.03% xylene cyanol FF, 60% glycerol, 60 
mM ethylenediamine tetraacetic acid], and 10 jil were analyzed by 1.5% agarose gel 
electrophoresis. Gels were stained with 0.5 (J-g/ml ethidium bromide to confirm that a single 
product of correct size was present. The gel was visualized and digitized, and each band 
density was measured with FlourChem 8000 version 2.0 software (Alpha Innotech Corp., 
San Leandro, Calif). Analysis of variance was performed to determine differences between 
band density values of iron-depleted vs control samples. Band densities were background 
corrected by subtracting the background density within the reaction lane from the sample 
band density. Estimated differences were considered significant if the p-value of a /-test was 
<0.05. 
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Results 
Iron depletion studies 
Preliminary growth studies were performed with M. gallisepticum and M. pulmonis to 
determine optimal concentrations of 2,2'-dipyridyl, sodium citrate or desferyl mesylate to use 
in studies with M. hyopneumoniae. The rationale for these studies was that M 
hyopneumoniae growth is difficult to quantitate since it grows poorly on agar surfaces giving 
rise to pin point size colonies only under undefined ideal growth conditions. Both M. 
gallisepticum and M. pulmonis grow well in comparison to M. hyopneumoniae, readily form 
colonies on agar surfaces, and like M. hyopneumoniae, have a host-adapted life style. It was 
thought that they would react in a similar fashion to M. hyopneumoniae under iron limiting 
conditions since all three species grow in an environment replete with transferrin and 
lactoferrin. Since little is known about iron sequestering mechanisms in mycoplasmas, three 
chelators with different iron binding mechanisms and affinities were used in the preliminary 
studies. Our goal was to identify a chelator that could slow or stop the growth of M 
gallisepticum and M. pulmonis while growing in serum-rich medium. Figure 3.1 shows the 
results of supplementing Hayflick's growth media with 2,2'-dipyridyl at 0.2 and 1 mg/ml. 
This demonstrates that 2,2'-dipyridyl consistently slowed growth but only at the highest 
concentration (1 mg/ml). Neither sodium citrate nor desferyl mesylate had an effect on 
growth at any concentration tested (data not shown). Assuming the same effect on M 
hyopneumoniae growth, subsequent iron-limiting studies with M. hyopneumoniae were 
performed with 2,2'-dipyridyl supplemented at a concentration of 1 mg/ml. 
Microarray studies 
We assessed the transcriptional profile of M. hyopneumoniae using microarrays 
containing 632 of the 698 ORFs in the genome (18)(also see Chapter 2). These arrays were 
constructed by spotting PCR products of 150-350 bp in size to glass substrates. Each of the 
PCR products were unique in sequence, even those of the paralog families (18). In a few 
instances, unique primers could not be designed or primers failed to produce the proper PCR 
products during reactions. These 66 ORFs were eliminated from our analysis. 
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Figure 3.1. Effect of 2,2'-dipyridyl on growth of M. pulmonis and M gallisepticum. 
Overnight cultures of both mycoplasmas were diluted 1:20 in fresh culture media containing 
100 pg/ml (open circles), 200 pg/ml (closed circles) and 1 mg/ml (open squares) and 
incubated at 37°C for the indicated time. Samples were removed, serially diluted and plated 
on mycoplasma agar lacking chelator for colony counts at the times indicated. 
To assess the effect of 2,2'-dipyridyl on M. hyopneumoniae global transcriptional 
profiles, broth-grown cultures were supplemented with the chelator and incubated for 2 h at 
37°C. Following centrifugation of the cells, total RNA was extracted from six replicate 
control and six supplemented cultures, and cDNA reactions were performed independently 
on each of the twelve RNA preparations. Total RNA concentrations post purification were 
approximately 15-20 pg total RNA, and cDNA concentrations ranged from 2-6 |ig total 
cDNA. Control and iron-depleted samples were paired and equal concentrations of total 
RNA were added to cDNA reactions. Three samples from each treatment were labeled with 
Alexa Flour 555 and three with Alexa Fluor 647. The label incorporation of fluorescent dyes 
ranged from 20-65 base pairs/dye molecule, which is well within the recommended range of 
label incorporation (http://probes.invitrogen.com/ resources/calc/basedyeratio.html). To 
account for variation due to dye incorporation, the experimental design included a dye swap 
with the three remaining sample pairs. One control and the paired 2,2'-dipyridyl 
supplemented labeled cDNA samples were mixed and hybridized to a single M. 
hyopneumoniae array overnight. Following scanning, the spot finding was performed to 
obtain signal intensity values at the two wavelengths representing the two dye adsorption 
maxima. 
Data from each of the six replicates was used in the statistical analysis. Some amount of 
error was attributed to the dye, but the effect was not significant in the experimental model as 
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analyzed by ANOVA. Statistical analysis indicated that 27 genes had significant 
transcriptional differences with a p-value <0.01. The results are presented in Table 3.1 and in 
Figure 3.2. Nine genes demonstrated a significant increase in transcriptional activity under 
iron limiting conditions as compared to control cells grown under normal in vitro conditions. 
Eighteen genes, however, were down regulated under these conditions. Figure 3.2 displays 
the results of the 632 genes as a volcano plot, with up and down regulated genes marked. 
4.5 
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Figure 3.2. Volcano plot of transcriptional differences in M. hyopneumoniae during low 
iron growth conditions. Data represent individual gene responses plotted as Log; fold change 
vs. -Log p-value. Points above -Log 7;-value = 2 are significantly up or down regulated at 
/?<0.01. 
Validation of microarray data 
Semi-quantitative RT-PCR was performed on a subset of genes to validate the microarray 
results. RT-PCR reactions were performed using the 12 RNA samples from the control and 
low iron studies. The reactions contained equal RNA concentrations and were performed at 
the same time to reduce experimental error. Reaction products were separated on an agarose 
gel, stained, and the band intensities quantitated. The twelve experimental replicates for each 
gene (six control and six low iron samples) were analyzed for significance. The RT-PCR 
product signal intensities for genes mhpl40, mhpl51 and mhp558 from low iron conditions 
was significantly different than control at p <0.01. Genes mhp275 and mhp639 were not 
significantly different at p = 0.01. The primers used for the RT-PCR reactions are given in 
Table 3.2. The results are shown in Figure 3.3. 
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Table 3.1. Differentially expressed genes of M. hyopneumoniae during growth under iron 
limiting conditions. 
Gene ID Gene Description jD-value g-value FC 
Upregulated 
mhpl40 UH Unique Hypothetical 0.0083 0.0957 1.29 
mhpl51 CH Conserved Hypothetical 0.0069 0.0957 2.35 
mhpl52 WO Myo-Inositol Catabolism 0.0083 0.0957 2.15 
mhp275 CH Hypothetical Protein, PI02 Paralog 0.0076 0.0957 1.68 
mhp317 gW Glycerophosphoryl Diester 0.0024 0.0957 1.42 
Phosphodiesterase 
mhp319 mglA ABC Transporter ATP Binding Subunit 0.0013 0.0633 0.98 
mhp505 ackA Acetate Kinase 0.0049 0.0957 1.95 
mhp510 UH Unique Hypothetical 0.0041 0.0957 1.34 
mhp558 potB Spermidine/Putrescine Transport Permease 0.0007 0.0588 1.33 
Downregulated 
mhp030 gatB Glu-tRNA Amidotransferase, Subunit B 0.0063 0.0957 1.63 
mhpOSl UH Unique Hypothetical 0.0055 0.0957 1.23 
mhp083 fusA GTP-Binding Chain Elongation Factor EF- 0.0012 0.0633 1.63 
G 
mhp085 rpsL 30S Ribosomal Protein S12 0.0002 0.0347 1.34 
mhp087 CH Conserved Hypothetical 0.0031 0.0957 1.35 
mhp 117 hpt Hypoxanthine Phosphoribosyl Transferase 0.0097 0.0957 1.53 
mhp 167 oppD Oligopeptide Transport System Permease 0.0042 0.0957 2.41 
mhp168 oppC Oligopeptide Transport System Permease 0.0062 0.0957 2.12 
mhp169 oppB Oligopeptide Transport System Permease 0.0050 0.0957 1.50 
mhp 176 CH Conserved Hypothetical 0.0009 0.0631 1.50 
mhp190 rpL2 50S Ribosomal Protein L2 0.0100 0.0957 1.76 
mhp337 UH Unique Hypothetical 0.0062 0.0957 1.17 
mhp411 CH Conserved Hypothetical 0.0079 0.0957 1.13 
mhp450 metK S-Adenosylmethionine Synthetase 0.0100 0.0957 1.36 
mhp637 rplL 50S Ribosomal Protein L7/L12 0.0028 0.0957 1.46 
mhp639 CH Conserved Hypothetical 0.0001 0.0333 1.60 
mhp651 ushA 5'-Nucleotidase 0.0003 0.0347 2.46 
mhp666 CH Conserved Hypothetical 0.0047 0.0957 1.31 
* UH= unique hypothetical; CH=conserved hypothetical; FC = Fold Change 
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Table 3.2. RT-PCR primer sequences. 
Gene ID Primer Name Primer Sequence (5'-) 
rRNA RNA-F AGACGATGATGTTTAGCGGGG 
RNA-R T GCTGCT CTTT GT AGT AGCCAT G 
mhp 182 182-F T A AAA ACCGT GATT G AGGGC 
182-R GCT GTT CAAATGCTT GT CCC 
mhp275 275-F T GAT ATT GTT GAT CTAGTCGACGG 
275-R GGGCTT AC ACCTT CTTT GGC 
mhp374 374-F TTTGGTTATT CT AATT GGCG 
374-R AACC ACTT GGTTTT AGTT CGAC 
mhp558 558-F GAAGCCGGGACTG ATTT AGG 
558-R AGGGTCACCAAAACAAGCG 
mhp639 639-F AGGTCATCGAAAACGGGC 
639-R ATAGTTTCAAGGGCTTGGCG 
mhp677 677-F CC AG AAT AT GTTT GGT GGGG 
677-R TT GAT C AACT CGGG AC ATCG 
mm; 
mnuiG 
mnp 
mhp 
1 3 11 
miplc-1 
mnc275 
U L'91 
<0.GC1 
:JJ l'PM'f'M'M'I'l r 51 
Figure 3.3. Semi-quantitative RT-PCR. Semi-quantitative RT-PCR was performed on the 
mRNA transcripts in control and iron depleted samples. Lanes 1, 3 ,5, 7 and 9 are control 
samples from M. hyopneumoniae incubated in normal growth media. Lanes 2, 4, 6, 8 and 10 
are samples from M. hyopneumoniae incubated in media containing 2,2'-dipyridyl. Lane 13 
is the genomic DNA control. The gene designation is given on the left and the p- value of the 
densitometry readings is given on the left. 
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Discussion 
Mycoplasma hyopneumoniae is found worldwide and is transmitted via aerosol from pig 
to pig. In order to survive, M. hyopneumoniae must establish itself in the upper respiratory 
tract of its host in the face of significant innate immune defense mechanisms. One of these, 
iron sequestration, operates by preventing access of the pathogen to the essential metal by 
binding available iron to transferrin, lactoferrin and lactotransferrin (21). The host uses these 
molecules to prevent free iron from undergoing oxidation reactions that are detrimental and 
by providing a pool for host purposes. Iron is vital to the survival of almost all known 
organisms because of its requirement as a cofactor or a prosthetic group for essential 
enzymes (26). By sequestering iron, the host is able to limit the growth of pathogens, 
providing a level of security. Iron exists primarily in the oxidized ferric form with a solubility 
constant of 1.4 x 10"9 M (21). Transferrin, lactoferrin and lactotransferrin have iron binding 
constants in the range of~1020(l, 3), and transferrin is never fully saturated under normal 
conditions, giving the host additional iron sequestration capabilities during bacterial 
infections. 
Bacteria, however, have evolved mechanisms for iron acquisition that are tightly 
controlled by the level and availability of iron in the environment (21). These mechanisms 
involve transcriptional regulators such as Fur and cognate DNA binding sites (Fur binding 
sites) at genes involved in iron uptake (32). The function of these genes involve binding of 
host transferrin or lactoferrin and its reduction and uptake, or siderophore production, 
secretion, and transport systems (21). The Fur regulated genes are also thought to contribute 
to virulence in many pathogens, because the existence of multiple iron acquisition systems 
allow for alternate means of iron acquisition and virulence under changing environmental 
conditions within the host during disease. The regulation of iron acquisition genes linked 
with virulence factors allows for cell invasion, and possibly cell death, increasing the iron 
available for uptake by the bacteria (25). Sequence analysis of the M. hyopneumoniae 
genome has not identified any putative/wr genes or their regulators (18), so it was of interest 
to determine if M. hyopneumoniae would respond to an environment in which iron was 
sequestered by a chelator other than transferrin or lactoferrin. 
The goal of this study was to determine the steady-state levels of individual mRNA 
species on a global level during growth of M. hyopneumoniae under normal laboratory 
conditions and compare those levels with organisms grown under iron limiting conditions. 
This would allow the definition of iron-regulated genes in M. hyopneumoniae as a first step 
towards identifying their mechanism of regulation and possible role in virulence. Like other 
mycoplasmas, the medium for M. hyopneumoniae is supplemented with serum, a rich source 
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of iron-binding transferrin. The medium used for M. hyopneumoniae growth is supplemented 
with 20% swine serum, a higher level than normally used in most other mycoplasma media, 
which is approximately 5-10%. Under in vivo conditions, M. hyopneumoniae is exposed to 
mucosal secretions, a rich source of iron-binding transferrin and lactoferrin and similar to the 
in vitro growth conditions in terms of iron availability. If mycoplasmas are to respond to host 
iron sequestration mechanisms during disease, they must contain mechanisms for binding 
and transporting iron across their membrane. 
Little research has been done to examine the binding of iron-acquisition proteins 
lactoferrin and transferrin by mycoplasmas. Whether M. hyopneumoniae or any other 
mycoplasma requires iron for growth is not known, but it is likely that enzymes with iron 
containing prosthetic groups are present in mycoplasmas. One study has examined the 
interaction of M. pneumoniae and Mycoplasma genitalium with these proteins and found that 
M. pneumoniae binds lactoferrin but not transferrin (30). Mycoplasma genitalium did not 
bind either protein. Iron storage occurs in M. capricolum (4), but iron acquisition or iron 
requirements have not been studied further in the mycoplasmas. 
The rationale for using chelators in this study was to expose the mycoplasma to 
conditions that prevent iron uptake through normal pathways. This should be reflected in 
slower or lack of growth under the iron limiting conditions assuming there is a requirement 
for iron. Our initial studies used M. gallisepticum and M. pulmonis with three different iron 
chelators to estimate the need for iron among the mycoplasmas and to identify a chelator and 
concentration that might provide a slower growth response. Both of these species grow well 
and readily form colonies on agar surfaces for quantitative purposes. They are also both 
respiratory pathogens, and like M. hyopneumoniae are exposed to the transferrin-lactoferrin 
mediated iron sequestration mechanisms of the host. Since both species demonstrated a 
growth effect with 1 mg/ml 2,2'-dipyridyl (Fig. 3.1), this chelator and concentration were 
used in transcriptional profiling studies with M. hyopneumoniae. We also chose a single time 
point, 2 hours, because it represents an approximate generation time for M. hyopneumoniae 
under the growth conditions employed. 
The effect of iron deprivation on mRNA levels in M. hyopneumoniae is shown in Table 
3.1 and Figure 3.2. Analysis of the data indicates that nine genes were up-regulated during 
iron deprivation. These genes include iolC (mhp 152), glpQ (mhp317), mlgA (mhp319), ackA 
(mhp505), potB (mhp558) in addition to four hypothetical genes (mhp 140, mhpl51, mhp275, 
and mhp510). One of these, mhp 275, is a member of the PI 02 paralog family (18). The 
function of PI02 or any of its paralogs is not known, but it is interesting to speculate that one 
of these might have a role in iron uptake. Some of the known genes (mglA and potB) are 
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involved in transport, while others (iolC, glpQ and ackA) are involved in metabolism. One of 
the genes, mhp 140, has a prokaryotic membrane lipid attachment site and is thought to be a 
lipoprotein (18). 
Eighteen genes were down-regulated during iron limiting conditions. Seven of these 
(mhp081, mhp087, mhp 176, mhp337, mhp411, mhp639 and mhp666) are hypothetical genes 
with no identified function. The remaining genes are identified as gatB (mhp030), fusA 
(mhp083), rpsL (mhp085), hpt (mhp 117), oppB-D (mhp 167-169), rpL2 (mhp 190), metK 
(mhp450), rplL (mhp637), and ushA (mhp651). Resistance to fusidic acid in fusA mutants of 
Salmonella enterica serovar Typhimurium, alters growth both in vivo and in vitro (15). So, 
although the serovar Typhimurium fusA mutants confer some antibiotic resistance, their 
ability to grow is also stunted. The down-regulated genes identified in this study have roles in 
translation and cell growth. The regulation or role of ushA in not clearly defined during 
transcription, however, it is known to increase 2-fold as cells enter the stationary phase (31). 
In M. hyopneumoniae this protein has a prokaryotic lipid attachment site and is thought to be 
a lipoprotein. Since ushA is down-regulated in this study, this could indicate a response to 
iron depletion or an instance where the majority of cells had not entered the stationary phase 
of growth, hpt is involved in the salvage of guanine for guanine nucleotide synthesis (36). 
Since cellular metabolism and growth are slowed during iron deprivation, the synthesis of 
nucleotides is expected to decrease as well. 
Our studies show that iron deprivation can reduce growth of M. gallisepticum and M. 
pulmonis suggesting that these mycoplasmas require iron for growth. It is thought that M. 
hyopneumoniae also requires iron, but the studies needed to demonstrate this have not been 
reported. The present studies do show, however, that M. hyopneumoniae alters mRNA levels 
of specific genes in response to low iron growth conditions, suggesting that regulation 
occurs. 
The degree of transcriptional change that occurs during low iron growth conditions may 
indicate that iron acquisition systems in mycoplasmas are tightly controlled. What 
mechanism(s) might be employed is not known. The hypothetical genes, though similar in 
number to the 44% of hypothetical genes in the genome (11 of 27), may play important roles 
in iron stress. Since there is no clear indication of the functions of those genes, additional 
studies are required to determine how they may be involved in iron acquisition or control of 
cellular metabolism. The evaluation of samples taken from the lungs of swine at the height of 
infection may be informative in conjunction with the data found here. However, laboratory 
grown organisms may be competing for iron in a vastly different ways than those found in 
their host niche. How M. hyopneumoniae secures sufficient levels of iron for its metabolism 
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and whether it is able to respond to low iron conditions through transcriptional regulation is 
not yet understood, but studies on the regulation mechanism(s) of several genes identified 
during this study may begin to unravel some of the mystery. 
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Abstract 
Mycoplasma hyopneumoniae causes swine pneumonia and contributes significantly to 
porcine respiratory disease complex. A lack of genetic tools prevents identification of 
virulence-related genes by classical genetic approaches. Newly emerging technology in the 
assessment of transcriptional activities across genomes, microarrays, provides an opportunity 
to compare strains of M. hyopneumoniae that differ significantly in their disease potential to 
identify virulence-related genes. Microarrays containing 632 open reading frames of M. 
hyopneumoniae were used to identify differences in transcriptional levels between virulent, 
low passage strain 232 and avirulent, high passage strain J. Thirty genes were identified that 
differed in mRNA levels between the two strains. In strain 232, 6 of 8 up-regulated genes 
were hypothetical with no known function. In strain J, nine ribosomal proteins and two 
elongation factor genes were up-regulated. These studies provide a striking contrast and may 
provide clues as to how mycoplasmas acclimate to growth in vitro and to which genes are 
needed for colonization and persistence in vivo. 
Introduction 
Mycoplasma hyopneumoniae is the causative agent of enzootic pneumonia in swine and a 
major component of the porcine respiratory disease complex. The annual economic loss to 
the swine industry is significant and has been estimated to be as high as $200 million per 
year in the US (15, 21). Surveys have established that M. hyopneumoniae-mduced lesions are 
present in over 80% of the swine slaughtered in the US (18). While vaccines are available 
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and do limit disease, they do not effectively prevent colonization and are not always 
protective against outbreaks of mycoplasma disease. In addition to the pneumonia it causes, 
the organism predisposes the host to other pathogens. For instance, studies by Thacker et al. 
have shown that M. hyopneumoniae colonization significantly enhances the disease due to 
porcine reproductive and respiratory syndrome virus (22). Enhancement of porcine circovirus 
2 disease has also been shown to occur as a result of M. hyopneumoniae infection (16). How 
M. hyopneumoniae effects this change in disease potential of other pathogens is not 
understood, but M. hyopneumoniae has been shown to adversely affect the pig immune 
system and perhaps the host's ability to respond to other infectious agents as well. 
Adherence to the ciliated epithelia is necessary to cause disease associated with M. 
hyopneumoniae. Previous studies have shown that strains of M. hyopneumoniae that adhere 
to swine cilia induce pneumonia in pigs while J strain, which is nonadherent, is incapable of 
colonization (29, 31). Once attached to cilia, M. hyopneumoniae causes cilia clumping and 
sloughing, with an accompanying reduction in mucociliary apparatus function (2). The 
mechanism involved has not been determined, but it may involve the release of calcium 
within ciliated cells (17). Thus, it is clear that attachment alone is not sufficient to cause 
disease. Other factors play a role in the virulence of M. hyopneumoniae. How the organism is 
able to affect host immune system function is not understood, but it may relate to gene 
products of the mycoplasma that interact with host immune effector cells resulting in 
abherent cellular responses. The lack of genetic systems to study pathogenesis in M. 
hyopneumoniae is a detriment to solving these issues. 
Progress, however, has been made in understanding the molecular basis for adherence to 
swine cilia. Following identification of the cilium adhesin and its description as a 97 
kilodalton protein, P97 (29), a series of subsequent studies established not only the role for 
P97 in cilium binding (9) but also characterized the cilium binding site within the protein (10, 
13). P97 undergoes posttranslational processing on the surface of the cell (3), and the 
proteolytic fragments remain cell associated through unknown mechanisms. This occurs for 
both the virulent strain 232 and the nonvirulent strain J. Processing of J strain P97, however, 
appears different than that for strain 232 (3). Additional proteins undergo proteolytic 
cleavage on the cell surface as well, but the extent to which this occurs has not been 
characterized. Differences in proteolytic processing can profoundly affect electrophoretic 
profiles and immunoblot analyses. 
The full complement of proteins that M. hyopneumoniae expresses can be estimated by 
analysis of the mRNA transcripts produced. By comparing virulent 232 and avirulent J 
strains, clues to the failure of J strain to produce disease can be obtained. To this end, a 
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microarray was constructed and used to assess transcriptional differences between strain 232 
and J grown under normal laboratory conditions. The data shows that 30 genes differ in 
transcriptional activity between the two strains. The majority are up-regulated in J strain 
relative to strain 232. Most of these genes are related to translational processes and could 
indicate that J strain is functioning at a higher metabolic rate than the virulent strain under the 
conditions examined. 
Materials and Methods 
Mycoplasma strains and culture conditions 
Pathogenic M. hyopneumoniae strain 232, a derivative of strain 11, was used in this study 
(12, 24) along with strain J, which is the type strain of M. hyopneumoniae (ATCC strain 
25934) (7). Cultures for strain 232 were passaged fewer than 15 times in vitro. J strain is the 
type specific strain and has been extensively passed in vitro. Both strains were grown in Friis 
media as previously described (6). Twelve individual cultures were established in 500 ml 
flasks containing 250 ml of Friis media and were grown at 37°C- to mid-log phase as 
determined by medium color change and optical density. Six of the cultures were strain 232 
and six were strain J. Mycoplasmas were pelleted by centrifugation at 24,000 x g, and one ml 
of RNAlater (Ambion, Inc. Austin, Tex.) was added to pellet. Pellets were stored at -70°C 
until the total RNA was isolated. 
Microarray 
The M. hyopneumoniae microarray consists of polymerase chain reaction (PCR) products 
(probes) spotted to Coming UltraGAPS™ glass substrates (Coming, Inc., Big Flats, N.Y.). 
Ninety-one percent (632/698) of the total open reading frames (ORFs) of M. hyopneumoniae 
are represented on the array as PCR products of 125-350 bp in length. Each product is a 
unique sequence even within paralogous families as previously described (14). The 66 
missing ORFs are due to an inability to design suitable primers (12 ORFs) or failed PCR 
reactions due to incorrect product size, multiple bands or no band (54 ORFs). Only ORFs 
greater than 125 bp are represented on the array and no tRNAs or rRNAs were included. The 
primer design, array construction, and validation have been described (Chapter 2). 
Experimental design 
Six independent RNA samples from strain J cells were paired with six independent RNA 
samples from strain 232 (control) cells for hybridization on six two-color microarrays. The 
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six arrays were spotted on a total of three slides. Each slide was divided into two regions 
(upper and lower), and each region contained the full array of spots. Each of the 632 
sequences in the array was represented by three replicate spots. 
For three of the six arrays, the control sample was labeled with Alexa 555 dye and 
compared to the iron-depleted sample labeled with Alexa 647 dye (Molecular Probes, Inc., 
Eugene, Ore.). The dye assignment to control and treated samples was reversed for the other 
three arrays. The three slides were hybridized under identical conditions as described below. 
RNA isolation 
RNA was isolated from frozen cell pellets using the Versagene™ RNA Purification 
System (Centra Systems, Minneapolis, Minn.) according to the manufacturer's protocol. The 
optional step of DNase treatment was routinely performed on column according to the 
manufacturer's recommendation. With a cut-off of 150 bp, 5S rRNA and tRNAs were 
removed from the samples, limiting interference in downstream manipulations. Samples were 
quantified and checked for purity using the Nanodrop® ND-1000 Spectrophotometer 
(Nanodrop, Wilmington, Del.). If necessary, samples were concentrated using Microcon 
YM-30 micro-concentrators (Millipore, Billerica, Mass.) for optimal cDNA generation. 
Target generation and hybridization 
Targets were generated from total RNA extracted from cell pellets as described above. 
Fluorescently labeled cDNA targets were generated and purified using the SuperScript™ 
Indirect cDNA Labeling System (Invitrogen Corp., Carlsbad, Calif.) with a set of 129 ORF-
specific six-mer oligonucleotide primers designed as previously described (Chapter 2). 
Targets were labeled with Alexa Fluor™ 555 Reactive Dye or Alexa Fluor™ 647 Reactive 
Dye (Molecular Probes, Inc.). Prior to cDNA generation, strain 232 and J RNA samples were 
paired and equal concentrations of total RNA were added to the cDNA reactions. All of the 
resulting cDNA was then fluorescently labeled. Following purification of the labeled cDNA, 
samples were dried in a vacuum centrifuge and then resuspended in 10 pi Pronto! 
cDNA/long oligo hybridization solution (Coming). Targets were denatured at 95°C for 5 min 
and centrifuged at 13,000 rpm for 2 min at room temperature. Targets from a control 232 and 
J strain culture were then combined, pipetted to an array, and covered with a 22 x 22 mm 
HybriSlip™ (Schleicher & Schuell, Keene, N. H.). Slides were placed in a Corning 
hybridization chamber and incubated in a 42°C water bath for 12-16 h. Slides were washed 
according to Coming's UltraGAPS™ protocol and dried by centrifugation. 
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Image acquisition and normalization 
Each array was scanned with each dye channel using a ScanArray Express laser scanner 
(Applied BioSystems, Inc., Foster City, Calif.) at least three times under varying laser power 
and PMT gain settings to increase the dynamic range of expression measurement (4). Images 
were quantified using the softWorRx Tracker analysis software package (Applied Precision, 
Inc., Issaquah, Wash.). Spot-specific mean signals were corrected for local background by 
subtracting spot-specific median background intensities. The natural logarithm of the 
background-corrected signals from a single scan were adjusted by an additive constant so 
that all scans of the same array-by-dye combination would have a common median. The 
median of these adjusted-log-background-corrected signals across multiple scans was then 
computed for each spot to obtain one value for each combination of spot, array, and dye 
channel. These data for the two dye channels on any given array were normalized using 
LOWESS normalization to adjust for intensity-dependent dye bias (5, 26). Following 
LOWESS adjustment, the data from each channel were adjusted by an additive constant so 
that the median for any combination of array and dye would be the same for all array-by-dye 
combinations. The normalized values for triplicate spots were averaged within each array to 
produce one normalized measure of expression for each of the 632 probe sequences and each 
of the 12 RNA samples. 
Data analysis 
A separate mixed linear model analysis was conducted for each probe sequence using the 
normalized data (25). Each mixed model included fixed effects for treatment (strain J vs. 
control), slide region (upper vs. lower), and dye (Alexa 555 vs. 647) as well as random 
effects for slide and slide-by-region interaction. A /-test for differential expression across 
treatments was conducted for each probe as part of our mixed linear model analysis. The 632 
^-values from these /-tests were converted to ^-values using the method of Storey and 
Tibshirani (20). These ^-values can be used to obtain approximate control of the False 
Discovery Rate at a specified value. For example, declaring probes with ^-values less than or 
equal to 0.05 to be differentially expressed produces a list significant results for which the 
False Discovery Rate is estimated to be approximately 5%. 
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Results 
Microarray studies 
Total RNA yields were between 9-17 \ig post purification. Approximately 9-12 p,g total 
RNA was included in each RT-PCR reaction. Fluorescent labeling efficiencies ranged from 
27-79 base pair/dye molecule, which is within the manufacturer's expected range of 
fluorescent dye incorporation rates (http://probes.invitrogen.com/resources/calc/ 
basedyeratio.html). A total of five arrays were a part of this study. One complete array was 
dropped from the statistical analysis based on the low quality of the array (scratches and 
smears). A total of 30 genes showed significant transcript differences between strain 232 and 
J at jpO.OI (Table 4.1 and Fig. 4.1). The ^ -values were less than 0.1434. Eight genes were 
up-regulated relative to strain J, and six of those were characterized as either conserved or 
unique hypothetical genes. Conserved hypothetical indicates a sequence with similar 
homology found in another organism but with unknown function. Twenty-two genes were 
up-regulated relative to strain 232 and many of these genes are involved in the translation 
process. 
Log2 Fold Change 
Figure 4.1. Volcano plot of transcriptional differences in M. hyopneumoniae strains 232 and 
J. Data represent individual gene responses plotted as Logz fold change vs. -Log p-value. 
Points above -Log/?-value = 2.0 are significantly up- or down-regulated at /XO.01. 
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Table 4.1. Transcriptional differences between M. hyopneumoniae strains 232 and J p<0.01. 
ID Gene1 Description p-value i g-value FC 
Lower levels of mRNA transcripts in J strain 
mhp016 CH Conserved Hypothetical 0.0063 0.1222 1.43 
mhp394 CH Conserved Hypothetical 0.0041 0.0992 1.36 
mhp441 sgaH Hexulose-6-Phosphate Synthase 0.0051 0.1074 1.57 
mhp446 CH Conserved Hypothetical 0.0035 0.0892 1.67 
mhp529 UH Unique Hypothetical 0.0069 0.1235 5.81 
mhp530 CH Conserved Hypothetical 0.0015 0.0601 20.6 
mhp535 UH Unique Hypothetical 0.0008 0.0531 14.3 
mhp686 pr2 Multidrug Resistance Protein Homolog 0.0011 0.0531 3.03 
Higher levels of mRNA transcripts in J strain 
mhp058 rpsB 3 OS Ribosomal Protein S2 0.0017 0.0631 2.23 
mhp059 Elongation Factor TS (EF-TS) 0.0045 0.1034 1.73 
mhp083 fusA GTP-Binding Protein Chain Elongation Factor EF-G 0.0012 0.0531 2.08 
mhpl21 recR Recombination Protein RecR 0.0001 0.0182 1.45 
mhp 135 rpsT 30S Ribosomal Protein S20 0.0055 0.1113 2.43 
mhp 157 nrdl Ribonucleotide Reductase 0.0068 0.1235 1.42 
mhp 158 nrdE Ribonucleoside-Diphosphate Reductase Alpha Chain 0.0003 0.0389 1.85 
mhp 164 CH Conserved Hypothetical 0.0029 0.0768 3.05 
mhp 165 CH Conserved Hypothetical 0.0002 0.0258 1.31 
mhp 166 oppF Oligopeptide Transport System Permease 0.0008 0.0531 1.53 
mhp 169 oppB Oligopeptide Transport System Permease 0.0011 0.0531 1.54 
mhp 180 alaS Alanyl-tRNA Synthetase 0.0018 0.0631 1.64 
mhpl81 CH Conserved Hypothetical 0.0083 0.1377 1.14 
mhp 182 Protein PI02 0.0024 0.0727 2.27 
mhp 197 rpS17 Ribosomal Protein S17 0.0049 0.1067 1.64 
mhp 198 rpL14 Ribosomal Protein L14 0.0006 0.0531 2.59 
mhp 199 rpL24 Ribosomal Protein L24 0.0021 0.0665 2.05 
mhp204 rpL18 Ribosomal Protein LI8 0.0089 0.1434 1.72 
mhp257 rpL35 Ribosomal Protein L35 0.0012 0.0531 1.40 
mhp258 rpL20 Ribosomal Protein L20 0.0000 0.0141 2.79 
mhp592 UH Unique Hypothetical 0.0028 0.0768 1.82 
mhp672 rplM 50S Ribosomal Subunit Protein LI3 0.0074 0.1279 2.20 
1 UH= unique hypothetical; CH=conserved hypothetical 
2 (+) indicates that gene is up-regulated in strain 232 relative to J; (-) indicates that gene is 
up-regulated in strain J relative to 232. 
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Discussion 
The molecular basis of pathogenesis in M. hyopneumoniae is not understood. Aside from 
the participation of P97 in adherence to swine cilia, little is known about the cell-cell 
interactions that result in ciliated epithelial cell death and alteration of the host immune 
system. In lieu of a genetic system for the construction of defined mutations, insight into 
pathogenic mechanisms is often gained by comparing strains that differ in phenotype. For 
instance, spontaneous mutations arising in Mycoplasma pneumoniae were instrumental in 
defining the molecular interactions that direct the PI adhesin to its membrane location on the 
attachment organelle (I, 8, 11, 19). Isolation of mutants of M. hyopneumoniae, however, has 
not been possible because of its poor growth on agar surfaces, a prerequisite for mutant 
screening protocols. Thus, studies that identify colony-associated phenotypes or depend on 
multiple clonal isolates are simply not possible with M. hyopneumoniae. To compensate for 
these deficiencies, organisms that have been repeatedly cultured in vitro have been compared 
to low passage strains. The former lose their cilium adherence activity and disease potential 
during in vitro passage (30, 31). Other studies have compared different strains to gain at least 
some knowledge concerning M. hyopneumoniae's mechanisms of pathogenesis (23, 24, 29, 
31). These studies have been difficult to interpret because of the variable protein patterns, 
which may be related more to surface proteolytic processing than to differences in gene 
expression (3). In addition, these comparative studies have not been extensive because there 
are few field strains available to study; M. hyopneumoniae is one of the more fastidious of 
the animal pathogens. 
One approach to identifying factors related to virulence in organisms refractory to genetic 
manipulation is to compare the transcriptional profiles of virulent and avirulent strains on a 
global scale to identify genes that may contribute to virulence. Based on the assumption that 
virulent organisms express factors that are either missing or down-regulated in avirulent 
strains, global expression profiling can be performed using microarrays representing the 
complete gene repertoire of an organism. 
The strains used in this study are well characterized regarding their disease potential and 
have been used in numerous investigations. Strain 232 is a virulent isolate that has been used 
repeatedly in pig challenge studies. It grows well in culture compared to recently isolated 
field strains that are sometimes difficult to culture at all. It is maintained at low passage both 
in pure culture and as swine lung homogenate, and it reproducibly causes lung lesions when 
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used to infect mycoplasma-free pigs (22, 27, 28). Strain J is the type strain, is in high 
passage, and cannot colonize pigs or cause disease (31). It is nonadherent to swine cilia. 
Transcriptional differences between strains 232 and J show a preponderance of 
transcripts related to translational processes up-regulated in avirulent strain J. This includes 
nine ribosomal protein genes and two elongation factor genes, fus A and tsf This is somewhat 
surprising and suggests that laboratory adaptation to artificial growth media such as had 
occurred with strain J involves increased levels of translation-associated gene products. This 
can occur either through increased transcription rates or decreased transcript turnover 
resulting in increased steady state levels. Not all translation-related proteins vary between the 
strains, however, so how these specific genes contribute in a meaningful way to the strain J 
phenotype is not clear. Since ribosomal RNA genes were not included on the array or in the 
primer set for cDNA generation, we were unable to determine if the structural RNAs were 
also up-regulated in the avirulent strain J. 
Eight genes up-regulated in strain 232 relative to strain J include six hypothetical genes 
of unknown function. Since none of the genes identified in this study are lipoproteins or have 
identifiable functional motifs, additional studies will be required to establish the function and 
virulence relationship of these genes. Also up-regulated in strain 232 is mhp 182, the gene 
encoding PI 02, and mhp686, Pr2, a multidrug resistance protein homolog. The role of PI 02 
has not been elucidated, but Pr2, more correctly described as an ABC type 
multidrug/protein/lipid transporter, might be involved in increased protein translocation. This 
could infer that increased protein secretion is important to colonization and disease and less 
important to growth in broth in the laboratory. This would not be surprising since the 
organism has little competition for nutrients in vitro in contrast to the highly competitive 
environment of the host mucosal surfaces. 
In summary, these studies show that strain 232 and J vary in transcriptional activity in at 
least 30 genes. For strain J, the variation is related to translational processes, but in the 
virulent strain 232, variation is mostly found in hypothetical genes of unknown function. 
Future studies should focus on the function of the genes up-regulated in strain 232 and 
determination if they are involved in pathogenesis. 
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Abstract 
Mycoplasma hyopneumoniae attaches to swine cilia in the respiratory tract resulting in 
colonization and disease. The overall attachment process is poorly understood, but one 
component, P97, has been defined as the major cilium adhesin. Studies with a nonadherent, 
high passage strain of M. hyopneumoniae, strain J, showed that P97 must be working in 
concert with other mycoplasma components. To study this system further, a high adherent 
and a low adherent variant of the virulent strain 232 were compared by transcriptional 
profiling using a microarray containing 91 % of the open reading frames of M. 
hyopneumoniae. Only when compared against each other and not to the parent strain were 
transcriptional differences observed at /?<0.05. Genes up-regulated in the high adherent 
variant included the heat shock protein gene dnaJ, the signal peptidase gene lepA, and the 
gene for lipoprotein P65. Genes up-regulated in the low adherent variant included translation 
components and pdhD, the gene for dihydrolipoamide dehydrogenase. Both variants had 
genes up-regulated with unassigned functions that will require additional analysis. 
Introduction 
Mycoplasma hyopneumoniae causes enzootic pneumonia in swine and is a major 
component of the porcine respiratory disease complex. The disease is endemic worldwide 
and results in significant annual loss for the swine industry. It has been estimated that as 
many as 80% of swine at slaughter have lesions consistent with mycoplasma pneumonia 
(35). Vaccination programs limit the disease, but do not prevent colonization of the 
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organism. Chronic, low-level disease serves as a source of infection for naïve or other 
unprotected swine and has been shown to enhance disease due to other pathogens (1, 5, 38) 
In addition to the pneumonia it causes, M. hyopneumoniae predisposes the host to other 
pathogens. For instance, studies by Thacker et al. have shown that M. hyopneumoniae 
colonization significantly enhances the disease due to porcine reproductive and respiratory 
syndrome virus (38). Enhancement of porcine circovirus 2 disease has also been shown to 
occur as a result of M. hyopneumoniae infection (30). How M. hyopneumoniae effects this 
change in disease potential of other pathogens is not understood, but M. hyopneumoniae has 
been shown to adversely affect the pig immune system (4, 20, 26, 39) and perhaps the host's 
ability to respond to other infectious agents as well. 
Adherence to the ciliated epithelia is necessary to cause disease associated with M. 
hyopneumoniae. Previous studies have shown that strains of M. hyopneumoniae that adhere 
to swine cilia induce pneumonia in pigs (45, 48). Once attached to cilia, M. hyopneumoniae 
causes cilia clumping, cell death and reduces the mucociliary apparatus function (6). The 
mechanism involved in cilium clumping and epithelial cell death has not been determined, 
but it is thought that the interaction of M. hyopneumoniae with the epithelial cell membrane 
induces the release of intracellular stores of calcium (31). The loss of mucociliary function 
can contribute to susceptibility to other pathogens and to the severity of M. hyopneumoniae 
infections. Thus, it is clear that attachment alone is not sufficient to cause disease. Other 
factors must play a role in the virulence of M. hyopneumoniae. How the organism is able to 
affect host immune system function is not understood, but it may relate to gene products of 
the mycoplasma that interact with host immune effector cells resulting in abherent cellular 
responses. The lack of genetic systems to study pathogenesis in M. hyopneumoniae is a 
detriment to solving these issues. 
Disease begins with colonization of the respiratory tract by M. hyopneumoniae and 
binding of M. hyopneumoniae to the cilia resulting in ciliostasis. Two adherent colony 
variants of M. hyopneumoniae strain 232 have been identified and characterized as high-
adherent variant 91-3 and low-adherent variant 60-3 (T. F. Young, Q. Zhang, B. Z. Erickson, 
and R. F. Ross, Abstr. 10th Congr. Int. Org. Mycoplasmol. abstr. P260, 1994). Preliminary 
reports using microliter swine cilia adherence assays (46) indicated that the variants and 
parent strain 232 differ significantly in adherence (R. F. Ross, personal communication). The 
investigators' results also included pig infection studies that concluded that in vivo passage of 
the low-adherent variant resulted in its reversion to a moderate to high adherent state. In a 
tissue culture assay, Ross et al. showed that the high adherent variant 91-3 and non-adherent 
strain J mimicked adherence in vivo (43). The adherent variant 91-3 showed significant 
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binding, while the non-adherent strain J failed to bind cilia. In addition, the adherence 
phenotype can be lost during in vitro passage (R. F. Ross, personal communication). Thus, in 
the absence of cell surfaces, adherence is not required for growth and is not maintained. 
Several studies have sought to identify components involved in adherence to the cilia of 
the swine lung (17, 45, 47). The P97 adhesin has been well characterized and the epitope 
necessary for binding to the cilia defined (15, 27). The culmination of these studies indicates 
that P97 is the main adhesin for M. hyopneumoniae, but it also appears that other proteins 
may be involved in adherence to swine cilia. This study examined the relative mRNA 
transcript levels of the high-adherent variant 91-3 and the low-adherent variant 60-3 
compared to the parent strain 232. The results show differences between 91-3 and 60-3 that 
could give clues to accessory proteins and activities associated with the adherence 
phenotype. 
Materials and Methods 
Mycoplasma strains and culture conditions 
Pathogenic M. hyopneumoniae strain 232, a derivative of strain 11, was used in this study 
(23). Variants 91-3 and 60-3 are from single colonies picked from M. hyopneumoniae strain 
232 plated onto solid media (R. F. Ross, personal communication). Cultures used were 
passed fewer than 15 times in vitro in Friis media as previously described (11). One hundred 
twenty-five ml cultures were grown at 37°C to mid-log phase as determined by medium 
color change and optical density. Cells were pelleted by centrifugation at 24,000 x g, and 1 
ml of RNAlater (Ambion) was added to pellet. Pellets were stored at -70°C until the total 
RNA was isolated. 
Microarray 
The M. hyopneumoniae microarray consists of polymerase chain reaction (PCR) products 
(probes) spotted to Coming UltraGAPS™ glass substrates (Coming, Inc., Big Flats, N.Y.). 
Ninety-one percent (632/698) of the open reading frames (ORFs) in the M. hyopneumoniae 
genome are represented on the array as PCR products of 125-350 base pair in length. Each 
product is a unique sequence even within paralogous families as described by Minion et al. 
(29). The 66 missing ORFs are due to an inability to design suitable primers (12 ORFs) or 
failed PCR reactions due to incorrect product size, multiple bands or no band (54 ORFs). 
Only ORFs greater than 125 base pairs are represented on the array and no tRNAs or rRNAs 
were included. The primer design, array construction and validation have been described 
(Chapter 2). 
94 
Experimental design 
Each array consists of 632 ORF-specific PCR products spotted in triplicate using a 
nonadjacent, well-spaced format. Each slide contains two complete arrays, one at each end. 
Six independent RNA samples from variant 91-3 cells were paired with six independent 
RNA samples from control strain 232 cells for hybridization on six two-color microarrays. 
The six arrays were spotted on a total of three slides. Five independent RNA samples from 
variant 60-3 cells were paired with five independent RNA samples from control strain 232 
cells for hybridization on five two-color microarrays. The five arrays were spotted on a total 
of three slides. Each slide was divided into two regions (upper and lower), and each region 
contained the full array of spots. 
For three of the arrays, the control sample was labeled with Alexa 555 dye and compared 
to either variant 91-3 or 60-3 sample labeled with Alexa 647 dye (Molecular Probes, Inc., 
Eugene, Ore.). The dye assignment to control and treated samples was reversed for the other 
two arrays. The slides were hybridized under identical conditions as described below. 
RNA isolation 
RNA was isolated from frozen cell pellets using the Versagene™ RNA Purification 
System (Centra Systems, Minneapolis, Minn.) according to the manufacturer's protocol. The 
optional step of DNase treatment was performed on column according to the manufacturer's 
recommendation. With a column cut-off of 150 base pairs, 5S rRNA and tRNAs were 
removed from the samples, limiting interference in downstream manipulations. Samples were 
quantified and checked for purity using the Nanodrop® ND-1000 Spectrophotometer 
(Nanodrop, Wilmington, Del.). If necessary, samples were concentrated using Microcon 
YM-30 micro-concentrators (Millipore, Billerica, Mass.) for optimal cDNA generation. 
Target generation and hybridization 
Targets were generated from total RNA extracted from cell pellets as described above. 
Fluorescently labeled cDNA targets were generated and purified using the SuperScript™ 
Indirect cDNA Labeling System (Invitrogen Corp., Carlsbad, Calif.) with a set of 129 ORF-
specific hexamer oligonucleotide primers designed as previously described (Chapter 2). 
Targets were labeled with Alexa Fluor™ 555 Reactive Dye or Alexa Fluor™ 647 Reactive 
Dye (Molecular Probes, Inc.). Following purification of the labeled cDNA, samples were 
dried in a vacuum centrifuge and then resuspended in 10 ^1 Pronto! cDNA/long oligo 
hybridization solution (Coming). Targets were denatured at 95°C for 5 min and centrifuged at 
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13,000 xg for 2 min at room temperature. Targets from a control strain 232 and either a 91-3 
or 60-3 adherence variant culture were then combined, pipetted to an array, and covered with 
a 22 x 22 mm HybriSlip™ (Schleicher & Schuell, Keene, N. H.). Slides were placed in a 
Corning hybridization chamber and incubated in a 42°C water bath for 12-16 h. Slides were 
washed according to Coming's UltraGAPS™ protocol and dried by centrifugation. 
Image acquisition and normalization 
Each array was scanned with each dye channel using a ScanArray Express laser scanner 
(Applied BioSystems, Inc., Foster City, Calif.) at least three times under varying laser power 
and PMT gain settings to increase the dynamic range of expression measurement (8). Images 
were quantified using the softWorRx Tracker analysis software package (Applied Precision, 
Inc., Issaquah, Wash.). Spot-specific mean signals were corrected for local background by 
subtracting spot-specific median background intensities. The natural logarithm of the 
background-corrected signals from a single scan were adjusted by an additive constant so 
that all scans of the same array-by-dye combination would have a common median. The 
median of these adjusted-log-background-corrected signals across multiple scans was then 
computed for each spot to obtain one value for each combination of spot, array, and dye 
channel. These data for the two dye channels on any given array were normalized using 
LOWESS normalization to adjust for intensity-dependent dye bias (9, 41). Following 
LOWESS adjustment, the data from each channel were adjusted by an additive constant so 
that the median for any combination of array and dye would be the same for all array-by-dye 
combinations. The normalized values for triplicate spots were averaged within each array to 
produce one normalized measure of expression for each of the 632 probe sequences and each 
of the 10 control and 10 adherent variant RNA samples. 
Data analysis 
A separate mixed linear model analysis was conducted for each probe sequence using the 
normalized data (40). Each mixed model included fixed effects for treatment (adherent 
variant versus control), slide region (upper versus lower), and dye (Alexa 555 versus 647) as 
well as random effects for slide and slide-by-region interaction. A /-test for differential 
expression across treatments was conducted for each probe as part of our mixed linear model 
analyses. The 632 ^ -values from these /-tests were converted to q-values using the method of 
Storey and Tibshirani (37). These q-values can be used to obtain approximate control of the 
False Discovery Rate at a specified value. For example, declaring probes with ^-values less 
than or equal to 0.05 to be differentially expressed produces a list significant results for 
96 
which the False Discovery Rate is estimated to be approximately 5%. Along with ^-values, 
estimates of fold-change were computed for each probe by taking the inverse natural log of 
the mean treatment difference estimated as part of our mixed linear model analysis. 
Results 
Microarray studies 
Microarrays were used to compare mRNA steady state levels between strain 232 and two 
adherence variants isolated from its clonal population. Total RNA yields in the preparations 
were between 9-17 |ig post purification. Approximately 9-12 jug total RNA was included in 
each RT-PCR reaction to generate cDNA for preparation of fluorescently labeled targets. 
Following labeling reactions, fluorescent labeling efficiencies ranged from 18-47 base 
pair/dye molecule, which is within the manufacturer's expected range of fluorescent dye 
incorporation rates (http://probes.invitrogen.com/ resources/calc/basedyeratio.html). This 
provided significant signal intensities for spot finding and analysis. Five arrays were 
analyzed for variant 91-3; one complete array was dropped from the statistical analysis based 
on the quality of the array (scratches and smears). Four arrays were analyzed for variant 60-
3. The fifth array was dropped from the statistical analysis due to poor label incorporation 
and low probe signals when scanned. Since each array contained triplicate spots for each 
ORF, the analysis included 12 and 9 values for adherent variant 91-3 and 60-3, respectively, 
and 21 control 232 values. 
Statistical analysis was performed using a mixed linear model design. When each variant 
(91-3 and 60-3) was compared to parent strain 232, no significant transcriptional differences 
were identified (p<0.05). Variants 91-3 and 60-3 were then compared directly to one another 
to determine if any transcription differences between the two variants would yield insight 
into mechanisms of adherence. ANOVA was used to determine differences between signal 
intensities of variants 91-3 and 60-3. Estimated mean differences were significant for 34 
genes at p<0.05 (Table 5.1) with a Rvalue of 0.2882. Eighteen of the 34 genes (53%) 
differentially transcribed are classified as hypothetical. 
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Table 5.1. Variation in signal intensities between variants 60-3 and 91-3 at /?<0.05.* 
Fold 
ID Gene Description p-value Change 
Genes with increased signal intensities in 60-3 
mhp025 CH Conserved Hypothetical 0.0471 2.08 
mhp083 fusA GTP-Binding Protein Chain Elongation 0.0135 4.69 
Factor EF-G 
mhpl 10 smpB SSRA-Binding Protein 0.0095 2.39 
mhp200 rpL5 Ribosomal Protein L5 0.0456 2.17 
mhp215 CH Conserved Hypothetical 0.0114 1.60 
mhp321 UH Unique Hypothetical 0.0433 2.12 
mhp340 CH Conserved Hypothetical 0.0149 2.19 
mhp359 CH Conserved Hypothetical 0.0309 2.02 
mhp504 pdhD Dihydrolipoamide Dehydrogenase 0.0260 2.74 
mhp548 Phosphoglucose Isomerase B 0.0266 1.54 
mhp608 thrS Threonyl-tRNA Synthetase 0.0193 1.78 
mhp639 CH Conserved Hypothetical 0.0113 3.50 
mhp650 CH Conserved Hypothetical 0.0177 2.50 
mhp670 CH Conserved Hypothetical 0.0053 2.89 
mhp694 valS Valyl-tRNA Synthetase 0.0393 1.50 
Genes with increased signal intensities in 91-3 
mhp046 UH Unique Hypothetical 0.0352 4.80 
mhp073 dnaJ Heat-Shock Protein 0.0318 2.18 
mhp078 lepA 30 kDa GTP-Binding Protein LepA, 0.0388 3.30 
Signal Peptidase 
mhp091 CH Conserved Hypothetical 0.0334 5.55 
mhp092 CH Conserved Hypothetical 0.0095 22.18 
mhp094 rpsP 30S Ribosomal Protein SI6 0.0474 10.18 
mhp095 trmD tRNA (Guanine-N 1 )-Methyltransferase 0.0257 42.10 
mhpl 00 pyrG CTP Synthetase 0.0381 5.00 
mhplOl CH Conserved Hypothetical 0.0301 19.10 
mhpl 32 CH Conserved Hypothetical 0.0161 2.93 
mhpl75 ftsH Cell Division Protein 0.0307 6.78 
mhp247 CH Conserved Hypothetical 0.0282 2.22 
mhp304 gW GTP-Binding Protein 0.0228 3.80 
mhp530 CH Conserved Hypothetical 0.0113 6.69 
mhp542 CH Conserved Hypothetical 0.0470 5.82 
mhp583 UH Unique Hypothetical 0.0423 3.64 
mhp588 nagA N-Acetylglucosamine-6-Phosphate 0.0242 3.34 
Deacetylase 
mhp677 p65 Surface Lipoprotein 0.0351 10.64 
mhp693 CH Conserved Hypothetical 0.0090 7.84 
* UH = unique hypothetical; CH = conserved hypothetical. 
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Figure 5.1. Volcano plot of transcriptional differences in M. hyopneumoniae high-
adherent variant 91-3 and low-adherent variant 60-3. Data represent individual gene 
responses plotted as Logz fold change vs. -Log p-value. Points above -Log p-value = 1.3 are 
significantly up- or down-regulated relative to variant 91-3 at p<0.05. 
Discussion 
Mycoplasmas adhere tightly to host epithelial cells and should be considered surface 
parasites because of their need for macromolecular precursors. This is due to their limited 
genome capacity and lack of biosynthetic pathways for amino acids, purines and pyrimidines, 
and membrane components, i.e., phospholipids and cholesterol (32-34). A guiding principle 
has been that nonadherent mycoplasmas do not cause cell damage or disease (18). 
Mycoplasmas must adhere tightly to their host's mucosal surfaces to initiate and perpetuate 
disease. 
99 
The interactions of mycoplasmas with eukaryotic cells have been classified into various 
categories including hemagglutination (28) and hemadsorption of red blood cells (22), 
attachment to tissue culture cells (13, 47) and attachment to organ expiants (12, 44) and 
epithelial surfaces (25). The most significant advances in unraveling adherence mechanisms 
in mycoplasmas have occurred through isolation of mutants lacking adherence activity. For 
instance, Mycoplasma pneumoniae spontaneous hemadsorption-negative mutants were used 
to identify components of the adherence apparatus (22). In that species, the adherence protein 
PI is organized into a specialized attachment organelle by interacting with multiple proteins 
that serve to organize the attachment organelle structure (21). Mutations in any of the 
components involved resulted in a hemadsorption-negative phenotype and were easily 
recognizable. By comparing protein gel patterns of the mutants with the wild type strain, it 
was possible to identify these components. 
Mycoplasma hyopneumoniae adherence has proved difficult to study because it has no 
attachment organelle; the adhesin is distributed around the cell surface, and it is difficult to 
study individuals in a population. This species is more fastidious and is difficult to grow on 
agar surfaces. Despite these limitations, it was possible to identify cell populations with high 
and low adherence phenotypes. Parent strain 232 was plated onto agar media following 
dispersion of clumps by passing through a 26-gauge needle, and after 10 days of incubation, 
94 well-isolated pinpoint colonies were picked to broth. Eighty-one colonies grew and were 
tested in the swine cilium adherence assay (46). One high and one low adherent variant were 
identified and designated variant 91 and 60, respectively. Single colonies were picked from 
each of the variants and the adherence phenotype was consistent. The designation 91-3 and 
60-3 were indicative of the number given to the second set of colony isolates. These variants 
were studied further by immunoblot analysis, and pig challenge studies. By one-dimensional 
electrophoresis, only one protein band difference was observed between the two variants, a 
106-kDa protein that has not been identified (R. F. Ross, personal communication). In 
challenge studies, the mean onset of coughing was different (11.6 days for variant 91, 25 
days for variant 60) and both caused lung lesions. Pigs receiving the low adherent variant had 
fewer lung lobes with pneumonia per pig and lower lesion scores than either the high 
adherent variant or the parent strain 232 (R. F. Ross, personal communication). Upon 
reisolation from challenged pigs, the low adherent variant had improved its adherence to 
swine cilia to a moderate to strong phenotype, so the variant 60-3 is fully competent to regain 
adherence and cause disease. Because of the lack of genetic tools to generate more precise 
mutants in this mycoplasma species, these two variants represent the best models for 
studying adherence mechanisms in M. hyopneumoniae. 
100 
Microarrays were used to identify transcriptional differences between the two phenotypic 
variants. Like most bacteria, it is thought that mycoplasmas control gene product 
concentrations by regulating transcription. We hypothesized that the low adherent phenotype 
was due to changes in transcript levels of one or more proteins involved in adherence. When 
the transcriptome profiles of the adherence variants were compared to their parent strain 232 
by microarray, however no transcriptional differences were observed at £><0.05. This can be 
explained if one considers strain 232 as a mixed population of cells arising from small 
genetic changes occurring during DNA replication. This has been referred to as quasispecies, 
a population of related, nonidentical genotypes (2). This population would consist of varying 
phenotypes, and any value arising from an analysis using this population would therefore 
represent a mean. Not surprisingly, transcriptional profiles of the adherence variants were not 
significantly different from this control mean. 
Direct comparison of transcriptional profiles between variants 91-3 and 60-3, however, 
did show significant differences at/K0.05. Genes that had higher signal intensities and are 
consequently thought to be up-regulated in variant 60-3 included eight of fifteen (53%) 
hypothetical genes (Table 5.1). The gene for elongation factor FusA was up-regulated as well 
as two metabolic genes, pdhD (dihydolipoamide dehydrogenase) and pgiB (phosphoglucose 
isomerase B). In addition, other genes up-regulated in variant 60-3 seem to be responsive to 
environmental stress. During amino acid starvation, valS (mhp694), a valine synthase, is 
transiently derepressed (14). Mutations in pgiB (mhp548) cause a decrease in growth in the 
presence of glucose in Escherichia coli (10) suggesting that it has an important role in 
glycolysis. PdhD is also involved in glycolysis, and its gene is up-regulated in 60-3 relative 
to 91-3. This molecule has been previously characterized as having a lipoyl-binding domain, 
which is normally associated with pdhC (24). thrS (mhp608) is autoregulated negatively at 
the translational level in E. coli (36). Perhaps thrS is regulated transcriptionally in M. 
hyopneumoniae. How these genes with assigned functions contribute to the low adherent 
phenotype is not known. 
A greater number of genes had higher signal intensities in variant 91-3 relative to 60-3. 
Forty-seven percent of these were hypothetical genes, a number that is similar to the overall 
estimation across the genome (29). Among the genes with assigned functions were the heat 
shock gene dnaJ (mhp073) and the gene coding for the membrane lipoprotein P65 
(mhp677)(19). Lipoproteins play important roles in mycoplasma physiology and 
pathogenesis, often undergoing phase switching and size variation (42). For mycoplasmas 
containing these gene families, the membrane surface is in constant flux, changing in random 
fashion and providing a variable antigenic profile to the host immune system. It is unlikely 
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that M. hyopneumoniae has the capacity to vary its surface structure in this way; no 
lipoprotein gene families were found in the genome sequence (29). Fifty-three putative 
lipoproteins were found in the genome and none have an assigned function. In some 
mycoplasmas, however, lipoproteins participate in cell adherence processes (19). Whether 
P65 can assist in the binding of M. hyopneumoniae to swine cilia is unknown, but this would 
explain the increased adherence associated with this variant. Other genes up-regulated in 91-
3 are trmD and rpsP, which are regulated at the translational level in E. coli (3). Our data 
suggest a different mode of regulation in mycoplasmas, but the purpose for that regulation is 
not clear. Two gene products associated with cell division and DNA replication, FtsH 
(mhpl75) and PyrG (mhpl00), are up-regulated in variant 91-3 as well. How these two gene 
products might be involved in adherence is not understood. Finally, lepA is up-regulated in 
variant 91-3. This signal peptidase may play a critical role in processing of proteins involved 
in adherence as shown previously by Djordjevic et al. (7). Perhaps the proteolytic processing 
associated with the increased expression of this peptidase results in the exposure of 
additional binding epitopes in the high adherent variant. 
Further studies will be required to gain a better understanding of the adherence process in 
M. hyopneumoniae. These data in conjunction with other studies (16) indicate that P97 
probably does not act alone; additional adhesins or supportive proteins probably participate 
in yet undefined ways. Unlike M. pneumoniae where proper placement of the P1 adhesin is 
critical for adherence (21), M. hyopneumoniae lacks an attachment organelle and the proteins 
involved in adhesin organization. The M. hyopneumoniae adhesin, however, is processed on 
the mycoplasma cell surface, so variation in processing may account for differences in the 
adherence phenotype (7). The hypothetical genes identified this study may play yet 
undefined roles in adherence as well. Further study with these variants may provide 
additional evidence for the contribution of specific proteins to the adherence process. 
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Abstract 
Mycoplasma hyopneumoniae is the causative agent of porcine enzootic pneumonia and a 
major factor in the porcine respiratory disease complex. A clear understanding of the 
mechanisms of pathogenesis does not exist although it is clear that M. hyopneumoniae 
adheres to porcine ciliated epithelium by action of a protein called P97. Previous studies have 
shown that variation within different isolates of M. hyopneumoniae exists in not only the 
gene encoding the cilium adhesin P97 but also in other genes, however, the extent of genetic 
variation among field isolates is not known. Since M. hyopneumoniae is a worldwide 
problem, it is reasonable to expect that a wide range of genetic variability may exist given all 
of the different breed and housing conditions. This variation may impact the overall virulence 
of a single isolate or strain. Using microarray technology, this study examined potential 
variation of eight field isolates in comparison to strain 232 on which the array was based. 
Genomic DNA was obtained, amplified with TempliPhi™, and labeled indirectly with Alexa 
dyes. Post genomic hybridization, the arrays were scanned and data analyzed using a mixed 
linear statistical model. Results indicate that genetic variation could be detected in six of the 
eight field isolates but in different loci suggesting that variation occurs throughout the 
genome. Thirty-six of forty-six loci were hypothetical genes. 
Introduction 
Genetic variation is thought to occur among bacterial species as a survival mechanism in 
both adverse environmental and host niches. A natural consequence of evolutionary and 
environmental pressures, genetic variation in pathogenic species results in changing 
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phenotypes. Genetic variation can occur by three general mechanisms, local nucleotide 
sequence changes, intragenomic recombination resulting in reshuffling of genome sequences, 
and acquisition of foreign DNA (1). It can also occur vertically and horizontally. Vertical 
transmission refers to passage of genetic material to siblings through cell division and its 
accompanying replication mistakes (point mutations, inversions and spontaneous deletions). 
Horizontal transmission involves the acquisition of new genetic material. This could occur 
among closely related species by transformation of native DNA, transduction by phages or 
by conjugation mechanisms, giving rise to organisms with subtle changes in phenotype. 
Alternatively, it could occur between dissimilar species by similar mechanisms that result in 
dramatic changes in phenotype. For example, pathogenicity islands are thought to arise by 
uptake and insertion of large DNA segments that encode large blocks of genes related to a 
virulence phenotype (7, 18). While it is clear that numerous species of bacteria have acquired 
large segments of DNA (19), there is no evidence for gene acquisition in mycoplasmas. 
Mycoplasmas are cell wall-less bacteria that are thought to be the smallest organisms 
capable of self-replication. Their genome sizes range from 580 kilobases to over 1,700 
kilobases (15). Their small genomes do not restrict their ability to generate high rates of 
diversity, however. This type of variation is not a consequence of environmental signals, but 
rather occurs through random events. There are numerous examples of both small sequence 
changes and recombination to introduce genetic variation in mycoplasmas (28). This 
variation is usually expressed by the generation of new chimeric surface molecules with high 
rates of antigenic diversity. The mechanisms by which this occurs include slipped strand 
mispairing during DNA replication and recombination between homologous sequences. 
Genetic variation can result in phase switching when it occurs within homopolymeric tracts 
of adenine in promoter regions (29) or in structural gene sequences (31), or by DNA 
inversion (12, 20). The generation of chimeric genes by intragenic recombination also occurs 
(11). There is no evidence that any of these mechanisms are operative in Mycoplasma 
hyopneumoniae, however. Analysis of the M. hyopneumoniae genome sequence failed to 
identify families of lipoprotein genes that could undergo phase switching through 
mechanisms employed by other mycoplasmas for surface variation (14). 
Mycoplasma hyopneumoniae is the primary agent of porcine pneumonia (16). There is 
increasing evidence that M. hyopneumoniae has a predisposing influence on other infectious 
agents (21, 22, 27). Genetic variation is known to occur in M. hyopneumoniae (2, 3, 8, 24), 
but there are few studies examining the extent of variation within field isolates at the 
molecular level (23). Phenotypic variation does occur within M. hyopneumoniae as described 
by Young et al. within the context of protein immunoblotting (30) and in some cases within 
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specific genomic regions (24), but no studies have been reported that examine genetic 
differences in field strains of M. hyopneumoniae within genes on a global basis. This is due 
to the difficulty in isolating and cloning M. hyopneumoniae from field samples and adequate 
tools have not been available until recently (14). 
The studies reported here examine genetic variation in M. hyopneumoniae on a genome-
wide basis using microarray technology. The arrays were based upon the genome sequence 
of strain 232. Our results with eight field strains show that microarrays can be used to 
examine genetic diversity and that six of the strains of M. hyopneumoniae vary in at least one 
genetic loci. Two of the strains could not be differentiated from strain 232 using this 
approach. 
Materials and Methods 
Mycoplasma strains and culture conditions 
Pathogenic M. hyopneumoniae strain 232, a derivative of strain 11, was used in this study 
(13). Eight field isolates designated 29024, 1879, 27533, 29726A, 27644, 426, 27604B, and 
27008 were cultured from case studies from the Iowa State University Veterinary Diagnostic 
Laboratory (Ames, Iowa). All M. hyopneumoniae strains were grown in Friis media as 
previously described (6) and are from in vitro passage less than 15. Cultures consisted of 125 
ml of Friis media in 250 ml Erlenmeyer flasks incubated at 37°C with slow agitation until the 
culture reached mid log phase as indicated by color change and turbidity. Mycoplasmas were 
pelleted by centrifugation at 24,000 x g, and the cell pellets were stored at -70°C until the 
chromosomal DNA was isolated. 
Microarray 
The M. hyopneumoniae microarray consists of polymerase chain reaction (PCR) products 
(probes) spotted to Coming UltraGAPS™ glass substrates (Coming, Inc., Big Flats, N.Y.). 
Ninety-one percent (632/698) of the total open reading frames (ORFs) of strain 232A are 
represented on the array as PCR products of 125-350 base pairs in length. Each product is a 
unique sequence even within paralogous families as described by Minion et al. (14). The 66 
missing ORFs are due to an inability to design suitable primers (12 ORFs) or failed PCR 
reactions due to incorrect product size, multiple bands or no product (54 ORFs). Only ORFs 
greater than 125 base pairs are represented on the array and no tRNA or ribosomal RNA 
sequences were included. The primer design, array construction and validation have been 
described (Chapter 2). Each slide was divided into two regions (upper and lower), and each 
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region contained the full array of spots, printed in triplicate in a noncontiguous well-spaced 
format. This design allowed two independent hybridizations simultaneously to reduce 
variation due to slide interactions. 
Experimental design 
TempliPhi™ amplified DNA samples from field isolates were compared to control strain 
232 using a two-color experimental microarray design. Independent samples from one isolate 
labeled with one dye were paired with control samples labeled with the alternate dye; the 
samples were mixed and hybridized to the microarray. For isolate 29726A, three independent 
DNA samples were paired with three independent DNA samples from control 232. For two 
of the three arrays, the control sample was labeled with Alexa 555 dye and compared to the 
field isolate sample labeled with Alexa 647 dye (Molecular Probes, Inc., Eugene, Ore.). The 
dye assignment to control and treated samples was reversed for the third array (dye swap). 
The arrays were hybridized under identical conditions as described below. This procedure 
was repeated for isolates 1879 and 27533 for a total of four arrays each including two dye 
swaps, isolates 27644 and 27604B for a total of five arrays each including two dye swaps, 
and isolates 426 and 27008 for a total of six arrays each including three dye swaps. 
DNA isolation 
DNA was isolated from frozen cell pellets as follows. The cells were first resuspended in 
1 ml of TNE buffer (10 mM Tris, 140 mM sodium chloride, 1 mM ethylenediamine 
tetraacetic acid, pH 8.0), and Proteinase K was added to a final concentration of 70 (ig/ml. 
The suspension was incubated at 50°C for 5 min, and then sodium dodecyl sulfate was added 
to a final concentration of 0.1% and incubation was continued at 50°C for 4 h. The 
suspension was then extracted with an equal volume of 25:24:1 phenol:chloroform:isoamyl 
alcohol three times, and the DNA was precipitated by the addition of one tenth volume of 3 
M sodium acetate and bringing the solution to 70% ethanol as described (17). The DNA 
pellets were dissolved in nuclease-free water, and samples were quantified and checked for 
purity using the Nanodrop® ND-1000 Spectrophotometer (Nanodrop, Wilmington, Del.). 
TempliPhi™ reactions 
Field isolate samples yielded low amounts of genomic DNA compared to strain 232 due 
to their fastidious growth and lack of adaptation to growth media. To overcome the issue of 
limited quantities of DNA, genomic samples were amplified using the TempliPhi™ 100 
Reaction Kit (Amersham, Biosciences, Piscataway, N.J.) according to the manufacturer's 
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protocol. A total of five reactions were combined for each field isolate and strain 232, 
yielding approximately 5-8 (ig total DNA in each preparation which was subjected to 
mechanical shearing. 
Nebulization 
The DNA was mechanically sheared prior to labeling to ensure an optimized fragment 
size for efficient labeling and hybridization. Each amplified sample was added to the 
modified nebulizer (product #4100, MEDEX, Carlsbad, Calif.) containing 2 ml of sterile 
50% glycerol. The nebulizer was modified by removing the plastic cuff, trimming the edge 
and inverting it during reassembly. The samples were sheared using a 10 psi nitrogen stream 
for 15 min. The fragment size of less than 1,000 base pairs was optimal for efficient labeling 
and signal strength. This was confirmed by gel electrophoresis on 1.5% agarose gel. 
Target generation and hybridization 
Targets were generated and purified from mechanically sheared DNA samples using the 
BioPrime® Plus Array CGH Indirect Genomic Labeling System (Invitrogen Corp., Carlsbad, 
Calif). A set of 129 open reading frame-specific hexamer oligonucleotide primers (Chapter 
2) was used to generate amino-allyl modified DNA targets. These targets were then labeled 
with either Alexa Fluor™ 555 Reactive Dye or Alexa Fluor™ 647 Reactive Dye (Molecular 
Probes, Inc.) according to the experimental design. Following purification of the 
fluorescently labeled cDNA per manufacturer's instructions, samples were dried in a vacuum 
centrifuge and then resuspended in 10 pi Pronto! cDNA/long oligo hybridization solution 
(Coming). Targets were denatured at 95°C for 5 min and centrifuged at 13,000 x g for 2 min 
at room temperature. Labeled targets from one 232 control and one field isolate were then 
combined, pipetted to an array, and covered with a 22 x 22 mm HybriSlip™ (Schleicher & 
Schuell, Keene, N. H.). Slides were placed in a Coming hybridization chamber and incubated 
in a 42°C water bath for 12-16 h. Slides were washed according to Coming's UltraGAPS™ 
protocol and dried by centrifugation. 
Data acquisition and normalization 
Each array was scanned with each dye channel using a ScanArray Express laser scanner 
(Applied BioSystems, Inc., Foster City, Calif.) under varying laser power and PMT gain 
settings to increase the dynamic range of measurement (4). Images were analyzed for spots 
and signal intensities quantified using the softWorRx Tracker software package (Applied 
Precision, Inc., Issaquah, Wash.). Spot-specific mean signals were corrected for local 
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background by subtracting spot-specific median background intensities. The natural 
logarithm of the background-corrected signals from a single scan were adjusted by an 
additive constant so that all scans of the same array-by-dye combination would have a 
common median. The median of these adjusted-log-background-corrected signals across 
multiple scans was then computed for each spot to obtain one value for each combination of 
spot, array, and dye channel. These data for the two dye channels on any given array were 
normalized using LOWESS normalization to adjust for intensity-dependent dye bias (5, 26). 
Following LOWESS adjustment, the data from each channel were adjusted by an additive 
constant so that the median for any combination of array and dye would be the same for all 
array-by-dye combinations. The normalized values for triplicate spots were averaged within 
each array to produce one normalized value for each of the 632 probe sequences. 
Data analysis 
A separate mixed linear model analysis was conducted for each probe sequence using the 
normalized data (25). Each mixed model included fixed effects for field isolate differences 
(isolate versus control), slide region (upper versus lower), and dye (Alexa 555 versus 647) as 
well as random effects for slide and slide-by-region interaction. A /-test for differential 
expression across treatments was conducted for each probe as part of the analysis. A />value 
was reported for each probe tested. 
Results 
TempliPhi™ reactions 
Genomic DNA from all mycoplasma isolates were subjected to amplification by 
TempliPhi™ because of low chromosomal DNA yields in several of the field isolates. Figure 
6.1 shows the results of an amplification reaction before and after mechanical shearing and 
resolved on a 1.5% agarose gel. The optimal time of nebulization (15 min) and nitrogen 
stream pressure (10 psi) was determined empirically by taking samples at various time points 
during the shearing process and analyzing them by electrophoresis. All amplified DNA 
preparations were then sheared using that time point and nitrogen pressure, and the fragment 
size was confirmed by electrophoresis as shown in Figure 6.1 prior to labeling. 
To determine if there were any effects on signal strength due to the TempliPhi™ reaction, 
strain 232 nonamplified DNA was compared to TempliPhi™ amplified DNA from the same 
batch of chromosomal DNA in a dye swap experiment. Equal amounts of DNA were sheared 
and added to the labeling reactions. The chromosomal DNA sample was mixed with an 
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amplified DNA sample (alternate dye label) and hybridized to one array; a dye swap mixture 
was hybridized to the array at the opposite end of the same substrate. The probe signal 
intensities were quantified, and these values after background subtraction were compared 
using correlation analysis. Pearson's correlation coefficient was R=0.9803 (Fig. 6.2). 
Figure 6.1. Analysis of TempliPhi™ amplified and nebulized mycoplasma chromosomal 
DNA. Left, molecular weight markers (arrow indicates 1,000 base pairs); Right is 
TempliPhi™ amplified DNA; Center is nebulized, amplified DNA. 
Microarray studies 
Data from each of the field isolate replicates was used in the statistical analysis. Some 
amount of error was attributed to the dye, but the effect was not significant in the 
experimental model as analyzed by ANOVA (data not shown). Statistical analysis indicated 
that 47 genes for the combined field isolates had significant differences from the control 
strain 232 at ap-value <0.05. The results are presented in Table 6.1. 
The field strains differed in the number of genes that varied with the control strain 232. 
The strain with the most variation was strain 1879 with 25 loci. Two of the strains, 27533 
and 27604, showed no variation at/K0.05. Only a single locus, mhp024, showed differences 
in more than one strain, strains 426 and 1879. The majority of the genes showing differences 
(35/47) were hypothetical with no known function. 
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Figure 6.2. Comparison of mean log signal intensity values of genomic vs TempliPhi™ 
amplified chromosomal DNA. Data represent Log mean intensity values following 
background subtraction. Correlation analysis was performed and Pearson's coefficient was 
R=0.9803. 
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Table 6.1. Genetic variation of M. hyopneumoniae field isolates compared to strain 232 with 
/?<0.05*. 
Field 
Isolate 
426 
1879 
27008 
ID Gene Description p-value 
mhp024 UH Unique Hypothetical 0.0264 
mhp025 CH Putative ABC Transporter ATP-Binding 0.0291 
mhp435 CH Conserved Hypothetical 0.0262 
mhp024 UH Unique Hypothetical 0.0287 
mhp027 UH Unique Hypothetical 0.0089 
mhp041 recA RecA Protein 0.0250 
mhp044 UH Unique Hypothetical 0.0016 
mhpl57 nrdl Ribonucleotide Reductase 0.0491 
mhpl58 nrdE Ribonucleoside-Diphosphate Reductase 0.0236 
Alpha Chain 
mhp338 UH Unique Hypothetical 0.0118 
mhp342 UH Unique Hypothetical 0.0123 
mhp348 UH Unique Hypothetical 0.0014 
mhp398 UH Unique Hypothetical 0.0269 
mhp404 CH Conserved Hypothetical 0.0463 
mhp446 CH Conserved Hypothetical 0.0060 
mhp452 CH Conserved Hypothetical 0.0484 
mhp522 UH Unique Hypothetical 0.0153 
mhp526 CH Conserved Hypothetical 0.0094 
mhp527 CH Conserved Hypothetical 0.0290 
mhp529 UH Unique Hypothetical 0.0303 
mhp530 CH Conserved Hypothetical 0.0393 
mhp531 CH Conserved Hypothetical 0.0089 
mhp535 UH Unique Hypothetical 0.0218 
mhp538 CH Conserved Hypothetical 0.0292 
mhp639 CH Conserved Hypothetical 0.0168 
mhp650 CH Conserved Hypothetical 0.0248 
mhp658 UH Unique Hypothetical 0.0114 
mhp692 CH Conserved Hypothetical 0.0240 
mhp068 UH Unique Hypothetical 0.0059 
mhp236 CH Putative Chromate Transport Protein 0.0021 
* UH= unique hypothetical; CH=conserved hypothetical; strains 27533 and 27604 are not 
included because they had no differences at ^ <0.05. 
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Table 6.1.Continued. 
Field 
Isolate ID Gene Description p-value 
27644 
mhp278 clpB ATP-Dependent Serine Proteinase, Heat 
Shock Protein 
0.0253 
mhp279 CH Conserved Hypothetical 0.0457 
mhp331 CH Conserved Hypothetical 0.0059 
mhp436 CH Conserved Hypothetical 0.0388 
mhp473 CH Conserved Hypothetical 0.0277 
mhp484 CH Conserved Hypothetical 0.0498 
mhp488 Phosphoglycerate Kinase 0.0462 
mhp497 asnS Asparaginyl-tRNA Synthetase 0.0236 
mhp520 pepF Oligoendopeptidase F 0.0112 
mhp660 CH Conserved Hypothetical 0.0234 
27926 
mhpl35 rpsT 30S Ribosomal Protein S20 0.0391 
mhpl56 nrdF Ribonucleoside-Diphosphate Reductase 
Beta Chain 
0.0257 
mhpl60 UH Unique Hypothetical 0.0409 
mhp229 gmk Guanylate Kinase 0.0486 
mhp361 CH Conserved Hypothetical 0.0220 
mhp619 CH Conserved Hypothetical 0.0399 
29024 
mhpl36 CH Conserved Hypothetical 0.0468 
Discussion 
Mycoplasmas have shown a surprising ability to undergo rapid antigenic variation, which 
is primarily associated with surface lipoproteins (28). This variation arises from mutations at 
homopolymeric tracts of adenines and repeated sequences generated during DNA replication 
and by recombination within homologous sequences in the genome. This type of variation is 
random and is thought to support survival of these organisms during innate and adaptive host 
immune responses. This high rate of variation is associated with specific genes and gene 
families, but mycoplasmas are also thought to evolve at high rates from random mutations as 
a consequence of inadequate proofreading and DNA repair systems (33). Thus, it is not 
surprising that mycoplasmas show a significant level of genetic variation (9). 
Previous studies have shown that different stains of M. hyopneumoniae vary in their 
virulence potential (32). Genetic variation within M. hyopneumoniae is not well understood, 
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however. Mycoplasma hyopneumoniae does not contain the lipoprotein gene families found 
in other mycoplasma species that undergo high rates of diversity (14). It is possible that M 
hyopneumoniae, like M. pneumoniae, is more "stable" and generates most of its diversity 
through spontaneous mutations randomly distributed in the genome. In some instances, these 
changes can be observed using randomly amplified polymorphic DNA analysis (2, 23), but 
no studies have been reported in mycoplasmas that examine variation systematically 
throughout the genome. 
In unpublished studies, one locus was identified that displayed significant sequence 
variation in two of the field isolates used in this study, isolates 426 and 1879 (Strait et al., 
unpublished). This chromosomal region involved mhp024 and included both a deletion and 
sequence variation. The region was identified using a nested PCR test that failed to identify 
these two strains with the inner primer pair (10). It is significant that the present studies 
confirm the variation within mhp024 in those two strains since the regions containing this 
sequence variation are represented on the array (Table 1). 
Our data indicate that the M. hyopneumoniae microarray can identify genetic variability 
across the M. hyopneumoniae genome rapidly and accurately. Further confirmation of these 
changes will require sequencing the indicated genomic regions. These data can be used to 
improve diagnostics by screening more field isolates and eliminating the variable genes from 
consideration for PCR targets. Ideally, the PCR target should be homogenous across multiple 
field isolates. In addition, the arrays can be used to screen other mycoplasmal and bacterial 
species to enhance the specificity of the PCR target sequences for M. hyopneumoniae by 
eliminating those open reading frames that are cross-reactive. In summary this microarray is 
a powerful tool for genomic analysis, which has potential for improving diagnostics. 
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CHAPTER 7. GENERAL CONCLUSIONS 
General Discussion 
The construction and application of this microarray represents a significant advancement 
for the field of mycoplasmology. Weiner et al. were the first to report a global transcription 
profiling experiment in mycoplasmas (11), but their studies involved membrane based arrays, 
a technology that is falling into less favor and is thought to be inferior to glass substrates and 
fluorescent signals. The most important difference between membrane and glass substrate 
arrays is the ability to have a control sample hybridized at the same time as an experimental 
sample. This allows for direct comparison of the two samples and diminishes error associated 
with independent hybridizations. The smaller amount of target necessary to visual data is a 
benefit, especially when minimum samples are available. Smaller hybridization volumes 
increase the opportunity for probe:target interaction. Glass substrates can accommodate 
substantially more probes than a membrane. This is especially important when samples are at 
a premium and all possible gene products can be evaluated on a single substrate. 
Additionally, the exposure to radioactively labeled targets is completely omitted. 
This project required the design and construction of microarray s because they were not 
commercially available for mycoplasmas, particularly M. hyopneumoniae. The construction 
of the microarray was possible due to the completed genome sequence of M. hyopneumoniae 
(6). Glass substrates were used for the arrays because of the improvements in technology and 
detection systems. The construction process entailed a complex series of steps (Fig. 7.1), 
each of which required careful optimization through trial and error. The process was 
complicated by the lack of suitable components during the early construction phases, 
particularly in substrate quality and reproducibility, and PCR product spotting buffers. Post 
construction, poor mycoplasma RNA yields of initial isolation methods had to be overcome. 
Several isolation techniques were evaluated for quantity and quality of the RNA. Labeling 
efficiencies also hampered data acquisition. Whether these complications were due to the AT 
richness of the genome, especially long homopolymeric tracts of adenines, or problems with 
manufactured kits was never clearly determined. The bulkiness of the dyes could impede 
efficient labeling if strings of modified nucleotides were incorporated into the cDNA and 
competition for those locations made binding an issue. The addition of a second modified 
nucleotide to the Invitrogen kits seemed to resolve some of the labeling issues. The task of 
quality assurance also proved challenging. Finding a staining or hybridization method that 
would give a good evaluation of the array without wasting precious samples proved difficult. 
Once a suitable system for detecting the quality of the arrays could be ascertained, the studies 
could commence. 
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Figure 7.1. Steps for microarray construction and utilization. 
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Using the microarray to elucidate previously unknown transcriptional and genomic 
differences proved to be a powerful tool in the studies conducted. Numerous genes of interest 
have been identified in response to environmental stress, strain variation and field isolates. 
Additionally, a look at variation across the heat shock and iron deprivation studies has 
pointed to numerous genes that show both common and diverging responses under both 
conditions (Table 7.1). Thirty-two of the 53 overlapping genes are conserved hypothetical 
genes. A paralog of the PI 02 family was also identified in both studies. The remaining genes 
were involved in translation, stress response, and transport. Of these 53 genes, 6 were 
differentially transcribed, meaning up-regulated in one treatment group and down-regulated 
in the other. These genes could be useful in determining possible promoter sequences. 
One additional conclusion that should be drawn from the culmination of these studies is 
the identification of potential housekeeping genes. By examining those genes with highly 
conserved homology across the transcriptional studies with little to no transcriptional 
difference among treatments or variants, genes can be identified as housekeeping or 
reference genes in future analyses. Table 7.2 provides a list of 15 genes that could serve as 
putative housekeeping genes and serve as transcriptional controls in any further applications. 
For example, an accurate method of quantification using real-time PCR relies on a robust set 
of genes that do not show genetic variation or altered expression. These genes could provide 
those controls. 
Recommendations for Future Research 
Now that a powerful molecular tool is available to investigate transcriptional and genetic 
differences, future experiments can be designed to examine these differences more 
intricately. In response to environmental stress, additional studies should evaluate the 
response of M. hyopneumoniae to cold shock and acid tolerance. Studies by Zielinski et al. 
have shown adherence is impaired significantly by a decrease in temperature (12). Using this 
global approach, when taken in concert with the heat shock study results, the additional 
information could outline a more complete picture of how M. hyopneumoniae responds to 
fluctuations in temperature. M. hyopneumoniae may also find itself in an altered pH 
environment following the influx of neutrophils into regions of lung containing mycoplasma 
antigen. It is likely that mycoplasmas experience a change in pH as the lung disease 
progresses. Initially, colonization occurs at the upper respiratory surface on ciliated cells, but 
eventually, these cells are lost, mycoplasmas are trapped in the lung surfactant and in fluids 
at deeper regions and lymphocytic infiltration ensues, causing additional tissue damage. In 
these inflammatory loci and areas of active lymphocyte activity, the microenvironment pH 
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drops (1,4, 5). These changes in the microenvironment have profound implications on 
immune cell function (3, 5, 9), but they could also cause changes in the pathogen as well. A 
comparison of acid tolerance and in vivo response could have correlated data and help define 
how the organism survives in the host respiratory tract. 
Another environmental factor that might be examined is M. hyopneumoniae''s response to 
carbon dioxide. Mycoplasmas are normally grown under conditions where CO2 
concentrations are quite low. In the lung, one can expect concentrations of CO2 to reach 5% 
and under pneumonic conditions, possibly higher, i.e. 6%. A study of normal broth grown 
organisms and those cultured in 6% CO2 might give insight into transcriptional changes M. 
hyopneumoniae undergoes in vivo. 
Some bacteria have been shown to respond to hormones, possibly through a mechanism 
involving a structural mimic. For Escherichia coli 0157:H7 this appears to be in a quorum 
sensing system (7). There have been some studies in Mycoplasma pulmonis infections in 
mice, but these appear to affect the host more than the mycoplasma although that could not 
be ruled out (2, 8). The effect of hormones on the mycoplasma was not tested directly. It is 
not unusual to have high concentrations of epinephrine in the lung during infections. Perhaps 
M. hyopneumoniae can respond to epinephrine to facilitate its persistence in the lung. This 
kind of study would be simple to perform by adding epinephrine to cultures at concentrations 
that simulate the levels expected in the lung. 
Studies in other bacterial organisms are indicating that the ribosomal genes are 
contributing to variation in transcription and translation through conformational changes, 
acting as chaperones and other possible unknown functions (10). The microarray constructed 
for these studies did not include any of the ribosomal or transfer RNA genes. A subarray 
constructed with these genes may give insight into any possible regulatory effects the 
ribosomal genes may have on transcriptional variation. 
Having analyzed field isolates from across the country as well as inter-continental 
isolates could help determine the true genetic variation present in M. hyopneumoniae. This 
would be both a challenging and costly undertaking, but would provide relevant information 
especially for identifying conserved genes for diagnostic purposes. The array might also 
prove useful in epidemiologic studies. Since M. hyopneumoniae is endemic worldwide, if 
proven vaccine programs could be put in to practice using attenuated strains and the 
"genotype" established, then any "new" infections could be detected, characterized, and the 
origin of infection identified. 
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Table. 7.1. Genes with significant (p<0.05) transcript values in both heat-shocked and iron-
depleted studies. 
Gene ID1 Gene2 Description p-value H p-value I H3 I 
mhp005 CH 0.00329 0.01495 
- -
mhp007 UH 0.00073 0.01435 
- -
mhpO13 UH 0.00648 0.04918 - -
mhp023 CI I Putative ABC Transporter ATP- 0.00407 0.01478 - + 
Binding Protein 
mhp030 go# Glu-tRNA(Gln) Amidotransferase, 0.00324 0.00626 - -
Subunit B 
mhp060 fjh Signal Recognition Particle Protein 0.00860 0.04635 + + 
(fifty-four homolog) 
mhp064 CH 0.00071 0.01959 + -
mhp071 UH 0.00192 0.03527 + + 
mhp072 dnaK Chaperone Protein dnaK 0.00002 0.03556 + + 
mhp078 lepA 30 kDa GTP-binding protein LepA 0.00399 0.04766 + + 
mhp085 rpsL 30S Ribosomal Protein S12 0.02290 0.00021 - -
mhp087 CH 0.02272 0.00312 - -
mhpl 17 hpt Hypoxanthine Phosphoribosyl 0.02385 0.00965 - -
Transferase 
mhpl28 serS Seryl-tRNA synthetase (Serine-tRNA 0.00423 0.04630 + + 
Ligase) 
mhpl44 CH 0.00800 0.01198 + + 
mhpl46 rbsC ribose ABC transporter 0.03053 0.04079 + + 
mhpl 47 rbsA Ribose transport ATP-binding protein 0.00527 0.03613 + + 
mhpl 50 CH 0.00112 0.02044 + + 
mhpl51 CH 0.00131 0.00689 + + 
mhpl52 MC myo-inositol catabolism 0.00413 0.00825 + + 
mhpl67 oppD oligopeptide transport system 0.03350 0.00420 
- -
permease protein 
mhp 169 oppB oligopeptide transport system 0.04435 0.00495 
- -
permease protein 
mhpl 76 CH 0.00314 0.00093 - + 
mhp275 CH PI02 paralog 0.00234 0.00756 + + 
mhp278 clpB ATP-dependent serine proteinase, 0.00031 0.02153 + + 
heat shock protein 
mhp 3 09 UH 0.04443 0.03562 
- -
mhp315 UH 0.02183 0.02743 
- -
Shading indicates differentially regulated genes between heat-shock and iron depletion.2 CH = Conserved 
hypothetical; UH = unique hypothetical.3 H = Heat shocked genes; I = Iron deprived cells; (+) up-regulated; 
(-) down-regulated. 
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Table 7.1. Continued. 
Gene ID Gene' Description p-value H p-value I H 
mhp325 
mhp337 
mhp342 
mhp374 
mhp411 
mhp419 
mhp421 
mhp427 
mhp443 
mhp447 
mhp461 
mhp471 
CH 
UH 
UH 
CH 
CH 
CH 
ruvA 
CH 
CH 
CH 
CH 
nadE 
Branch Migration of Holliday 
Structures; Repair 
NH(3)-Dependent NAD+ Synthetase 
0.04769 
0.00201 
0.01677 
0.00102 
0.04943 
0.00050 
0.01921 
0.03877 
0.02940 
0.01274 
0.01567 
0.04455 
0.02067 
0.00618 
0.02216 
0.01007 
0.00789 
0.01501 
0.04102 
0.03104 
0.04119 
0.01353 
0.04233 
0.01145 
+ 
+ 
mhp476 
mhp486 
mhp497 
mhp511 
alpD 
CH 
asnS 
ATP Synthase Beta Chain 
Asparaginyl-tRNA Synthetase 
46kD Surface Antigen Precursor 
0.00551 
0.00667 
0.00240 
0.00219 
0.01 109 
0.02187 
0.02807 
0.02293 
+ 
+ 
+ 
+ 
mhp526 
mhp528 
mhp574 
mhp639 
mhp650 
mhp651 
mhp653 
mhp672 
CH 
UH 
UH 
CH 
CH 
ushA 
CH 
rpIM 
5-Nucleotidase 
50S Ribosomal Subunit Protein LI3 
0.00028 
0.02831 
0.01326 
0.01639 
0.01800 
0.01649 
0.02766 
0.00988 
0.01669 
0.01647 
0.03069 
0.00010 
0.02905 
0.00031 
0.02553 
0.01345 
+ 
+ 
+ 
+ 
mhp679 rpmG 
mhp697 CH 
50S Ribosomal Protein L33 0.01292 
0.00676 
0.03545 
0.03037 
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Table 7.2. Putative housekeeping genes 
ID Gene Description 
mhp 142 UH Unique Hypothetical 
mhp 143 CH Conserved Hypothetical 
mhpl 61 UH Unique Hypothetical 
mhp236 CH Conserved Hypothetical 
mhp248 lip 3 lipase-esterase 
mhp293 UH Unique Hypothetical 
mhp345 CH Conserved Hypothetical 
mhp350 CH Conserved Hypothetical 
mhp357 CH Conserved Hypothetical 
mhp377 CH hypothetical lipoprotein 
mhp381 sn-glycerol-3-phosphate transport 
system permease 
mhp404 CH Conserved Hypothetical 
mhp405 CH Conserved Hypothetical 
mhp483 CH Conserved Hypothetical 
mhp583 UH Unique Hypothetical 
Since the proposed studies outlined in this "future studies" section are all in vitro, the 
next major step is to examine samples taken from pig challenge studies. These studies would 
be challenging, but technology is now available to perform them. In addition, the natural 
host, the pig, provides some advantages not found in other model host-pathogen infection 
models. Mycoplasma hyopneumoniae cells can be isolated from bronchial alveolar lavage 
samples in sufficient numbers to use on the array. This kind of study could provide additional 
clues to the mycoplasma's response to the host environment. It would be instructive to 
correlate the results from these in vivo grown organisms with those exposed to heat shock or 
iron deprivation in vitro. Archived lung and bronchial alveolar lavage samples should be 
tested using the array. Laser capture microdissection could be used to collect M. 
hyopneumoniae cells that are still bound to the cilia from these samples and compare their 
transcriptional profiles with in vitro grown organisms or those isolated from alveolar lavage 
fluids. Would mycoplasmas attached to cilia have the same transcriptional profiles as those 
released into the lung? This is an interesting and provocative question. Likewise, an in vivo 
time course study could reflect changes M. hyopneumoniae undergoes to combat host 
immune responses. Knowing what genes and transcripts are involved in pathogen adaptation 
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and survival might prove important to developing new more effective vaccines by 
pinpointing better targets. 
Arrays are not the answer to all questions. While they can be used to interrogate samples 
for genetic and transcriptional variation, any alterations to phenotype at the translation level 
would not be detected. With the abundance of hypothetical genes showing significant 
differences between strains and isolates, a protein array could give valuable insight to post­
radiational modifications affecting virulence and pathogenicity. 
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APPENDIX A. CIRCULAR REPRESENTATION OF THE MYCOPLASMA 
HYOPNEUMONIAE GENOME STRUCTURE 
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Mycoplasma hyopneumoniae 
Functional Assignments 
Amine aod biosynthesis Replication RNAs I I Cellular Processes I I Other 
Wk Biosynthesis of cofacrors, prosthetic groups and carriers • Transcription • Biosynthesis of polyamines • Central Intermediary Metabolism • Unassigned 
I 1 Fattvaodand phospholipid metabolism H Translation O Biosynthesis of sugars H Energy metabolism 
m Purines,pyrrnidines, nudeosides and nucleotides H9 Transporrtand Binding B6 Cell envelope |__| Hypothetical 
Circular representation of the M. hyopneumoniae genome structure. The dnaA gene is at 
position one. Starting from the outside: circle one, replication arrows; circle two, the location 
of the putative coding sequences on the positive strand; circle three, the location of the 
putative coding sequences on the negative strand (the color code for the functional 
assignments are given in the figure); circle four, position and direction of transcription of the 
P97 (black) and PI02 (orange) paralogs; circle five, scale in bp; circle six, paralogous 
families of three or more members (colors indicate relationship and not functional 
assignment); circle seven, predicted lipoproteins. 
132 
APPENDIX B. PRIMERS USED IN THE MYCOPLASMA HYOPNEUMONIAE 
MICROARRAY 
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Table A.l. PCR primers for the M. hyopneumoniae microarray construction. 
Gene ID Left Primer Sequence Right Primer Sequence 
mhpOOl TCGATTCGTGAGCTTGAAGG ATCAGATTGCAATATCGCGG 
mhp002 AATCAACAAACGCGACATCC TTTTCTGGCGAAACTATCAAC 
mhp003 TAAAAACTGGAACTCCCCCG TCGAAAAATATTTGGTGGCG 
mhp004 TGGTTCTAGCCCCAGAGAATG CATCAACGCCGTACGAACC 
mhp005 GATGGAGATTGTCTGGGTGC CTCTGAAGCAGCCGAAAAAG 
mhp006 TGCAGTTGGCAATCACAAAG ATGAATGTGGCACTTTTCCG 
mhp007 TGGGCCAATTTCCTGAAC TGAGTGGGGATTTTTAGCCG 
mhpOOS TTTAATCGACACAGCCGGAC TAAATCATCCATCGCTTCGC 
mhp009 CAGATTTTGGACTTGCTCGC AAACCATTGCGTGACAAAGC 
mhpOlO AGCTCGAAAATGAGCAGG CGCTGTTTTCACAATTCGG 
mhpO 11 AGCTCGAAAATGAGCAGG AGCGCTGTTTTCACAATTCG 
mhp012 AAAAATAGAAATCGCTCCCCC AAAAACTGAGCCCACCAAGC 
mhpO 13 GAATCCGCTCATTTTAGCGAC TAATTATCGCCGAGTGGGAC 
mhp014 GCTCTCCATTTGGATCATGG CAGGGACTTTCAATCTGGGG 
mhp015 CCGGGATTATTTTATACGGGC TCCCTAGTCCCACCATATTTTTC 
mhpO16 TC AA AGATT AAC AGT AG AGTCGTGG GCATCATCCTTATATTGCTCCC 
mhpO 17 TTTTAACAGCTGGGTTTGCG TTCCGCTTCCAAACTTGAAC 
mhpO 18 TCCGGTTACTAGAATGAAAGCAA CCGCTAATTAAAATTGGGACG 
mhp019 GCGAATGAAGAGAAAAACCCTT TTGATTTAGTTTTTCACCTTGAG 
mhp020 AAGCGAATGAAGAGAAAAACCC ACCGCCAGATAAATCTTTTAC 
mhp021 GCTCAACTCAAATGTTCAGGG TCGGCCTTGTAAATCGTTTG 
mhp022 GGGTTGAGGCTGTTAGCAAG TTTTGTGCCAGGCTTGAATC 
mhp023 GCTCAACTCAAATGTTCAGGG TCGGCCTTGTAAATCGTTTG 
mhp024 CGCTTCTCGGAGCAAAATC GTATCTCCAACCCGTACCCG 
mhp025 GGCCTTAGTGAATCTGGTGG AAACAACCACTCCCGATG 
mhp027 GAACCTCAGGAATTGGCTCC TTCTGCGTGGCGTTAGAATC 
mhp028 AATGTCGAAGGAAACTCGATG AAATCCAAAAGTACGGCTATC 
mhp029 TTCACCGAATTTACGCGG CAATCAATGGAACCCCAC 
mhp030 AGAAAATGGATCACTTCGTGC GATGGGGTAAGTGGAACCTG 
mhp031 TGGGGTATTATGGCATTCTGAC AAATAGCCGCTACCAAATCAAC 
mhp032 GCCACTTTTTGGTGAGGATG ATTGAGACAAACCATTGCGG 
mhp033 TGACTGATCTCACGTCAGCG AAAAGGAGGCTTTTCATCGC 
mhp034 TTGCCCAGGAATGAAAAATG GTTGCATCGATCACTTCGC 
mhp035 GCAATTAATGGCTTTGGACG AGGCAAGGACTTTGGGTCTC 
mhp036 TCAACATTTAGAGGCGGGAG TGCAGCACCTGTTGATGAAG 
mhp037 TGTACCCCCTGTTTCACCTG CCGGTTTTATTCCCCAAAAC 
mhp038 ATTGGTCATAAAAGCGAGCC TCCTGCTTGACATAATGGGC 
mhp039 TGATAAGCGGAAATGCGG TTGCCTCATTTTGTTCAATGG 
mhp040 GTTGATAAGCGGAAATGCGG TTGCCTCATTTTGTTCAATGG 
mhp041 AAAGCGCTCCGAAAAATCAC AGAATTCCAAGTTCCTCGCC 
mhp042 ATCATTCCGCGAGGGTAAC CGAAAGGAATGATTTGAGGG 
mhp043 GATAATATCGTTTCGCCGGG GACCTCCTCGACCTCCTTTG 
mhp 044 CAAAAGACAAAGCCGAGTGG ATCGCCGAAACTTCCTCTTC 
mhp046 TTTCCAAATATTTATGCCAACGA AAATTGACCGTTCCGAAAGC 
mhp 04 7 GCAGGCATT AT GCAGGTTTC CGGAAAC ACCGT CT AAG ATTTG 
mhp048 TCTTGCATTAGCGTTTTGGC AGCACAAACCGGGAAAATTG 
mhp049 TTAGGTGCAGGACTGGCG TTGTGCTTCAGGATTACGGG 
mhp050 GCAATCGATAATGCGCGTC AGCAATCAGACTTTGCTGGAG 
mhp052 AGCATGCAATTGCCTATCG CCAACCCGTGAGACTGAAAG 
mhp053 AAGCATGCAATTGCCTATCG CCAACCCGTGAGACTGAAAG 
mhp054 TTAGATCGAGGCATTGCTGC TTCTGCGCTACGAAGAATGG 
Table A.l. (Continued) 
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Gene ID Left Primer Sequence Right Primer Sequence 
mhp056 GAATCAAGTCCTTATTCAGTGACAG AATTTGAGGAGGAAATCACACC 
mhp057 AAACCGCGGAATGTTTCTC AGCACAACCAAAATGTTCTC 
mhp058 TATTAGCGAGATTCCAGCGG TGTTCGGACAGCTTGTTCTTC 
mhp059 AATCAGATCGAATTGCCGC TTTTAAAAACGCGACGCAAG 
mhp060 GTTGGCCTTCAAGGTTCTGG TCTTCGTTGATTGAAAGCCG 
mhp061 ACAGGCATCTGGACACCTTG AAATACCCTGAGCTGTCTCCG 
mhp062 GTTGGATTCTCTGGTCGCTG ATCGAGCGCGAGTAGAACTG 
mhp064 TTGGGATAAGTGTGGCTGAC TCAAAATCGAATCCACACTGC 
mhp065 ACTTGCAGTTATTGGTGGGG GCGAAGCCACTGATTCTTTG 
mhp066 ACTTGCAGTTATTGGTGGGG GCGAAGCCACTGATTCTTTG 
mhp067 TTTTGATGAAGCCTCGCAAC TTCTTGTGGCCTTTCGATTG 
mhp069 CATATGAATTTTCGCCCGC AAGTATGCAATGCCTGAATGC 
mhp070 GATGCTGCCAAACCAGGTAG TTTTGACTTTTTGCTGCGTG 
mhp071 GTTAAACAAAATGACGGCGG CCAAAAACAACAAACTAACTGCAAG 
mhp072 ATTATCCGGTGGAACCTTCG AGTT CAACGTTAATCGGCCC 
mhp073 TGGTTTTGGTGGCTCACAAG TTTTTCCACGGCACTTTTTG 
mhp077 GCCGAAATTTAAATACAAAACCG T AAAACAAGG CC GACAACCA 
mhp078 GTAAATCGACTTTGGCCGAC TGCCTGAATCCCTTGACTTG 
mhp079 ACGATCTTTAGCGGCAACTG GGTGGCGGGATCAAATTAAC 
mhp080 AAAACGCATTCAGGAAGAAGC ATTGGTGGCATTTCAAGTCG 
mhp081 TTAGCATGCGATAAAAATGGC GGGATTAGGGTACTAGAATCGGC 
mhp083 CCGTTCGCAATGTTTTAGCC AGTGCGAGAGTTTGTTGTCG 
mhp084 TCCCGTTCGCAATGTTTTAG GCGT AGTGCGAG AGTTTGTTG 
mhp085 CAGCAAAAGCACGTATTTCAA TTCCTTTTTCATCAAGCTCTTTTC 
mhp086 TGTTCGTTTGGAGTCAAATTCA TTCCGATTTCAACGTGGTTT 
mhp087 TGTTCGTTTGGAGTCAAATTCA TCCGATTTCAACGTGGTTTT 
mhp088 CAAAACGAAACAATTGAACG AAATATAACTGAGTTCTCGTTGTGC 
mhp090 CCTAAACGCAAATCTTGAGGTC AAAATGGTGTTTTGCCACTC 
mhp091 CCGGAGAATCTGGTATTGGG ATTTTCGCGCAAAGGCAC 
mhp092 GGGGAGTTCAACGCTTTTTG TCCT GAGGAAATTAGTGCCG 
mhp093 GGTTCTGGCAGCGACATC TTTCAAGCCCCAAAAATC 
mhp094 AATTGTCGTAGCAGATGCCC TTGTGCGCCTATATGCAATC 
mhp095 TGCGAGAAAGCTTGCAAAAG CGCTGTTCCTGACGTCATTC 
mhp096 TTGAATCAAGCCAAATCCG GCGGCGAACTTTATTTGACC 
mhp097 AT AGCAAAGCAACCCGGAAG TTGGTCTAATGGCCTCATGG 
mhp098 GAATTGAAAAAGATCCAATTGTTG TTTGGTGAAATTCGATACGTT 
mhp099 TGCAGGTGATGACAGTAGCG AACCACCTCAAATCGGTGTC 
mhp 100 TGCAGGTGATGACAGTAGCG AACCACCTCAAATCGGTGTC 
mhplOl TCAATGAACTTGCAGCAACC TTGAAGAGGCTGTGCCAT AAG 
mhp102 GCTGAATTACAACAACTAAGCGG AAGCGAGGTAAAATCCAGCG 
mhp103 GACCACGAAAGGGTATCACG TCCTTAACCTCATCCAGGGC 
mhpl 04 CGAAGGTCAAATTTACGGGG TGAGCGAATATAGCAACCGC 
mhp105 GTCTTGGCAAATGAGCTTGC GACAATAGGAAGGTTGGCCTG 
mhp106 CAAAACATCCAGCTTTTGATCC GGGCGAAACCGAGTTTTAAG 
mhp107 TTAAGTATTGGCGGCTTTGG CAGATCAAGCCCGAACTTTG 
mhp108 GCAGACTCAGATGGAAACGG TTAGGCCCAAGAATTACTGC 
mhp 109 AAATTTCACGGTCTACGGGC GCCTTTTCCTGGGCATTTC 
mhp110 GGTCATGAACTTTTTCTTTCG AAAAATTTTGCGGCCTCC 
mhp 111 ATTGGTTTCCAAGACCCACC TTTTAAGTGAAGGCGCATCG 
mhp 112 AGCCTGAAAAATCCTGAGCC ACCAT CGCTCGTTT AATTCG 
mhp 113 AAAGCCGGCGAAATAATCC TATCGCAAGCCGAAGAAATC 
Table A. 1. (Continued) 
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Gene ID Left Primer Sequence Right Primer Sequence 
mhp 14 CATTCATAAAATGGACCCGC AAAACCCGGTATTGTGGAGC 
mhp 15 TAATGAAATTCGTCGGCGTG GTTCCTTGGGGATCAAGTCC 
mhp 16 CAACATGGATCAGCTTGTGC AGCG AT GT CAT CTT CA AC CG 
mhp 17 AGGTGTGCTTAAAGGTTCGC AGCGTCCGGAACTACAAAGC 
mhp 18 TTTTATGCGAGGATTCACGG AAACCGGAAAGGACAAAAGC 
mhp 19 AGAAACGCCATACAATTCGG TTGTGTGAGGACTGCATTACTTTAG 
mhp 20 AAGACTAATTTGGCCCGCAC AACACCTCTATTCTCCAGGCG 
mhp 21 TATGCCTTGATTTCCAACG TGC A AGCCG AGT AATTTT AAG 
mhp 22 TTACCGGTGATTTTGAACTAA AACTTGATTTGGATAATCGGT 
mhp 23 TAAATTGCACCCACAAAACG TTGGACACGGGAGAGAATTG 
mhp 24 TTGAATTCCGAGTTCTAAACTACC TTTCATAATCCCAGCGTAAAGC 
mhp 25 ATCTACCGTCGGCTTTCAGG TTTGTTACTCGTTGGCGGAC 
mhp 26 AAAGCAATTTTAGCCGGACC ATTTATCCATTTCAGCCCCG 
mhp 27 GCTGTTTTTATTCCGGGGG AACTTGCTGCATTTCTTGCC 
mhp 28 CGGAGGCAGAGACACAAAAG TTGAAAATCGCCGCAATAAC 
mhp 29 TCAAAAAGGCGTAATGACCG ATTTGAGGCATGTTCTCCCC 
mhp 30 AACGGTTATAAAGGTGTTGAGC TGTGATCCACCTGATTTCCG 
mhp 31 TTTGAGGATGTCCAAGTGGG CGCCGAGCTAGCAACAGAG 
mhp 32 AATTTTTGCCATCACATCGG GGATTCCATTCCGGAAAAAG 
mhp 33 TCTTCGACTGGATTTCGTGC GGTGGCAGTTAGGCGATTTAG 
mhp 34 GATTCCGCATAAAGTCTGGG TTTGTGAAGTGCCAGGTTCC 
mhp 35 GCTCGCGCAAGAAATAATG CTGGTGTTGTGTAAGTATTCGC 
mhp 36 TTCTGAGAAGGACGATGTTGC GTAAATGCGCATCTCCTGGG 
mhp 37 TAAGATTGCTTCGCAGGCAC ATTCGAATTGACCCTGAGCC 
mhp 38 TTTCTTTGGCCAAGGTGC TTCATAGCGAAACATTGGGC 
mhp 39 C ATTAAAT GCGGCAATCCAG TTCTGCGATATTTCGATCCG 
mhp 40 TGTGCTGGGTTCCCTAAAATC CGTTAGTCGGGGCAAACTC 
mhp 41 TCCAGGGATTTTTGTCCC TGACTTTATCGCTTCTAAGTTCTC 
mhp 42 CAGAGCGTGGTATGGATTTAGG TTTAGCGCTGCACTTATCGG 
mhp 43 GAATATGCCGGAATTGGC AAATATTCCTCAGCCCGTTG 
mhp 44 TCAAATCGGCTTTATGCGTC CCGGCTTGCTGTCATTATTC 
mhp 45 GCCCAGATTCCATTAGGAGG CTTTTCCATCTGGGCCTTTC 
mhp 46 TTTATCACTTCGAGGGGCG GAAAGGGCACCT AAAATCGC 
mhp 47 TCGCTTTCGATCTCACAAAAG TTTTTCGGGATAACGCTGC 
mhp 48 GGCCTTAGGAGCGAAAGTTG CGCATGAGCAAAATGACCAG 
mhp 49 CAAGAAGACCCGATCCTGTG CCGATGATCACCAAAGGTTG 
mhp 50 TTTCACCGTTGGACATAATCG TCGATTGTTGCCATTGAACC 
mhp 51 GGCGAAGTGATTACCTATCAAG TCGATCCGATCAATTCAAGG 
mhp 52 TGCAATTGGGCTTAGTCGTC GATTTTGCAAGCGAAGTCCC 
mhp 53 GAGACCCAAATGGTT AGCCG TGATTGATCATTGCATTGGC 
mhp 54 TGCTGGTGGGCATTTAAGTC ATAAGCCCGGCAATATGAGC 
mhp 56 TTTATGGTTGGGGTTCATGC AATCAGGCGAATAACATCGG 
mhp 57 TAATACCCATCGGTTTGTCG TGGGAAATAATTGTGCCTGC 
mhp 58 CAGCCTTCAACTCCAAGCAC TCAAGCGCTTCCTCTGAGTC 
mhp 59 TTATCCAGGGAAGTTTTGCG TTTCCAAATTTCAAGATGCTG 
mhp 60 GCTTGGGTAATATTGTTGTTGCTC TCTTCAATTCTGGCAAATAAATC 
mhp 61 GGGATTAGGCTCATTACTCGC GAGGAGAAAACGGAGGTTT G 
mhp 62 TGTTGTCACAGCAAATCTAGTAAACC AACAATTCTTATTGAAACTATTCCG 
mhp 64 CAAGCCAAGTTTTTGATGGC CTCGGTGATATCAAAGGGGC 
mhp 65 AG ACCTACGA A A AGC AGGGC TTGATCCTCGATTGTCTGCC 
mhp 66 TATCTCTGATCGAATCGCGG CACCTTTTTAGTTCGGCAAAAG 
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mhp 167 CAGCTGTCTTCCAGAATCCG AAGCTTGCACGGTTGTATCC 
mhp 168 TGTGGAAATTGATGGTTGCTC AAACATCGCGACCTTGTGAG 
mhp169 TAGTTTAAGGCCGCGTGTTG GAAAGTGCAATCGCTGGAAG 
mhp170 GGCGTTTTCTTGAGGTTAGAC CAGCTATTGACTCGGGTTGG 
mhpl71 TAATGGATGAGCCGACCAAC TTTTTCCGTGAAGTTGCCTG 
mhp 172 ACCTCAGATGTGCTTTTGCC ATTCCGGCGGTATCAAAAAG 
mhp173 TGCTGGCTGCCTTGATTTAG ATTACGGAAGGCAACTTGGG 
mhp 174 CCGGTTTTGATCGTGTCTATG AAATGGCTCGATCTTCACCC 
mhp175 TGCCTACCATGAAGCTGGTC TTGGGCCAAGTGAAGACATC 
mhpl76 TTTACGGGCAAATATCAACG AGCCCCACTAGTCGATTTCC 
mhp177 ATTGTCGGCCTTGGTAATCC TGTTTTGATTGCTGCCTGG 
mhpl78 TCAAGGGAAAACAACCCGTC TTGGAGTCAAATTGGAAGGC 
mhp179 AGCACTTGATCTTGGCATC TTGTTTTGTAGTCAGCCGCTC 
mhp180 GGCACCCACCTTTTATTTGC ACCGTAACGAATTTGGGTCC 
mhp 181 TCCCAAAAACTAAGCGGGG CATCAAACCCACCTTCAGGC 
mhp 182 TAAAAACCGTGATTGAGGGC GCTGTTCAAATGCTTGTCCC 
mhpl83 AGCAGCCAAAAAGATCCCTC GGCTGAACTTCATCTGGGC 
mhp184 ACAACCAAGTTTTGGATTTTT GCAGAAAGCGAGATGGCTAA 
mhp 186 CATCGTCAAATCGATGCTGC ATTCAAACCCCAGCAGGAAG 
mhp187 AGCAAATACGAAGCCAAAGC TTCATGTCCTAAACGCCCTG 
mhp 188 CACCAATTTTCGTAGGCGG CATTTGGTAGGTTTCGTGCC 
mhpl89 TCCAAAAACTAACCGTTCTGAG CATCAATTTTACAAGCGCC 
mhp190 TATGATCCAAACAGGTCGGC AAATCCGACGGTATTCTCCG 
mhp 191 CGATGAAGCAATTGCGAAAA TCCAACAAACTGGGGAAAAA 
mhp194 AATACGGTTATTCGCCGTGAC CTCCATTAAGTCGCCCACAG 
mhp195 TTCAGCTGCCCAAATTGAAG CGGTAATTTATGTCCGCCAAG 
mhp 196 TCGTTCCGAGTTATTCACCTT CATTTTCAGCACTCATTTCTTGC 
mhp197 GGAATTGTCATTAGAACCTCCCC TTCGACTAAACGGAAGTGTTTTG 
mhp198 CGTGGGTGTAATTCGCAATC CGGACCAAAAACCCTTGTTC 
mhp199 TGATAAAGGAAAGCAAGGCG CAACTCGGGTAGGAATTGCG 
mhp200 TAACTTCAAATCGCCTTCGC GAAAGTCCACGGAAATCACG 
mhp201 GTTCGCGCCTATACTCGTTG TCCTTGGTGTGCTAAAACTCG 
mhp202 ATTGCTGATATGCTCACCCG TTTGATGCACTTGTATAAACCCG 
mhp203 TCCTCGAAAGACAATTTGC TTTGTTTGTCGATCCCTTTG 
mhp204 ATCAAACCGTGAAGACAAGC TTTGCAAATGCTTTAACCCG 
mhp205 TTGTAAAAGGTGGTCGTCGC TCCGGCAAGTTCGACTACAG 
mhp206 GCCGGAAAAGGTAAACAAGC TTTTCTGCGCGGCTATTG 
mhp207 TCCAATCCATCGGCTATCAC TGTTGAAAACGACGGGGTAG 
mhp208 GCTCCTGGCTCAGGTAAAGG AACTGTTGAAGCGTTCGAGG 
mhp209 AATTATCACGGTTTTCCGGC TTTGCCTATCCCATGACCAG 
mhp210 CACGTTTTTAATGCCCAGGA TTTTTCCCGCGATATGACAG 
mhp211 GAATTGGAAAATCGCTGGC TGACCACGAACAGGTAAGCC 
mhp212 AATGTTACCGTCGGCATCG TAAATCATTTTCGAGGCGGG 
mhp213 AATTTCGCTGCTTGAGTCCC GAAAAACGGCGGATAGGTTC 
mhp214 TCGCCAAGTTTTTCGTTCAC AACAATCCGAGTATACCCCC 
mhp215 TTATCGGAAATGGGGGTTTG AACCCGGTAGTTTGGAAATC 
mhp216 TTGTGATGATAGGGCAAGTC CATACTAGGCGATTTGGGTG 
mhp217 TGGAGGAGGAACAGTTGCAG ATGAGACAACATCCGATGCG 
mhp218 TATTGGCGCTTCTAAAGGGG AATTTGCTTCGAATTGCGG 
mhp219 AAGTCCGAAATTAAGCGTTTT CCGGCGTTTGTCTTCGTAAT 
mhp220 ACGACGTTTGGGACGAATG AATAACTCCGCGGCACCTAC 
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mhp221 TTTAAACGCACCTTCAACCG GACGGTGGCCATAACTTGAG 
mhp222 TTTCAGCGTTTTGATATTCAGG TCAAGTATTTCTCCTTCCTCG 
mhp223 TCCAATTTCAGGACCGCAG GAAAGAGTACTGCCGGTATTTGTG 
mhp224 CGAAAAAGAGCAAATAACAGGTG TCATCCTGGTGATCAAAGCC 
mhp225 AAAAAGCCTACTGTCCTTATTCAG TCAGCGCAAACTTGCAAAC 
mhp226 TGTCGATACTCCCGGCTTTC TGATCGGATGGATAAGCAAAC 
mhp227 ATGGTAGCATTGGGCGTTAG TTGCATCAGCATTTTTGG 
mhp228 TTCCGGAAATTATCGTGGTG TGGGGAGGATCTAGGAAAATG 
mhp229 GGAGAGACGAAATTAACGGAG ATTCAATGGAAGGAGGGAGG 
mhp230 TTCGTCCAAAAGTAGCCAAC AAAACTGGTTTTTCCGACCC 
mhp231 TCCCGAAGAGCAAATTAAGC TCCTTAATGCCACCATCAAC 
mhp232 ATCCAGGAAGCAGTTGGG GCAGCTTGAGATACAGAGCC 
mhp233 TTTGATGGCGGAGAAGGAG TTTCGATATTTTCGCGCTC 
mhp234 TGCCAAAAATCCATTTAGCC AATTTCTGGGCCTGCATTTC 
mhp235 TGGTGAGGTTCTCGGACTTG TTTCCCCTTTTTGGCCTC 
mhp236 AAAATTTTTCGGCCGGTG GGTTGAAGGCAAGTTAGGGC 
mhp237 GCCTTCGGTTGTGCAAATG GGTACAAGCGCTAGATTATAAGGG 
mhp238 CCCAGCACAAAAGTCCATC GCATCTTTTTCAAGTGAGCTG 
mhp239 CCGAAATCGGCCCTAATACC TGGAATGCCGGTAGATTCAC 
mhp240 TTCGGAAATGCTTGTCTATGAAA TTCCATATTTGTTATATAAGTGGCAA 
mhp241 TGGGCCTTATCGTCAGTCAG TCCGCGAACTAGGTCATTTC 
mhp242 CAGGTTTTATCGGTCTTGCG AAAATTCAACCATCGTCGGC 
mhp243 GCTTTAGCAGGCGGGTTTAG AATACCGGTGGGAATATGGG 
mhp244 AAGACCAAAGCAAACCCTGG TACCTGACCCGGACTGATTG 
mhp245 AGCGGGAAGACCACAAAAAC TCACCATGTTCACCCATCAC 
mhp246 GGACTTAACGGTAAAGCGGG TAATCTGCATTGTTCCGCC 
mhp247 ACGGTGCCAACTGGCTTATC AGGCAATTCCAATCGACCAG 
mhp248 GTCGGACATTCGATGGGAG GCTTGCTCAATTTGGTCC 
mhp249 ATGGCAAAGACCAAAGCAG TTAGCCATTACTACTGTTGCG 
mhp250 AAATCGACAAAAACGAGGGAG TGTAAATAGTTGGCGGTGCC 
mhp251 CGGGAATCTTGAAAACTGGG AATTTTGCGGAAAGCCATAG 
mhp252 ATCCCATGATACTGAAGGCG TTGAATGGAGGTAACGCTGG 
mhp253 TGGAGGAGCTGGAGTTCTTG TTAACAGTGCTTCCATCCGC 
mhp254 TGGCGAGTCAGCTTTTATGC TTGGTGAGTTCCCGACAAAG 
mhp255 GGAATTATGATTGCCCGTGG CCTGAACTGACTCGATTGGG 
mhp256 GCGGTCGTGAAATTACTAGGG GCGATCACGTTCAAGATGC 
mhp257 ATGGCCATGCTTATCGTTCA GTTGATTTTCTTGATTGACGTT 
mhp258 AGCAAAAGGCTATTGAGGGC TCACTTTGGTGATGAATTGCC 
mhp259 AGTGGAAAT AATCGCTCGCA TTTTTCCTGAGGCTGTTTTTAGTG 
mhp260 CAGGCGGGTTAAAAGTTTCAG TCGCATTAAAACGCGTGTATC 
mhp261 TTGGATTGATAGGGTTCAAATG TCGTCAAGTAAAATTGCGACG 
mhp262 CGGGATCAATAGGGTGTGTG TAACGGTGCAATCAAACTGG 
mhp263 AAGGGAGACGCAAGACAAGC AAGTCCCATTGTGGATGCAG 
mhp264 ATTCTCGCGTTGTTCTTTGG TTCAAGAGCCCTAACACCCC 
mhp265 TGCCCCTAACTTTGGTGAAG TAGCGCTTCGTAAAACTCGC 
mhp266 ACTTGCGGATGGAAAAGCAC ATCAACAATTGCTCCAGCTC 
mhp267 CTTTATGAGGTCCACGTGCC AATGCAACCATAAATTGCCG 
mhp268 ACCGCAGACAAAATACAACG TTGGCATCCTTTTGGCTAAC 
mhp269 CTGCCATAGGATCAAGTCGC ATGAGAATTCGCCGTATCCC 
mhp270 ATTCCGACTGGAATTCACCC AAGAATCTCAAAATCGGGGC 
mhp271 GAAAAAGCGGCAGTATCCG CCTTGACCTTTTTCATTGCG 
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mhp273 GATTTTCCGCACGGGATAG GAAAACCAAGATAGTACTCCCATAC 
mhp274 TAAAAACCGTGATTGAGGGC GCTGTTCAAATGCTTGTCCC 
mhp275 TGATATTGTTGATCTAGTCGACGG GGGCTTAC ACCTT CTTT GGC 
mhp276 GGAAATACAAGCGTTCAGATTG GCAAT AAAACCGCGCATTG 
mhp277 TTCAGGAGCCTTTACTGGGG CGTTGCTGTTTTGCCAGTTC 
mhp278 GGAGACTACCAAAAAGCCGC TTAAACCGCAAAATCGCATC 
mhp279 AAGCGAAGTCGAACTGCTTG AATTGGGTCTTCCGCTTGAG 
mhp280 AATGTCTGAAACACAGCCCG CGGCTTGTTCATTTTCTTGC 
mhp281 AATTTTTCAAGGCCGAGCAG TGGCTCAGCATT AAATTGGC 
mhp282 ATCAGAAGTGGTGGCCTTTC GAGTTGTCCATCAGGAGCG 
mhp283 TCTTCATTAATTCAGCCAGGG CCCAGTTGCAAGACCAAAAC 
mhp284 TGCCAACGAAATTGAAAG TTCAAGGTATGCTTGTGTTACTTG 
mhp285 AAAAAGCG AGCCCGTT AT G TTCGGCTGTTTTTGCCAC 
mhp286 TGGCTATTGAGATGAAATCCAAA CGCGAATTAGTCCTGGATTATG 
mhp287 GAATATCGAATGTGCCTCGC TGT AATAACCGAAATTCGCCC 
mhp288 TTTAATCTGCAAACTGGGCG TCGTTGAGCTTCTCCTCCTG 
mhp289 AAGGTTTTCATGGGGCTG TGGGTCCCCAGCAGTTACTC 
mhp290 CGGGAAAAACAAATTTCCGT GAACATTCTCCATTATTATTATTTCTTG 
mhp291 AAATTTAAATACATCAAAATTGCCG AAATTCTTCTGCAAAATGTAAAAT 
mhp292 AACCTTTAGTCGTCGCTCCC AAATCAGGAGTGCCTGAGCC 
mhp293 CGAACATGGCAGCTATTC AATTTCGCCATTATCGCC 
mhp295 ACAAATATGGCCGGAAGAGG GCCTTCGATTTTCTTTTGGG 
mhp297 AGTTTTAATGCCTGGCGACC AAGTGCGGGAAAAGAGCAAG 
mhp302 TCAAGAGGCGATTTCGTATG TTTGAAGTAATTATGGGATCTTCG 
mhp303 TCAGCGGTATTGGTAGTCCG TCCTCCGATAGTTTTTCGACC 
mhp 3 04 AGCAGGTCTCATTGGACTTC TTATTACCCAAACCTTCGCC 
mhp305 GACATCGAAGTTCTCCAGCG AAGAAGAGCCACAAAACGGG 
mhp306 TTTTGCGGTTTAGTCTTGCTG CGGGGATTTCAAGACCTACC 
mhp307 TCGAGGAATTTGTACGTCGG GCCCGAAATTCTGTTGATTG 
mhp308 GGTTGTTTCTTGTCCAACGG CCGCTGTCTTTTGTGTTTTT 
mhp309 AATCGGAAGAGTAGTAATGACG TGCCACTAGAAGATAAGGCG 
mhp 310 TGCCTCATTGGTTTTGCG GCG AG AG CG A AG A ATT AACG 
mhp311 GCTAACAACGTTGGCCAGTC CATAAAGGCCATATCAAAATGC 
mhp312 TTCGCTAGATATAAAGGAGCC AAAATAGAGGAGAACCTGACG 
mhp313 ATATGCGAGACAGCGAGC AACTTCTGCTATTGCTTGGGC 
mhp315 CTAGCAAAAACCGGCGATG TGCTAGTTGTGCTTGCATGTTC 
mhp316 TGCAACTCAACTACCGGGTG CCTTGAATCCCATAAGCAAGAC 
mhp317 CAAGTATCTCCATCCTTGAGTGG AAATATTTTTGGTAGCGGGC 
mhp 318 GAAACCCAATCGGCACTAGG CAACTTGCGTTAATGAGGGC 
mhp 319 TGAAAATCCTTTGGTCGATG CTAAGTTCCCAGTTGGCTCG 
mhp320 CGCTAAAAGAGATCGCCAAC CTCCCTCGGTAAAAACTCCG 
mhp321 TAATGCCGGAGCAAGAGTTC GCCAGCGGGAATTTGTTAG 
mhp322 GCAACACCTGAGGAACGAAG ATCAGGATCAGGCACAAAGG 
mhp323 TCTGGTGCAGCAATGTCG TTGGACTCAATCGCTATCAG 
mhp324 TGGATCATGAGAAACATACTGAGC TACATTCTGGGCATTTTGGC 
mhp325 ACGGCCGAATTACAAGATGA CAAATTCACTTTGGTCTATATCTTTTGC 
mhp326 TGCGTGAATAGGAAGAACGG ATTCCATCCAACCCCTTG 
mhp327 CCATTAACCGTAGAAACTGACGAG AACCACAGCAGCTATTGGAAG 
mhp328 TGGATGAAAATGGCACTG TCTCTTGAAAGCGAACGGAG 
mhp330 AAATTCTCGTGGCGATTGG GTAAAGGTTCGTTTTCCGCC 
mhp331 TATTTTAAAGCGCCGACAGG ATTT AAAAGATGCGCCACCC 
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mhp334 ATTTTGGCCCTTACCCTTTG CATACTTTCGGCGAATGAGC 
mhp335 TCAACAACTCCCTTTACATACATC ATATGGCGGAACCGGAAG 
mhp337 CCCTAATTTCGGGAGTACTGA CCGATAGTAGCCTGATTTTTC 
mhp338 CGTGGGAAAAACAAATCTCCA G AACATTCTCC ATT ATTT CTTG A 
mhp339 GAAGCTAAAATGATCGGTCGG TATTGGCAGTTTCTCCAAGC 
mhp340 TGGGCAAGTTTTTACACCAG AATTTGCACGGAAAATGGC 
mhp341 A AACGG C A AGTTCGTTTC CGTTCTGGAGTAAGCCGC 
mhp342 AAATCTTGGCAAGTTGGACG ATAAGCCACCCAGGGTATCG 
mhp343 GTTGGAAAAGAAAGGGGTGC GACACTTCCAGCTGCTGTGC 
mhp344 TGCCTTTTGGGAGCAAAAAT TGATGGACAACTCTTTCAAGTTT 
mhp345 TGCCACGATAAAAGTCAAACAG GCATA AGCGCTTCA TTTTCC 
mhp346 TGTTGCTACCAATACCCAACTAGG ATTCAAGCCCTTGATGAGCC 
mhp347 TTGCATTTTGAACTTTGGGG TGATGCTTGCAATTCTGGG 
mhp348 TCGCGACTCATTTATTGTTGG TTGTCAGGGAAACTTACTTTTACG 
mhp349 CACTAACTAATAGACCTGGTACGGG TTTTGAACCAATCATCGTACCC 
mhp350 TAACCAACTTAACCGCCGC GGCGCTCTCAGAACGAAAG 
mhp351 TGTTCACTATAAGCGCAAAGG TCGCCTTCAGTAGTAGCTTTGTC 
mhp352 GGTCTTTGTCGTTGGACCTTC TTCACGTGCTAATGATCGC 
mhp353 GCTCACGAACCTGACATCAC TTTCCGGTTTTTCCGTTG 
mhp354 TTCGGAATATCATTAATAGGCCAC CACCTGTATTTGCACTTGCC 
mhp355 CCGTAGAATACCTGCCTCCG TTGACGCTTCCAGCAATACC 
mhp356 GGTTTGCTAATGCTCTTGGG TTTCTTCTTTTGGTTTGTTGATTGA 
mhp357 GCCGCTGCATCTGGAATAG ATCTTTGCCCACTCAGGGTC 
mhp358 CAACATAGGGGCACAATAATTAGC AATTTCCTTGCGGTTCCTTG 
mhp359 AAGAAAATCCCGTCAGTGGC ACCGATTGCCAAGACTAGCA 
mhp360 CAATCCAATTTCTAAGCAAACC TGAACGTTGAATACTATCCCCAC 
mhp361 AACTCTTCG AGTTGA ATAGCG GCTTTTAATGCATTTCGCAC 
mhp362 TTCCAAAGTTGCCCTTATTG CAGGGACCAAAATTTGCC 
mhp363 CAGGACCGGGTATTAAATGATG TTGCGTTAATGCTAATCTGGG 
mhp364 ATATGCTTGGATATGCCGGG TTCACGAGAAGGGATAATTGC 
mhp365 TTCCAGTTTCACCAGGTCATTT TTTGTTGTGCCTCTTTTTCGTT 
mhp366 TAACACAAGCCAGCGAAAGC GGC A A A CCG AAT GTTT CG AG 
mhp367 AAATCGGGTTAGGGCAAAAG CTGAGGCTCCTATTCCGTTG 
mhp368 CTTTCTTCAAACAGCAGGGG AACTGGAGGCAAGGCAAG 
mhp369 ATCGCTGCATGCCATCATAC AAACTAGGGGCAATGATCGG 
mhp370 TGGAACCGGATGTTTTATGC CAATAAGGTGCCCCAAGTCC 
mhp371 ACAATCGAAGACGATCCCG TTTGCTCCCCTTCTTGAGTG 
mhp372 TTTAAGTCAGACGGCTACCTC TGTTTTCGGATCTAGTGCTG 
mhp373 TGTAATCGACCCGATGCG CGATAACCCCAGTTGCCG 
mhp374 TTTGGTTATTCTAATTGGCG AACCACTTGGTTTT AGTTCG AC 
mhp375 TTTATTCGGGGACAAAACCA GCTTCTGGAGGTGTCTCTGC 
mhp376 AGCTTGAATCACGCCTGC AAACCTCATGTTGAATGGCG 
mhp377 CAACCTGGATATTTTCCTGCC CCGGGGAGATTTTTCATTTC 
mhp378 CTCCGCTTGAGTATTTTGCC TCCATCGCTGGCTTTTAATG 
mhp379 CCGCAACTTTTTAGCGTTCG GCTGCAAGACCAGCTTTGAC 
mhp380 TAAAGGCGAACTTGTCACCC TTAGCATTTACCTGGGCGTG 
mhp381 TCCTTGCACCGAAAATATGC ACTGTCGAATCGGTGAGGC 
mhp382 CTAACAGCATTAGCCGCCTG TG ATCCTTG ACGGGAAACTG 
mhp383 TGGTTTT CG ATGATT AGCGG TCCATCAGTAAAAGCTTGTTGAA 
mhp384 ATTTGCCAAGCGACTAAACG GCCAGTGAAATTTTCGGGTAG 
mhp385 AGCAGTTTCACTGACCTCCG TTGCCCGAGTGATTCAGC 
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mhp386 CAGCATCAAACTGACAAGATGC TTGCAACATCTTCAAAAGCG 
mhp387 TGTGGAAATGGAATGGGAAC AAGAACCGGAGTTAGCGCAG 
mhp388 GCCTTAATGACCGGGGT A AG TTGGCAAAAACACCCATAGC 
mhp389 CAAATGTTGGTCGGGATGTC GCTCTTGCTGCAACCTCAAG 
mhp390 ATCGAAAAAGGCGGAGGTAG GGACTCCAGAAAGGACTGCC 
mhp391 TGGAAAGTCAAAACAGTGCG TTTGGCAAATTCCCTAAGAC 
mhp392 CAAGTCAGCTTTCAGGGACG TGAATTAAACGGAATCGCCC 
mhp393 ATCTAGTTACAAATGCGCCG TGTCTGGAAAGATCGGTTTG 
mhp394 GAAAGGTTCAGCCGGAAGAC CATGAGCCGCCTTTTTGTAG 
mhp395 TATCGCGAGGATTGCCTATG TCCACGATTTAGGGATCGAAG 
mhp396 TTTGACATCCATTCAACTGAGG ACATAACCCTCAAAACGGCG 
mhp397 CAATCCATGCAAGTAAGGTCG TACAATTGCCCCGATTAGCC 
mhp398 CCAAAAACCGTTGCCTTACC AAATGCGGGTGGCTGTAAC 
mhp399 CTGACCAAAAACAATTAGCAA AAATTATATCAAAGCCGCCG 
mhp400 TGTT ATTGTGGAGCCAAGGG GTAAAACTGCGAGTGCCACC 
mhp401 AAGTTAATCTTGGACTTGTTTTTGTCA TCCTGGATTTGTCCAGGGAG 
mhp402 GCAACCCCTGATCAGAAACA AGC AGTTTT ATTTT ATCGCCA 
mhp403 AAAATGCTCGAGAAAAAGCG TGAAGATCTTTCTGGTTTGG 
mhp404 GCAACCCTAACCCATTTGATG ACAACTGATTTTGCATCGGC 
mhp405 TCGAAATGAACTTGAAGGCG TCAGCGGTCATTTCGCTATC 
mhp406 TCAGGCTGTTCGGATTGAAG TTTGCTCGCGGATTTGAC 
mhp407 CTCAGCAATCGCTAAGGGTG GTGATGCGATAATGCCGATT 
mhp408 TTTAATCGAGGCTTGTAGGGC CTCCATAGGCATCAATTGGC 
mhp409 GCTTGAAATTGATGCACTCG TTGGCAAGACTAATGCAAGC 
mhp410 CCGGATTTGAGGCTAGATTG TAAAGCCCTTGGTACTCGCC 
mhp411 AACAGGACAGGAAAAGACCG CACCAGAGGAACCAAACGG 
mhp412 TTTGAATCTTTTTGTGCGGC GCTTCCTTTATCGACCTGCC 
mhp413 GGTTTCTTGTGGGGGAAATAG TGGGCGGGAAGATTATCAG 
mhp414 AGCAGCGAGAGCAAAAACAC AAATTGTAGTTCGCCATCCTTG 
mhp415 TTGAAATATTGGTTAAATTCCCACC TTTTT ATTTTT C A T ACCGGCG 
mhp416 CTCCGAAAGCGTTTGCTTC GTGAGCCCCCAATTAACTCC 
mhp417 TGATTCTAACAAACTGAGCAAAAA GGCCGGAAAACTAAGACTAA 
mhp418 TTAGTTGTTGTCGGCGATCC TTTGAGCGTGCTAAAATGGC 
mhp419 GACAATCTTATTTACTCGTTGCCC AGAAGTTCGACAAAATCCGC 
mhp420 TTGATAAATCGGAAAATTAACCA TTTTTGCTCCCTTTTGGTTGT 
mhp421 AAAACGCTGGCAAAAATTCC GCATAATCAATTTGCCGTGG 
mhp422 TGTTCAGGGTCCTTTGCTTG ACGGTTTTGTAATGGCGTTG 
mhp423 TGCCGTAGCTCATTCTTCTG TAAGGCCG TTTTG TTTAGCG 
mhp424 CCTCCCAACTTATCGATGTC TTTGCTTTTACAACACCGGG 
mhp425 CCGCATCATCCGCTTTAG CATCGATCTGATAAAGTCCG 
mhp426 TAAGCAAGATTTCATCGGCG TTTCAAGATTGCCAGTTCCG 
mhp427 AGAAAAACGAGGGATCAGCG TTTCCTAGCTCAACGCCATC 
mhp428 TGAACAAAAACAATTAGCCTACA CGTTGAACGACAAACTGATAGACA 
mhp429 GCACTGAATCCGCACTTG TTTCCCTGGTTTTCCTCTAC 
mhp430 AAAACAAGGTCGAGGGCAAG GCTGGGAGTTCAATATCGAGG 
mhp431 TTATCTGCCGGACATGCTTC TTTCAGATGACCGGCTAACG 
mhp432 CATCTTGGTCTAAGTCTTGCTG AAGCGAAATTCAATAAGGAAGC 
mhp433 CGTTGTAGGACTTTCCGGTG ATATCCGGATTTGGGGTCAG 
mhp434 TTATTTTGGACCTCTGCCCC CATGGTAATCATTTTCGCGG 
mhp435 TCCAGAAAACAACCCTGCTC GGTTTTCGAGTTAAAAGCTGTGG 
mhp436 TTGATCCGAATGTCCTAGCC AGGCATTTGAAAGTGGTTGG 
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mhp437 TTGATGGCTATTGACTTGTTCC AAATTAGCTCCAAAGAACGC 
mhp438 GGATATCTACCTTGTGCAGTCCC AAACTCGGGAATGCCGTC 
mhp439 ACCTGGGGAAATGTCTCAGC TTATCTGCATGGGTTGTGCC 
mhp440 CCAATGATCTTGAAGCCGAG ACGGGCTGAACGAATTATCC 
mhp441 AAGCAGGCGCTGATTTTACC TATCCTCAACTTCAACCCCG 
mhp442 CCATTTCTCTCCTTTTCACGG TTTTTGGCTAATTTTCCTTGC 
mhp443 GTTCGGCAATCCAAACTCTG CTTTGGAGACGAGCAAGTCG 
mhp444 CCGCGAGAATCAAAATGG TTGGAGACTTTGACTATTTGGG 
mhp445 AACCTCAAAACCAACCTCGC ATCCTGCCCGCCTAGTAATG 
mhp446 GAGGCCTGGTACCTAAACGC AATTCTGGGGGATTGACTGG 
mhp447 ATGAACCAAAAACCCTTCGG GAATTTGAGTTGCTCGCCTG 
mhp448 AAAACCAGGCCGAACT CAG AATATTGCTCGGGTTGACTG 
mhp449 TGATATTTTTGGTGCCCCTG GGGCAATATTTAAGGGCCTG 
mhp450 AAGTGGCGCTTATATTGCCC GGAAGATCGAGCTCATCACG 
mhp451 TGATAATGTCCAAGTTGGCG CTCCATTGCTGGATCATGTG 
mhp452 GAAATCCGGTTGTCATTTCG AATTTGCGATAGGCATCACG 
mhp453 CAAAAAGTAATCATCTCATCGCC GGGCACCAAGGAAATTAAAG 
mhp454 TTGATGCAATTACGGTGCC TCAGCAATTGGTTTCTGG 
mhp455 GGTTCAACGCGAGCTACTTC TTCTCCCTGTTGTCCGATTG 
mhp456 TGATATTGCAG AAAAGCTCCG AATCTGCTCTGCCAATTTACC 
mhp457 GTTGTTCACCCTGGTGTTGG TTGTAATCGCCGGTTTTGAG 
mhp458 TGGTTCTTCCTCATGGAACG TTCGGCTACTGCCTTTTCAG 
mhp459 GGTCTTGGGATTGTTATGCC CCCATTTGCATTGCTGTACC 
mhp460 TTATCTGCTCAACCTTTAGTGC TGGCTTTTGTTTGGCTCG 
mhp461 TAAGCAAGATTTCATCGGCG TTTCAAGATTGCCAGTTCCG 
mhp462 AATACGCCCGATGCAGTATG GAATCACGGATATTTTGGGC 
mhp464 GGATCGTCTGCACAAGATGAG TTCAGGTTCGTGAAAAACTGG 
mhp465 TGCTAAGCTGCGCAAACC CTTGAATTTCCAGGTCAGGG 
mhp466 TCCAGGAGCAAAAATCGCTA TTCGTTCTCAAGCCGTGTCT 
mhp467 AAAATTCATCGGTTATGTTCCG TCGCGCTGAAGGATCAAG 
mhp468 TTTTTGAGCCAAATGATCGG AAGTTTGGGCGT CTTGGG 
mhp469 AATCAAGCGCCAGGAATG TTCCTTGATCTCCAAGGATAAG 
mhp470 GCTTCGGGCACTAGTAAGGG TCAGCGGCAAAGGAGTATTG 
mhp471 GACTATCGGGAGGGGTTG CAAACTAGTCATTCTAAGGCGTGG 
mhp472 AAAGGTGCTCAAGATGCCC ATTTGACCATTTGCCCGC 
mhp473 TGCCGATACTAATGAAGCAG TTCACTCGGAAGTTTACCCG 
mhp474 GATTTACGCCAACTCAAACG AAGGACATCTCAAAACAGAGGC 
mhp475 TTAACGGCGCTTTTGTTCAC AACACGTCGGTTTTAAAGGG 
mhp476 CAATGATAGTGCCAATGGGG ACGGGAGAGCACAAATGATG 
mhp477 TCTCAATCGGTCAAAAACGG CAGCTGGGAAGGCTTCTTTC 
mhp478 CCCTCAAATCTCCGAAAAGC CTTGCGCCTTCAAAGTCATC 
mhp479 ATTTTGCCCCAATTCAACCT TCGATTTTCTTCATTGACTTGTT 
mhp480 TTCTTTTACGCACAATTCGC ATTAAGTGCCCGATCGCC 
mhp481 CCGAGTTCCGTGATTATTATG TGCCATCACATTTGAGGATTC 
mhp482 TGAGTTTCTTGCTGTTCGAATG TTTTCCGACCAATTCAGAGC 
mhp483 AATACCGGAAATCCACTGGC TTTTCCCCTTGAAGATGTGG 
mhp484 TGCCTCATTTTTCACCGC TAGACAAGAATTCCTGCGCC 
mhp485 GCCAGAGACTAATCGGAATGG TTGTTGTTGCTGACTGCGAG 
mhp486 GTCGTAGTTTTCTTGACCTTGG GATGACGGGCGCCATAAC 
mhp487 GGTCAGGGCCACAAACTACC TCCTAGCGCTAAAAACTGCG 
mhp488 GCTGAGTCCAAAAACGATGC ATTCCGCCACCGATTAAAAC 
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mhp489 GCACAGGAAAATCCACAATTT TTCAGACCTTGGTTTGATATGC 
mhp490 TCTTTATAATTGGTGCGCCG TGCAAGACCCATTCCAAAAG 
mhp491 TTGTTTTGATTATTGCCGGA TTGGGCTATGACTTGGTTTAGC 
mhp492 AAAACCATTCCTGATTGGGG CGCAACTCCCCTGTCTTTC 
mhp493 CTTTGACAAAAGCTCACCGC CTTTGGATTAGACCCGAGCC 
mhp494 GGATCTGGAGGATCTGGGAC ACAGGCTCAATAACTGGGGC 
mhp495 CCCTAAAAGCGCCAATATGC C CGCC AGTAAT CCG AA AA AG 
mhp496 TTTAGCCAATGTTTTGCCAG CCGCCAACTTCGTCAGTATG 
mhp497 TCAGTCGGATATATTGCCCC GGTTCGATCGATGCCTTC 
mhp498 TCGCTTGGTTTTGAGCAG AGCCACTGGTTCATCGGC 
mhp499 TATTGCCGATGAGCCGAC TTTAGATCAGGGGGAGAACC 
mhp500 CAACTTCCAAGTGGCTGAGG TGCCAATATGAAATCCAAGG 
mhpSOl CAAAAGTAGCCGATCAAGGG CACTAATTGCGGCATCTTCG 
mhp502 ATTTATATACCCGCACCGGC TCAGGGGCATTTGTAGCATC 
mhp503 AAGCAATTGCAAGAGCGATG ATAAGCCCGGCGTCAGTATC 
mhp504 CAAGGTCTTGCTGAGGTTGG CAGAGGCAATTGCTTTCCC 
mhp505 TGCAAATCACAGTCAGGCAC TTCGGCCTTAATTGGGTAGG 
mhp506 CCGCAGTCAGAATTAGTGGC TCTTGAGTTGTTGATCCCCG 
mhp507 TTTTATTTTGAAAGGTGGACG GACCTTATATTCACGCAGTCGG 
mhp508 AAACCAAATTGAAGAATAAAGACCC ACACCGCGTTTTAATTTCCC 
mhp509 TCCAAGACCTGCAATGGTTT GCGCCATCAGAAATTGACAT 
mhp510 GCTCTTTCCTCTGGTATAGTGGC AAAAACCGCTCTGGTGAAC 
mhp511 AAGGTCTTTCACTTGCTGCG GATTGGATTCTTTGACCGGC 
mhp512 CCTTTCGATTGCAAAACAGC CCCTTGGAGGAAATTTGGAC 
mhp513 TTTTGGGCGCTCTGTTTATG AACCTTGGTTGATTACCCCG 
mhp514 TTTTCCTTTTGTTTTGCTTGTGA TGGTTTTGATGGCAGTTTTGA 
mhp515 ATTAACGCAATCGCCTTGTG CTGTCCAAAACCATTAGCACC 
mhp516 TTCCAACGAGAAAATGTTCAA ATGACAAAGTTGGCCCCATT 
mhp517 CGCAAATATGGTTTACACGAG TTTTCCATCGCACCTTTACC 
mhp518 GCAGCTATTATAAATTCCAAAGGTGAT TGACTTTTCATCAAGACTAGCAAA 
mhp519 TTGTATATGCCCAAAGATAAAAA AATTTTTGTTGCTTTTTCCGA 
mhp520 GGGGGTTCATATGGGCTTG TTACCTGACGTTGGACAGTCG 
mhp522 CCTTGGTCTTGTTGGCAGAC CTGAGCTGATCGGCTGTTTC 
mhp524 GGGCGGCATTTTCTTGTAGT GAGACCAAGAGAGGAATTTGAGAA 
mhp525 TGGAGTAGATCTCGAAAGTGCAT TGGGTCTTCTTGATTTTCTGG 
mhp526 GTCAGACTGGGATTTCTGGC TCCATAAGAAGCTGCCGTTG 
mhp527 ATGCCCCTATACCAAACAAG CTGTCTATTTTATCGGCCTG 
mhp528 TCTCCAGAATTCAGATCTAGAAAAA TTCTTGTTTTAATTCAGATAAAAGGG 
mhp529 ACTTGTGGGAATTATCGGGG GACTGTGTTTGTGGTGCTGC 
mhp530 AAACAGTTTCGAAAAGGGGC TTTGCTGAGCTCTTTGGGC 
mhp531 GGAATATCGAAAGAATCCCCG TTAAAGCGCAGCGAATAAGG 
mhp532 TTAATGTTTCGGCCCTAATG TTTCAATGATCGCCTCGG 
mhp533 TTCAGTCAGTTGTAAGTGGGC TAAACTGCCTTTCTTAGGGC 
mhp535 TTGAAGTTTGAAAGCAAGGC CAT C ACGGAAAT AACGGGC 
mhp538 TTTTCAGGAACACCAAACCG AACGCGGGAAAGAATAGGTG 
mhp539 AAGCAAGCTGAAGTCTCCCC TTCCGAAGCAGTGGATGAAC 
mhp540 TGGAAATTGTGGGTTATCGC TCGATTCCGCCTGTTACATC 
mhp541 GTAATGCAAGAATCAGCCCG TCCCATTTTTATAGGCCCCC 
mhp542 TTTTAATTTCGGGGTTTGGG CCGGTGTAATTAAAACGCCA 
mhp543 AGTTTGCCACAAGCAAATCC AAAAACGATCCCCTGCATC 
mhp544 GG A A AT CGGCGCT AAAATTC GTACCAAACCTTGTTGCCCC 
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mhp545 ATTGAAATGCGACTTGGACG 
mhp546 TGACTCAGGTTCAGGTTGGC 
mhp547 TGTCTGGTTTATTGGCCC 
mhp548 GCCCTTTTGAAAACAAACCC 
mhp549 CACCGTGCTGATTATGATGC 
mhp550 TTCGATTCCAATAACTAGCG 
mhp551 TTTCTGCTCCACTTCCATTAC 
mhp552 TTTTGGCGCGGTACTTCC 
mhp553 ATTTTTCTCGCCAAGTTCCG 
mhp554 CTGGA AGTTTT ACAGGCTGC 
mhp555 CGAGACAATTTCCCAGGC 
mhp556 TGAGTCCGAAGATGGTGAGG 
mhp557 AGTTTTTGCTCTCTGGCGAC 
mhp558 GAAGCCGGGACTGATTTAGG 
mhp559 TGACAGGATAAGCAAAAGCG 
mhp560 GCAGAGCAAAATAACAAAATCCC 
mhp561 TGACCTCAGTTTCAAAAGGC 
mhp562 CCAGCTTGCTGAATCAGGTC 
mhp563 CACTAACTTTGAAAAATGGGCTT 
mhp564 AATTCGTGGATCCCAAGATG 
mhp565 CGGATTGACGATTTCTGATG 
mhp566 ATCCCAGCGATTCCAAAGAT 
mhp567 TTTTTAGCCTTACCGCACG 
mhp568 ATGAGGCCCTAAATTCCGTC 
mhp569 TGTCGAACCCGCAAAAATAC 
mhp570 ATAATGCTTTTTGGGAAAGG 
mhp571 GCTTTTGCTGGTGCTCTCAC 
mhp572 GGTTCAGGACTAGGATCTTCAC 
mhp574 GCGAGCTTGAAAACAAAAGTG 
mhp575 TCCAGTTTTCTTATAAGTTTTCATTTGG 
mhp576 GTATTCAACGGTTGGGTTGC 
mhp577 CTCACAAAGCATTAGCGCAC 
mhp578 TTGAGCATGAGGTTCAGTTATTG 
mhp579 ACGGCAGAAGTGAGTATTCG 
mhp583 TGATCATGAAGTTCGTTTATCGTC 
mhp584 TCGCCAGTTGATTATAGCCC 
mhp585 CGGCTTGCAAATGAAAAAGA 
mhp588 ACCGGCTTTTATTGATTCGC 
mhp589 TAGCGCCAATGATTGTTTCG 
mhp590 TGGTTTTGCCAAAGACAACC 
mhp592 ACAAGCGCTCGAATCACG 
mhp595 ACTTAAAGATTTGGCGCCTG 
mhp596 GGGCGAAATTTTAAGCCCTA 
mhp597 AAATCGTGGGGAAGTTCAGG 
mhp598 TCCCAAGGGAAAACAAGTGG 
mhp601 CAAAGATCTTAGCCCCCGTC 
mhp602 GGCAGAGGCGCATATATTTTT 
mhp606 CTCGACCAGACGGAAACATC 
mhp607 TCTTCCGATTAGCCTTATTTATGC 
mhp608 ACCTTCACGCGCTTACTTTG 
mhp613 AATCGCCACAAATATCAATG 
TAAAGTCCCAATTCCCCCAC 
ATACAGTAGCGCCTCCCCC 
TTTTATGGCGTGAACACAAG 
AAAACGCTAAACCGACCACC 
AATCAAAAGCGACTCTGGGC 
CAAGCCGGTCAAAAATTCC 
TTCTTGGCGTTTTTGGTGAG 
TTGCACCCATTTCGGATG 
AACTTCATTTCCTGGCGGTC 
TTATTTTTCCGCTTTGGG 
AATCTCAAGCAGACTTTCAGG 
TAAGTCCGAATTTGCGAAGC 
CCTAAATCCTGGGCTGCTTC 
AGGGTCACCAAAACAAGCG 
GCGATCTTGCAAGTGCTACC 
TTAGCAAACGCAACCATAACG 
TCGCTATGAATTATTGGGTC 
ATTCCCGCTTCTTCTTCAGG 
TTCATTTTTCCCCGTTTTGA 
ATTCCGAGCTGTCCAATCAG 
ACTTTGCGACTTATCGACCG 
AAATTTCTGTGATGGGAAAAA 
TTTAACAGGTTGGCCGTCTC 
ATTTCGAGCGCCTGATTGTC 
ACAGGAGCAACTGCACCAAC 
CGTGCAGAGGTGTGATTTTC 
CATTTGTGCCGGTAATTTGG 
AAGACTTGGGGCAACATCAG 
AAAAGTTCCATTATTTCCTCCT 
TTTCCCCAAAGCATTAAATTTGT 
CAATTGTGAATTGTTCTACCG 
TTGAAACTTGTTCAGCGGG 
AACGTTTGCTCAACCGCC 
TTTTGTTTTAATGCTAGACTCGCC 
TCATTGTTTGCTCAACCGC 
CTAGCAAACTCCCAACGGC 
GCCACTATTTCCTGGCTCAA 
AAACCTTGATTGTGTGCCCC 
ATGACCAATTTCTTTCCCGC 
CATAGGCACAAATCTGCGG 
AACTTCAAGTCATGCGGCTG 
AGAACTGATGCTTGAACCGC 
CCCACTCAAAATCTAGTAGAAAAACG 
TTATTTGCGACAAGATCGCC 
AAAACCGOCTACCACCTGAC 
GATTATTGGCACATTTGCGG 
GGCAAGAGTGGAAATATTTGTCTT 
GCTGGGGAAGCTGATAAACC 
CAAAAACACACGTAAAATCACGA 
TCTGCAGCCATCAAAATTGG 
TTTGCATTTTTGACAGAGCG 
144 
Table A.l. (Continued) 
Gene ID Left Primer Sequence Right Primer Sequence 
mhp615 ACTTTTATTTGGGGCGCTTG TGGCCCATATACAGGTCCAG 
mhp616 ACCCGAATTACCTCGATTGG TCGACTCTGCTTAAGGCTGC 
mhp619 CGAAAGCCGGTTTGAGAGA ATAAAAGAGTTTAGAAATGGCATC 
mhp620 TTACTTACAACCAGCGCGAC AAACAGTTGACGGCTTTTCG 
mhp621 TTACTTACAACCAGCGCGAC AAACAGTTGACGGCTTTTCG 
mhp622 TGAGATGGCGATGCTCTTG GAATCAAGTCATTCCTGCGG 
mhp623 GCTGTCGCTGGACCACTTAC GAAATGGCTTCAGTTGCGAG 
mhp624 GAACTTTGATGTTCGCGGTG TCGGCCTTTATTGAGCACAC 
mhp625 CCCGTGAAGGTTTTGATGC GCCGCGAACGTAATAAAAAG 
mhp627 GGTCAGGCTTGAAAATTCCC AGCGCGTTTACAAAGTGAGC 
mhp628 CCCAGCTTCAAAAGTTGCC TCACCGGTAATTTCAATGCG 
mhp629 CACAAAACATGCCCTTGGC GTCGATTTCTCGCTGTGGAG 
mhp630 TGCCGCTTATCGAACTTTTG TTCATTGTCCCATGGAAACC 
mhp632 GAAAACGAGACAAGGCTACTCG GCTTTTGTTTGGTCAGGG 
mhp633 TAGTGCCGATTTTGGAGTCG TAGGATGGAGATTCACCCCG 
mhp634 CAGGAATGCGAGGTTTGATG AACA ATCTT CGGCAACAACG 
mhp635 CAGGAATGCGAGGTTTGATG AACAATCTTCGGCAACAACG 
mhp636 TCCAGTTGCTACCGAAGAGG TTTGAGAACTGAAGGGGCTG 
mhp637 TCCAGTTGCTACCGAAGAGG AATCGAAACTTCTGCTCCCG 
mhp639 AGGTCATCGAAAACGGGC ATAGTTTCAAGGGCTTGGCG 
mhp643 TTCATAAGATGAAACTTGCCG TTGCTTGCAATTTTGCGG 
mhp645 GCTTTTACATGGAGATGGAAGTAG TTTACTCCGGCATTAGGTTG 
mhp650 CATACAAACGACGAACACGG GCGGCAAGATCAAGAATGTG 
mhp651 TTCAGTTGCGATTGGAAACC TATCTGGAGTTGTCAGCCCG 
mhp652 TGCTCAGCTCTCGAAAATCC GTCCAGTCTGTTTTGTGGCG 
mhp653 TTAGGCAACTTTTCCGGTCC TTCGATGCTCTTGTTGCTCC 
mhp654 AGTTTTTCTGATGGCTCGAC TGGGTATTGTTTTCGTTGC 
mhp655 GCGGCCTTAAAACCCAAG TGCTTTTGCTATCATTGCCC 
mhp656 TAGCGGCCTTAAAACCCAAG TGCTTTTGCTATCATTGCCC 
mhp657 CGGGTCTCATGGTAGAGGAAC GAAAGTTGCTGGAGTTCGGC 
mhp658 CTATGTCACCAGAGCGAAAAG TCCTTTGTCGGAAAGTCCTG 
mhp659 CTATGTCACCAGAGCGAAAAG TTCAGCTGCAAATTGGAC 
mhp660 CCGACCTGGTTGACATACTG TTGATTGGAACTGTTGGG 
mhp661 GGCCGACCTGGTTGACATAC TATGCGAAAAATCCTTTGCC 
mhp662 TCCGGCAGTAAAACTTGAGG CCCAGGCAGC ATTTTT ACG 
mhp663 ATTGCTGATTCTTTCTGGGG TCATCAAGGTTGCAAGTGGG 
mhp664 AATAAGTTAGCCGAGCCCC TCCACTTGTTTGGATTGCTTG 
mhp665 GATGTTTCCCCTGGCTATGC TCCACTTGTTTGGATTGCTTG 
mhp666 GTTAAATGGGGCGCAAAAAC CGGAGTTAAAACTACCGCCC 
mhp667 A AGCC ACTTTT GGCTTTTG A CAATAGCTCGGTGATCTAACATGA 
mhp668 AAGCCACTTTTGGCTTTTGA CAATAGCTCGGTGATCTAACATGA 
mhp669 AATTATCAGGCCAACCGGAC AACTTCCGGGAT ATCAACGC 
mhp670 AATCATCAGTTGCCCGAG TAATCCTGGCCGGTAGTCTG 
mhp671 TGGAACTGGACGTAGGAAATC AAACTTTCAACAAGGCACGG 
mhp672 TGTCAAGCACCAAGAAGTCAAG TTCACGGGCTGTTCTCACTC 
mhp673 TATCCGCGATAAGTCAGGTG ACATTTGGTCAAAGTTGGCG 
mhp674 ATCGACATTCACTGCCATCC ATTTGGACTTCTTTTGGCGG 
mhp675 GTTGTCAGTCCCGATCATGG TAAAAACGCCGTGAGTAGCG 
mhp676 TACACTAGCGCCTTTTTCGG TGTTAGCGAATCGCCTAGTG 
mhp677 CCAGAATATGTTTGGTGGGG TTGATCAACTCGGGACATCG 
mhp678 TATGTTTGGTGGGGGAAGTG TTGATCAACTCGGGACATCG 
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mhp679 GAGAAGGTTTAACTCTAAGATGCAC ATGCAAAGTGTGTTTGTTGC 
mhp680 GCATTGAAGGGCAAGTGAAG TTCCATAGCCTTGTTCGGTG 
mhp681 GCAGCCCGAAATAACTAGTCC TTTTTCG TGCGTTAGC A ACC 
mhp682 GCCAGGGAAGCAGCT AATG TCAGGGGCTAGGGAAGAAAG 
mhp683 AAAACGGAAGCTCCAGCAAC TCAATTTGGTTCGGATCAGG 
mhp684 TGGTCCCTAATTTTGTTGC CAGTGATAATAGAAACAAGCGG 
mhp685 GAGGCGGGATTTCTAACCC CCAGTGATAATAGAAACAAGCGG 
mhp686 TAGTAGTAACGCATTCATTCATATGCC AAAAACCCCCTTGAGAGCG 
mhp687 GTCGATGTGATCTCTTGGGG AGTGCGTGGTGGGTAGTTTG 
mhp688 TGATCACCAGTTTTGTCTCG AGACAAGCGACTAAACCGTC 
mhp689 GACGGACTGAAAGACGCATTA AAAAAGGAGTATAATATGAAAAACACA 
mhp690 TCAGCCGCAATTTAGGTCAG TTAGTTGCCAGACCCTGCTG 
mhp691 AATGGGTGTTGCTGGTTCAG CCGGAAATTGTCAGAAACCC 
mhp692 CCTTTCAATTATCGGGTTGC TTTTTGGTTGTTAGCGATTC 
mhp693 ACGCACAAATTGCGCTTC AACCCCCAAAATTCTTCTGC 
mhp694 TCAGATACGCTAAGGCAGGC GCGAAGAAAAATCCCCGTAG 
mhp695 CACTTCCGTTATTATCCCAAGC GCCGAAGGGGAAATTAAGAG 
mhp696 CACTTCCGTTATTATCCCAAGC GCCGAAGGGGAAATTAAGAG 
mhp697 TTTCCGATTGTTTCCTGAGC ACAATTTCCTGACGGTGTCG 
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[Parameters] 
RunT ype=Micro Array 
BarcodesEnabled=0 
HaltBarcodes=l 
CacheBarcodes= 1 
ClearBarcodes=l 
WhereBarcodes= 1 
ExpectedBarcode 1 =[U nknown] 
ExpectedBarcode2= 
ReloadPins=l 
N umSourceP lates=2 
WashAfterEveryVisit=0 
WashAfterEverySample=l 
RequestLogInfo=0 
SourcePlate=384standard.microplate 
ToolType=4x4 384 split.tool 
PromptPlates=0 
PromptPlateslnterval=l 
SourceWiggle=0 
SourceDibble=0 
Remo veOneLid= 1 
TargetDip=0 
TargetWiggle=0 
SoftTouchDistance=0.479999989271164 
SoftTouchSpeed=4 
DelayBefore=0 
TargetDwell=0 
DelayAfterSpotting=0 
MultiStrikes=l 
SoftTouch=l 
T argetDepth=0.3400000035 76279 
ILayout=0 
PrespotRecycle=0 
UseCamera=0 
Microplates=l 
PreSpot=l 
SlideSize=25 
NumSamples=48 
LastPlate V isits=24 
SpotsPerSource=29 
Adapter?late=slidesvertical extra+1 .adapter 
Adapter?Iate2=slidesvertical extra.adapter 
[PinGrid] 
XSpots=12 
YSpots=12 
Line0=37, 38, 39, 40, 41,42, 43, 44, 45, 46, 47, 48, 
Linel=25,26, 27,28, 29, 30, 31, 32, 33,34, 35, 36, 
Line2=13, 14, 15, 16, 17, 18, 19, 20,21,22, 23,24, 
Line3=l, 2, 3, 4. 5, 6, 7,8,9, 10, 11, 12, 
Line4=37, 38, 39, 40, 41,42, 43, 44, 45, 46, 47, 48, 
Line5=25,26, 27,28, 29, 30, 31, 32, 33,34, 35, 36, 
Line6=13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 
Line7=l, 2, 3, 4, 5, 6, 7,8,9, 10, 11, 12, 
Line8=37, 38, 39,40,41,42,43,44,45,46, 47,48, 
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Line9=25, 26, 27, 28, 29, 30, 31,32, 33, 34, 35, 36, 
LinelO=13, 14, 15, 16,17,18, 19,20, 21, 22,23, 24, 
Linell = l,2, 3,4, 5, 6,7, 8, 9, 10, 11, 12, 
NthOrder=4 
PatternFormat=2 
ToolGridlndex=l, 1, 
Splice=0 
Pitch=0.360000014305115 
NumCopies=52 
[SlideLayout] 
BottomMargin= 10.0699996948242 
CentreHoriz=l 
CentreVert=l 
TopMargin=l 0.0699996948242 
LeftMargin=3.25999999046326 
RightMargin=3.25999999046326 
XSpacing=2.20000004768372 
YSpacing=19 
[Wash] 
lnterCycleDelay=5 
LeftSeconds=5 
RightSeconds=5 
DrySeconds=2 
V acuumEnabled= 1 
Cycles=l 
MWSCycles=l 
[RunPrefs] 
PrintReplicatesFirst=0 
SourceDipTop=0 
SourceDipBottom=0 
TargetDipTop=0 
TargetDipBottom=0 
VisionID= 
BioBankID=DEF AU LT 
IOControl=0 
Bathl2ZOffset=0 
Bath3ZC)ffset=0 
FeatureOffsetX=0 
FeatureOffsetY=0 
HumidStartRate=7 9 
HumidRunRate=7 7 
T argetHumidity= 102 
MinHumidity=89 
U seHumidityControl= 1 
U seHumidityHEP A=0 
PauseHumidity=0 
EndHumidityOn=0 
PrimeBath=l 
AskLoadTool=l 
WashAtStart=l 
WashAtEnd=l 
AskBioBank=0 
AskTrays=l 
SourceDwellTime=l 
T argetDwellT ime= 1 
Source Wiggles=0 
SourceWiggleSize=0.25 
SourceDips=l 
SourceDipSize=2 
TargctWiggles=0 
TargetWiggleSize=0.25 
TargetDips=0 
TargetDipSize=2 
SourceDepth=0 
TargetDepth=0 
BathFillTime=0.5 
BathDrainT ime=8 
RecirculateAction=1 
Recircu lateStatic=0 
RecirculateWiggleSize=0.200000002980232 
RecirculateDipSize=l 
BlotFirstTimes=l 
BlotFirstSlides=5 
CacheBarcodes= 1 
HaltNoWater=l 
BathWiggles=4 
Bath WiggleS ize=0 
HeaterOnT ime=0 
HeaterOffT ime=0 
HeaterCoolTime=0 
SourceSoftTouchSpeed=4 
T argetSoftT ouchSpeed=4 
SourceSoftT ouchEnab led= 1 
T argetSoftT ouchEnab led=0 
SourceSoftTouchDistance=l 
T argetSoftT ouchDistance= 1 
[PreSpotLayout] 
BottomMargin=5.94000005 722046 
CentreHoriz=l 
CentreVert=l 
TopMargin=5.94000005722046 
LeftMargin=3.40000009536743 
RightMargin=3.40000009536743 
XSpacing=3.20000004768372 
YSpacing=4 
ToolGridIndex=l, 2, 3, 
Splice=0 
[LogFile] 
Operator name*=_ 
Library=_ 
Gridding_Number=_ 
Set_Number=_ 
Rep lica_Numb er=_ 
Date=_ 
Time=_ 
[PreSpotting] 
Pitch-0.28999999165535 
SoftTouchDistance=0.479999989271164 
SoftTouchSpeed=4 
DelayBefore=0 
TargetDwell=0 
DelayAfterSpotting=0 
MultiStrikes=l 
SoftTouch=l 
T argetDepth=0.340000003 576279 
ISoftTouchDistance=l 
ISoftT ouchSpeed= 1 
lPitch=0 
IDelayBefore=l 
ITargetDwell=l 
IDelayAfterSpotting= 1 
IMultiStrikes=l 
lSoftTouch=l 
ITargetDepth=l 
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Hexamer oligonucleotide primer sequences for cDNA generation*. 
AACACA AACGRC AAGCGA 
AAGGYC AAGMCG AAGTAG 
AAGTGT AARTGC AATCGC 
AAWGCC ACGAGT ACTGGC 
ACTGTG AGACGA AGCAGA 
AGCGAG AGCSGC AGGAGC 
AGGGCY AGRAAC AGRTCG 
AGTACC AGTAGW AGTCCG 
AGTGGA ATACCS ATAGTG 
ATATAG ATCGGG ATCGTA 
ATCTGC ATGACA ATGCCC 
ATGCWG ATGCYA ATGTSG 
ATRGAA CAGAAG CAGGGG 
CATACC CATAGG CATGTT 
CCCGGC CCCKGT CCGGCG 
CCWGAA CGAAAA CGAGTA 
CGCATA CGCGAA CGCGGT 
CGGTGA CGGTTG CGSCAA 
CTGAAA CTGGCT CTGTAG 
CTSGGA CTTGTC GAAATA 
GAAGTG GAATAG GACTCA 
GAGGCT GAGTKA GATCSG 
GATKGA GCAAGG GCCATA 
GCCCCT GCCYGA GCGCAT 
GCTCAG GCTGGK GCTGTA 
GGAAAG GGAAGT GGCARC 
GGCCTY GGCTAG GGGACA 
GGGCTG GGMCAA GGTRTA 
GGTTCA GMCTGG GRGAAA 
GTAACA GTAAGC GTAGTT 
GTATCC GTCMGG GTCTGT 
GTGAGT GTGGCA GTKCAT 
GTRTAA GTTGGG GTTGGW 
KGAGAA KGTTGG RCAGAA 
SGGCCT TAGCGG TATGTG 
TATSGA TCCCGG TCGGCM 
TCGWGA TCTGKA TCWTGT 
TCYGCG TGAMCG TGCMCT 
TGGCTT TGGKTC TGGTCG 
TGTAAW TGTAGA TGTATC 
TGTSCC TGYCGA TTCTGG 
TTGCGT TTGTCT TTGTTG 
WGGACA WGTGCA WTGGAC 
* A=adenine, T=thymidine, G=guanidine; C=cytosine; Y=C or T; R=G or A; K=G or T; W=A or T. 
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HYOPNEUMONIAE MICROARRAY 
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Open reading frames missing from the M. hyopneumoniae microarray. 
Gene ID Gene Description nlength 
mhp026 CH Putative ABC Transporter ATP-Binding Protein 2325 
mhp045 UH Unique Hypothetical 1206 
mhp051 atpF ATP Synthase B Chain 588 
mhp055 atpD ATP Synthase Beta Chain 1413 
mhp063 rpoD RNA Polymerase Sigma Factor 2034 
mhp068 UH Unique Hypothetical 177 
mhp074 cmk Cytidine Monophosphate Kinase 687 
mhp075 CH Putative GTP-Binding Protein 1299 
mhp076 UH Unique Hypothetical 288 
mhp082 tnp Transposase 1656 
mhp089 UH Unique Hypothetical 579 
mhpl55 UH Unique Hypothetical 156 
mhp!63 UH Unique Hypothetical 210 
mhpl85 UH Unique Hypothetical 177 
mhpl92 UH Unique Hypothetical 738 
mhp!93 rpL22 Ribosomal Protein L22 609 
mhp272 CH Hypothetical protein P102 2835 
mhp294 CH GTP Binding Protein Motif 816 
mhp296 UH Unique Hypothetical 456 
mhp298 deoA Pyrimidine-Nucleoside Phosphorylase 1350 
mhp299 nox NADH Oxidase (NOXASE) 1380 
mhp300 CH Conserved Hypothetical 1347 
mhp314 UH Unique Hypothetical 189 
mhp329 CH Conserved Hypothetical 396 
mhp332 UH Unique Hypothetical 993 
mhp336 CH Unique Hypothetical 1470 
mhp463 CH Conserved Hypothetical 603 
mhp521 CH Conserved Hypothetical 1395 
mhp523 CH Conserved Hypothetical 1032 
mhp534 CH Conserved Hypothetical 3645 
mhp536 UH Unique Hypothetical 246 
mhp537 CH Conserved Hypothetical 1164 
mhp573 CH Conserved Hypothetical 453 
mhp580 UH Unique Hypothetical 858 
mhp581 UH Unique Hypothetical 441 
mhp582 UH Unique Hypothetical 210 
mhp586 CH Putative Serine Proteinase 660 
mhp587 pdhD Dihydrolipoamide Dehydrogenase 1458 
mhp591 nagB Glucosamine-6-Phosphate Isomerase 762 
mhp593 rpsD Ribosomal Protein S4 615 
mhp594 CH Conserved Hypothetical 432 
mhp599 dnaE DNA Polymerase 111 Alpha Chain 2 2955 
mhp600 rbfA Ribosomal Binding Factor A 327 
mhp603 nusA N Utilization Substance Protein A 1842 
mhp604 UH Unique Hypothetical 225 
mhp605 CH Alkaline Amylopullulanas 1998 
(Continued) 
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mhp609 trpS Tryptophanyl-tRNA Synthetase 981 
mhp610 CH Conserved Hypothetical 354 
mhpôl 1 CH Hypothetical ATP Binding Protein 3198 
mhp612 UH Unique Hypothetical 753 
mhp614 CH Conserved Hypothetical 300 
mhp617 CH Conserved Hypothetical 1806 
mhp618 CH Conserved Hypothetical 1482 
mhp626 CH Conserved Hypothetical 909 
mhp631 CH Conserved Hypothetical 2082 
mhp638 rplJ 50S Ribosomal Subunit Protein LIO 549 
mhp640 CH Conserved Hypothetical Membrane Lipoprotein 2466 
mhp641 CH Putative Methylase 1647 
mhp642 UH Unique Hypothetical 174 
mhp644 pr2 Conserved Hypothetical 1632 
mhp646 CH Conserved Hypothetical 1587 
mhp647 UH Unique Hypothetical 537 
mhp648 CH Conserved Hypothetical 1608 
mhp649 CH Conserved Hypothetical 1617 
mhp698 UH Unique Hypothetical 273 
mhp699 rpmH 50S Ribosomal Protein L34 141 
* CH = Conserved Hypothetical; UH = Unique Hypothetical 
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